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FOREWORD 
 
 
There has been tremendous work in biomedical text mining over the last decade. The size and 
coverage of the available literature and demands for text mining applications in the domains 
of biology and biomedicine are constantly increasing. These domains have become one of the 
driving application areas for the natural language processing community, resulting in a series 
of workshops and conferences that have reported on the progress in the field. Most of the 
work has focused on solving specific problems, often using task-tailored and private data sets. 
This data is rarely reused, in particular outside the efforts of the providers. This has changed 
during the last years, as a number of projects, initiatives and organisations have been 
dedicated to building and providing biomedical text mining resources (e.g. GENIA, 
PennBioIE, TREC Genomics track, BioCreative, Yapex, LLL05, BOOTStrep, JNLPBA, 
KDD data, Medstract, BioText, etc.). Although several resources have been provided for and 
from the community to support both training and evaluation of text mining applications, there 
have been few efforts to provide community-wide discussions on design, availability and 
interoperability of resources for bio-text mining. 
 
The aim of this Workshop is to focus on building and evaluating resources used to facilitate 
biomedical text mining, including their design, update, delivery, quality assessment, 
evaluation and dissemination. Key resources of interest are lexical and knowledge 
repositories (controlled vocabularies, terminologies, thesauri, ontologies) and annotated 
corpora, including both task-specific resources and repositories reengineered from biomedical 
or general language resources. Of particular interest is the process of building annotated 
resources, including designing guidelines and annotation schemas (aiming at both syntactic 
and semantic interoperability) and relying on language engineering standards. Challenging 
aspects are updates and evolution management of resources, as well as their documentation, 
dissemination and evaluation. 
 
The presented workshop papers cover many important aspects of biomedical resources. 
Several papers discuss features, design principles and experience in building lexical, 
terminological and knowledge resources, and present how these can be used to support 
different tasks, including term-level text annotations and disambiguation of different semantic 
classes (e.g. protein and gene names, chemical names and compounds, etc.). Also, the 
evolution of resources in a changing environment has been discussed, as well as using 
existing open sources (such as Wikipedia and domain semantic resources) to build 
terminologies and relation repositories. Building annotated corpora with different levels of 
terminological and functional mark-up has been of particular interest. Several papers present 
experience in building various biological, chemical and clinical corpora annotated with a 
range of entities and relations, including protein-protein interactions, tissue expressions, 
temporal relations and modalities. Quality of annotations (typically assessed through inter-
annotator agreements) and future challenges (e.g. normalisation of entity mentions or 
mapping of relations) have been also widely discussed, proving that building useful and 
effective resources constitutes a major task in future biomedical text mining research. 
 
The organisers would like to thank the authors for their valuable contributions and to the 
Program Committee members for their efforts in reviewing the submissions within a tight 
time frame. We are also grateful to the LREC 2008 organisers for logistical support and for 
hosting the event, and to the UK National Centre for Text Mining for sponsoring the 
workshop. 
 
Sophia Ananiadou, Monica Monachini, Goran Nenadic, Jian Su 
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A comparison of knowledge resource designs: supporting term-level text 
annotation 
Alicia Tribble, Jin-Dong Kim, Tomoko Ohta, Jun’ichi Tsujii 
Department of Computer Science, University of Tokyo 
Hongo 7-3-1, Bunkyo-ku, Tokyo 113-0033 JAPAN 
{alicia, jdkim, okap, tsujii}@is.s.u-tokyo.ac.jp  
Abstract 
What makes a knowledge resource, like a domain model, thesaurus, or ontology, effective for term-level text annotation in the Biology 
domain?  In this work we compare several approaches to ontology design with examples from well-known resources such as OBO, 
MeSH, and Genia.  Based on these comparisons we establish goals for a knowledge resource that supports term-level text annotation 
and text mining: such a resource should represent terms and relations that are expressed in contiguous spans of text, and its terms 
should bear meaningful correspondences with other knowledge resources.  Finally, we trace how these two goals have affected the 
re-design of the Genia Ontology over several iterations.  The result is a new term hierarchy and a new design process, both specifically 
tailored to term-level text annotation.  This research explores practical influences on the design of knowledge resources for  Bio-NLP 
systems. 
 
 
 
 
1. Introduction 
A growing number of structured knowledge resources in 
the biology domain are providing guidance to researchers 
who perform large-scale data annotations for text mining 
and other language technologies.  Some well-known 
examples include MeSH
1
, Genia
2
, and the ontologies of 
the Open Biomedical Ontologies Foundry
3
(OBO), among 
many others.  
For the purposes of this paper we refer loosely to such 
resources as “ontologies”, although most are not proper 
ontologies in the philosophical sense.  In fact, their 
structural differences reflect differences in their 
functional goals and in their appropriateness for certain 
NLP tasks.  This paper explores those differences with the 
goal of identifying some of the important design 
properties of knowledge resources that support term-level 
annotation and text mining, specifically. 
For example, consider the biological process ontology of 
the OBO Framework.  OBO ontologies are designed “to 
be interoperable and logically well formed and to 
incorporate accurate representations of biological reality” 
(Smith, Ashburner et al. 2007).  Their primary purpose is 
to serve as an accurate and standardized domain model.  
As a result, the biological process ontology divides 
cellular events into fine sub-categories such as 
transcription and its children via the IS-A relation: 
RNA-dependent transcription (reverse transcription) and 
DNA-dependent transcription. 
These events are also represented in another large-scale 
knowledge resource: the Medical  Subject Headings 
(MeSH), developed by the United States National 
Institutes of Health.  MeSH organizes 97,000 terms 
(“entry terms”) into a hierarchy of descriptors, where a 
link from child to parent descriptor denotes the relation 
“narrower-topic-than”.  In MeSH, the topic Transcription 
                                                          
1 http://www.nlm.nih.gov/mesh/meshhome.html 
2 http://www-tsujii.is.s.u-tokyo.ac.jp/GENIA/home/wiki.cgi 
3
 http://www.bioontology.org/repositories.html#obo 
ambiguously covers both the generic sense of the term 
and the specific sense of DNA-dependent transcription.  
Reverse Transcription  is the only child of this term.  
Justification for such an ambiguous structure can be 
derived from the context in which the MeSH hierarchy is 
used: MeSH terms serve to label and retrieve scientific 
papers from the PubMed/Medline database.  Consider a 
user searching for papers related to “transcription”.  
Taking DNA-dependent transcription as the most 
common meaning of this search term, a retrieval system 
has no need to distinguish between the generic and the 
specific.  The MeSH hierarchy conserves this ambiguity, 
which corresponds to the way users search for documents, 
but still allows “reverse transcription” to be distinguished 
if necessary.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The difference between these two structures is shown in 
Figure 1.  This is just one example of how 
well-researched, authoritative  knowledge resources in a 
similar domain can differ in their design choices. 
In this paper we compare three structured resources: 
MeSH, Gene Ontology (GO), and Genia version 1.0, 
showing how the intended use of each resource drives 
distinctions among them.  Our goal is to identify 
properties of knowledge resources that support term-level 
annotation.  Term-level annotation is the process by 
which human annotators classify the semantically 
significant expressions that present themselves in 
contiguous spans of text within a sentence, using the 
GO:0006410 : 
transcription, 
RNA-dependent
GO:0006351 : 
transcription, 
DNA-dependent
GO:0006350 : transcription
is_a is_a
OBO biological process 
Transcription, Genetic
[G05.310.700]
Reverse Transcription
[G05.310.700.500]
is_
subheading
MeSH
Figure 1. Partial hierarchies representing the 
biological event Transcription in OBO and MeSH 
3
terms from a structured knowledge resource as the 
annotation vocabulary.  Entities and events that are 
expressed in passages longer than one sentence are 
outside the scope of term-level annotation.  This type of 
annotated text is crucial for developing NLP tools 
including recognizers for named entities, biological 
events, and semantic relations.  Without these tools, it 
would be difficult to imagine a system that could provide 
answers for a detailed biological query, such as “What are 
all the suppressors of MAP phosphorylation?” (Miyao, 
Ohta et al. 2006). 
We characterize knowledge resources according to the 
granularity of their representational units and the 
interoperability of each resource with other knowledge 
resources in the domain.  Through this process we arrive 
at design goals for resources that support term-level text 
annotation: 
 
Granularity: A structured knowledge resource for 
term-level annotation should represent terms and 
relations that are commonly expressed in contiguous 
spans of text in the target domain.  
 
Interoperability: A structured knowledge resource for 
term-level annotation should represent 
consistently-defined relations among terms that bear 
meaningful correspondences with other authoritative 
knowledge resources in the target domain. 
 
Finally, we explore how the Genia Ontology in particular 
has improved on each of these goals over several design 
iterations (Genia version 1.0, Genia version 2.0, and 
Genia version 2.1).  The Genia Ontology plays an 
important role as the annotation vocabulary for the Genia 
Corpus, a large-scale corpus of scientific abstracts that are 
annotated at the term  level.  Because of this role, its 
structure has been discussed and revised both internally 
and externally (Schulz, Beißwanger et al. 2006).  By 
framing the evolution of the Genia Ontology in terms of 
granularity and interoperability, we can see how 
successive versions have improved in their fitness to 
support high-quality text annotation at the term level, 
which in turn leads to better-performing NLP systems in 
the biology domain.  Such an analysis is useful to 
researchers faced with building or choosing knowledge 
resources for a biomedical NLP system. 
1.2    Related work 
Much work has been done in the domain of engineering 
and integrating formal ontologies in the biology domain.  
Smith, et al. (2004) present principles for formal 
classification and definition using the Gene Ontology as a 
subject of constructive critique.  These principles are 
taken from best-practices in general ontology design and 
include univocity, positivity, and objectivity, among 
others.  Zhang & Bodenreider (2006) present a similar 
examination of the Foundational Model of Anatomy
4
, 
resulting in a different set of 15 design principles that 
cover hierarchical cycles, incompatible relationships, 
implicit relations, and the like. 
                                                          
4
 http://fma.biostr.washington.edu/ 
 
These papers give valuable analysis of knowledge 
resources in terms of their formal consistency as 
stand-alone representational artifacts.  Indeed, there are 
benefits that come from adopting a proper ontology as a 
biological domain model (machine-readability, automatic 
error detection in the model, logical inference, and 
others).  However in the current paper we focus in more 
detail on the relationship between the design of ontologies 
(or ontology-like resources) and the annotation tasks they 
support.  This line of reasoning follows in the tradition of 
(Tsujii and Ananiadou 2005), where the authors compare 
logical ontologies to thesauri in a text mining framework. 
A similar task-oriented approach is used by Witte, 
Kappler et al. (2007), who present some principles for 
formal ontology design with a view to text mining and 
other natural language processing (NLP) tasks.  These 
principles are expressed as component requirements for 
an ontology-driven text understanding system, including 
the following: domain model, text model, biological 
entities, and entity relations.  A fundamental assumption 
of that work is that the semantic vocabulary used for text 
mining should be the same as the vocabulary used to 
perform higher-level reasoning over the results.  Hence, 
their design principles are intended to result in formal 
ontologies that are appropriate for constraining the input 
to an automatic reasoner in the style of RACER (Haarslev 
and Moller, 2001).   
A survey of ontological, terminological, and lexical 
resources for text mining is given in (Bodenreider 2006).  
The profusion of resources described in that work 
indicates the importance of taking a particular task, like 
term-level annotation, into account when choosing or 
building an effective knowledge resource. 
Most of the principles described above govern structural 
properties and ontological soundness.  These principles 
can be further described as contributing to the goal of 
effective ontology integration, and hence to the 
interoperability of the resulting ontologies.  In developing 
our own principles, we are interested in both 
interoperability and granularity. 
Granularity plays an important role in characterizing 
ontologies as NLP resources, particularly in the domain of 
biomedical text.  The reason is that authors of scientific 
papers often use underspecified language to describe their 
results.  They depend on the reader’s contextual and 
background knowledge to interpret the precise meaning 
of words and expressions.  Research in term-level 
annotation has shown that for consistency, annotated 
terms and relations must have concise evidence in text 
(Kim, Ohta et al. 2007).  Hence,  an ontology that supports 
such annotation, and as a result empirical NLP systems 
(for text mining, named-entity and event recognition, etc.) 
should reflect the granularity of language used in the 
target domain. 
 
2. A comparison of ontologies based on 
intended use 
Defining an appropriate level of interoperability and 
granularity for a knowledge resource depends on the 
target use of that resource.  In this section we compare 
three existing biomedical ontologies according to their 
intended use: realistic domain modeling; classification, 
either of textual documents or of laboratory data (results 
4
databases); or annotating text at the term level.  As a 
result, we can derive specific definitions that can be used 
in the context of each of these tasks. 
2.1    Domain models: the Gene Ontology 
The Gene Ontology, or GO (Consortium 2000) is a 
member of the Open Biomedical Ontologies Framework.  
It includes three sub-ontologies: cellular component, 
molecular function, and biological process, which was 
introduced earlier.  Its purpose has evolved over time, and 
it currently serves as a domain model that represents 
terms and events grounded in biological truth. 
As such, it is successfully used as a controlled vocabulary 
to label biology databases, so that experimental results 
from diverse laboratories can be automatically compared 
(Camon, Magrane et al. 2004).  This annotation process 
relies on expert background knowledge as well as 
evidence in a broad sense, which comes from multiple 
documents in text, database, or other forms.  GO 
annotations are described in detail on the GO website
5
.  A 
sample GO annotation is given in Table 1. 
The online GO FAQ
6
  describes the annotation principles 
used in this process, as well as listing some target uses of 
the annotated data: 
 
…first, every annotation must be attributed to a 
source, which may be a literature reference, another 
database or a computational analysis; second, the 
annotation must indicate what kind of evidence is 
                                                          
5
 http://www.geneontology.org/GO.annotation.shtml 
6
 http://wiki.geneontology.org/index.php/GO_FAQ 
found in the cited source to support the association 
between the gene product and the GO term. 
 
…applications for which GO has already been used 
include the following: 
 integrating proteomic information from 
different organisms;  
 assigning functions to protein domains; 
 verifying models of genetic, metabolic and 
product interaction networks. 
 
Based on this description, the observation can be made 
that GO annotation is performed roughly on the document 
level (where a document may be a summary of a 
laboratory result in a database).  It allows the annotator to 
synthesize all of the evidence  given by a single source.  
This has implications for the granularity of the ontology: 
terms are specific enough to support domain modeling on 
a fine scale, and they may represent entities or events that 
are only implicitly present in any single span of text. 
That is, for a given document, the annotated ontology 
terms may not be explicitly represented by contiguous 
spans of text, but rather spread over the entire document.  
This feature of GO terms could help explain the results of 
(McCray, Browne et al. 2002), who searched 
automatically for GO term names in Medline text but 
found fewer matches than they expected.  
GO annotations have also been used as part of the training 
and test data in the BioCreAtIvE Challenges.  An 
investigation of the 2005 challenge results with respect to 
the task of aiding human annotation is given in (Camon, et 
al. 2005).  An interesting result of that work was the 
comment by annotators that automatic protein labeling 
systems trained on GO data were less helpful than they 
Covalent binding between N-acetyl-L-cysteine (NAC) and albumin was evaluated kinetically by conducting in 
vitro experiments. 
Genia 
Annotation 
Covalent  <term sem=”binding”> binding </term>  between  
<term sem=”Amino_acid_monomer”> N-acetyl-L-cysteine (NAC) </term> and  
<term sem=”Protein_molecule”> albumin </term> was evaluated kinetically by conducting in vitro 
experiments. 
GO 
Annotation 
GO ID: 0008144; Alb; CHEBI:28939; PMID:12458670; IPI 
Table 1.  Sample Annotations.  The sentence shown is an excerpt from PubMed document PMID:12458670.  Genia 
annotation is shown in-line in XML format.  GO annotation is shown as a database entry that can be paraphrased as 
drug binding, GO term 0008144,  occurs between Alb and the chemical with CHEBI ID:28939, based on experimental 
evidence type IPI described in the paper with PubMed ID 12458670. 
Genia Leaf Term Appearance in contiguous spans of text MeSH descendants 
Cells_cultured  “untransfected cell” “wild type cell line”  
“various cell line” 
Cell line; 3T3 cells; Swiss 3T3 
cells 
Amino_acid_monomer “acidic residue” “new amino acid” “CYS” 
“Nacetylcysteine” 
Aminobutyric acids; 
gamma-Aminobutyric acids; 
Vigabatrin 
Inorganic_compound “physiological oxidant” “radical”  
“messenger molecule” 
Alkalies; Carbonates; Lithium 
Carbonate 
Table 2.  Leaf terms from the Genia ontology often correspond to subtrees in MeSH.  Examples of Genia terms in 
text, along with specializations that can be found under the corresponding term in MeSH. 
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could be as pre-processors because the systems returned 
long passages of text as evidence for candidate 
annotations.  Human annotators preferred concise 
evidence, at most 5 lines in length,  when judging whether 
to keep or modify an automatically-generated annotation.  
This result speaks to the role of fine-grained textual 
annotations, such as the term-level annotations we 
describe in this paper, in providing evidence and 
explanations of document-level classification results.  
This GO usage scenario and the annotation principles also 
have an effect on the ontology’s interoperability.  Because 
they are intended to be shared across laboratories, GO 
terms are fairly precise and discriminative (although they 
do not list necessary and sufficient conditions for 
identifying terms).   
The ontology conforms to OBO recommendations, and is 
distributed in multiple formats: OWL and OBO, among 
others.  Relations between ontology concepts come from 
the OBO relations hierarchy (is-a, part-of), resulting in 
relatively clear & consistent relation definitions 
throughout GO (with some exceptions noted by (Smith, 
Köhler et al. 2004)).  All of these features contribute to 
ease of understanding for researchers from diverse 
backgrounds who want to use GO to annotate their own 
experimental results.  
2.2    Document classification hierarchies: MeSH 
The MeSH term hierarchy was introduced in Section 1.  
Nelson and co-authors describe the goal of the hierarchy 
as follows: 
 
…to provide a reproducible partition of concepts 
relevant to biomedicine for purposes of organization 
of medical knowledge and information. (Nelson, 
Johnston et al. 2001) 
 
In practice, MeSH terms are used to organize knowledge 
through the process of annotating scientific papers from 
the PubMed/MEDLINE
7
 database.  As documents are 
annotated with relevant concepts from the hierarchy, the 
documents themselves can be sorted, collected, 
organized, and retrieved more effectively. 
Like GO annotations, MeSH annotations are made at the 
document level.  However there are important differences.  
In GO, the referents of ontology terms are real-world 
biological entities; scientific papers are used as 
supporting evidence for applying a term to an instance of 
an entity in an experiment.  Scientific knowledge of the 
entity increases as a result.   
In MeSH, labels are applied directly to documents, and it 
is knowledge of the document that increases: i.e. what 
topic classes are dealt with in the document, what are the 
appropriate sub-headings, etc. 
These differences have a crucial effect on the granularity 
of concepts that are appropriate for inclusion in MeSH.   
This topic is also addressed by Nelson, et al. (2001), who 
give the following example: 
 
…MeSH contains a descriptor for 'Whales' but the 
domain of MeSH is biomedicine and not zoology. In 
the MEDLINE citation database, there are not 
sufficient citations to create a separate descriptor for 
                                                          
7
 http://www.nlm.nih.gov/pubs/factsheets/medline.html 
each specific whale species. Nevertheless, it is useful 
to have the species names as entry terms to the 
descriptor. Gains in precision of retrieval by creating 
more specific descriptors would be small. 
 
Again, we see that the granularity of  ontology terms (or in 
this case, terms from a hierarchical thesaurus) is derived 
from the intended use of the ontology.  In MeSH this 
principle is applied in support of document retrieval by 
representing terms that “become important in 
conceptually partitioning the literature” (Nelson, 
Johnston et al. 2001). 
The class and relation definitions in MeSH are more 
context-sensitive, and hence less interoperable, than in 
GO.  However MeSH does support interoperability 
through detailed mappings between MeSH concepts and 
concept identifiers from comparable resources.  For 
example, many major headings for chemicals in MeSH 
are mapped the corresponding structural name assigned 
by the Chemical Abstracts Service (CAS)
8
 , a registry of 
over 33 million organic and inorganic substances. 
Leaf-level mappings are an appropriate way of 
implementing interoperability for certain kinds of 
knowledge resources.   
Because the MeSH hierarchy represents topical relations 
among its classes instead of biological relations, it would 
be difficult to map entire subtrees or graphs from MeSH 
onto a domain model like GO.  In spite of this, identifying 
synonymous terms can certainly help users who are 
familiar with one ontology to understand the other more 
easily. 
2.3    Structured vocabularies: Genia version 1.0 
So far we have discussed the role of granularity and 
interoperability in domain models and in document 
classification hierarchies, using GO and MeSH as 
examples.  These principles work in concert with the 
target use of the ontology to drive concrete design 
choices.  In this section we turn to the Genia ontology, 
version 1.0
9
, a knowledge resource that was designed 
specifically for text annotation at the term level. 
Although “ontology” is part of its name, the Genia 
ontology version 1.0 is better described as a controlled 
vocabulary with a single-inheritance hierarchical 
structure. It includes 47 representational units that refer to 
biological continuants (non-event entities).  Occurrents 
(events) are outside the scope of version1.0. 
The design of the Genia ontology, version 1.0 is a direct 
response to the demands of term-level annotation in the 
Genia Corpus.  Annotations are made as in-line XML 
markup to scientific abstracts that have been sampled 
from MEDLINE.  An example is shown in Table 1.  The 
latest release of the corpus includes 18,545 annotated 
sentences. 
In designing the ontology, biologists familiar with the 
documents in the corpus selected a vocabulary of 
biological entities and roles that appear often enough in 
text to be consistently annotated.  Next, a hierarchical 
ordering was imposed that places more general terms at 
the top of the hierarchy.  Although the terms refer to 
                                                          
8
 http://www.cas.org/expertise/cascontent/registry/ 
9
http://www-tsujii.is.s.u-tokyo.ac.jp/~genia/topics/Corpus/geni
a-ontology.html 
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biological entities, the hierarchy treats these terms more 
like topics, where a parent-child link indicates a 
“specialization-of” relation.  Siblings in the hierarchy 
stand in a “topically-related” relation to one another.  This 
allows annotators to find terms like Protein_molecule and 
Protein_family_or_group grouped under the common 
parent Protein.  In a domain model, 
Protein_family_or_group might be moved to a branch 
representing sets.  In the case of Genia, the “set” concept 
itself is outside the scope of annotation and hence left out 
of the hierarchy.  As a result sets like 
Protein_family_or_group are placed near other terms to 
which they are topically related. 
The Genia ontology, version 1.0 has a maximum depth of 
6, more shallow than MeSH (depth 11)  and GO (depth >= 
7).  This reflects the intent of the hierarchy to include only 
terms of a granularity that is pertinent to term-level 
annotation.  Granularity is bounded at the most general by 
biological Substance and biological Source, dividing 
biological entities that can be described in terms of their 
chemical properties specific by terms that meet the 
standard for term-level annotation: these terms are 
commonly expressed in, and can easily be used to 
annotate, contiguous sub-sentential spans of text.  
Fine-grained distinctions that require additional context – 
a full document, as in MeSH, or full documents coupled 
with detailed background knowledge, as in GO -  are 
considered beyond the scope of term-level annotation and 
as a result do not appear in the hierarchy.   
This is a feature maintained in recent updates to the Genia 
ontology.  Some examples from the Genia term ontology, 
version 2.0 are given in Table 2. 
This table shows Genia leaf terms that correspond to 
internal nodes in the MeSH  hierarchy.  Typical examples 
of these terms appearing in contiguous spans of text are 
given in column 2.  Column 3 shows how these classes are 
further refined in MeSH.  Some strings bear the names of 
chemicals, but in many cases there is not enough evidence 
for sub-classification without additional context. 
This structure imposes a low cost on annotators, whose 
goal is to quickly find the right term in the hierarchy for a 
textual expression that merits labeling.  In addition, 
annotation principles that were developed to ensure high 
inter-annotator agreement have been translated into 
features of the ontology: terms that resulted in poor 
agreement were dropped from the vocabulary, and 
expressions that occurred often in text but fell outside the 
scope of the term hierarchy spawned additional terms.  An 
example of a Genia term-level annotation is shown in 
Table 1. 
3. Definitions of granularity and 
interoperability 
The three resources described above demonstrate a 
pattern that links the granularity of concepts in a 
knowledge resource to the level on which annotation or 
retrieval is performed.  Distinctions among biological 
entities can be made at finer levels of detail, given more 
contextual evidence. 
Consider annotating the sentence: “I(kappa)B(beta) is 
constitutively phosphorylated.”  Using the Genia 
term-annotation style,  two entities can been annotated: a 
Protein_molecule (“I(kappa)B(beta)”) and the process 
Phosphorylation (“phosphorylated”).  As an alternative,  
by relaxing the requirement that annotations be assigned 
to contiguous spans of text, we could use the full sentence 
to determine a label  The result is that a finer-grained 
subclass of Phosphorylation can be identified: I-kappaB 
phosphorylation.  This subclass of phosphorylation is 
present in the Gene Ontology, where annotations are 
made at the document level.  
This observation is supported by the granularity of terms 
we find in the Genia ontology, and can be expressed as a 
design goal for resources that support term-level 
annotation: 
 
 Granularity: A structured knowledge resource for 
term-level annotation should represent terms and 
relations that are commonly expressed in contiguous 
spans of text in the target domain.  
  
Interoperability seems to be linked to annotation level 
more indirectly than granularity.  In domain models like 
GO, interoperability is achieved by using individual term 
and relation definitions that are specific enough to be 
directly imported and exchanged among ontologies.  In 
MeSH, sharing definitions and relations directly would 
impose class distinctions that conflict with the goal of 
appropriate granularity for document retrieval.  The 
Transcription example given in Section 1.1 demonstrates 
how this can occur.  Leaf-level mapping of some MeSH 
terms contributes to interoperability while allowing 
granularity to be the primary design goal.    
In the Genia ontology, version 1.0 interoperability was 
not yet a design goal.  However researchers both inside 
and outside the project have recognized the potential of 
clarifying the definitions of Genia terms and organizing 
them in a more consistent structure (Schulz, Beißwanger 
et al. 2006).  This would increase interoperability and as a 
result annotations could become more accessible both to 
researchers and to downstream inference systems.    
A working definition of interoperability at a level that 
supports term-level annotation should represent a 
commitment to making results interpretable, without 
imposing structural requirements that compete with the 
goal of granularity as it was just expressed.  One such 
definition is the following:   
 
Interoperability: A structured knowledge resource for 
term-level annotation should represent 
consistently-defined relations among terms that bear 
meaningful correspondences with other authoritative 
knowledge resources in the target domain. 
4. Using design goals to drive ontology 
improvements 
Genia, GO, and MeSH are all updated regularly in 
response to issues that arise during annotation.  The first 
major redesign of the Genia ontology occurred when 
event annotation was added to the mission of the Genia 
project.  A second revision effort is currently underway.  
4.1    Genia 1.0 to Genia 2.0 
In the first major revision of the ontology, designers have 
removed the Substance/Source distinction from the 
hierarchy, refined the class definitions, and added a new 
section of the ontology to cover biological occurrents.  
The Genia ontology, version 2.0 is a single-inheritance 
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hierarchy represented in OWL-DL.  It is included in a 
Genia corpus release that can be downloaded from the 
project homepage .   
The first change, removing Source and Substance, results 
in a hierarchy where the criteria that distinguish one 
branch from another are less opaque.  The hierarchy 
rooted at Substance originally referred to entities that 
could be classified according to chemical structure.  In 
updated versions this sub-tree tree is headed by the more 
revealing term Chemical, but it maintains the same depth 
and sub-classes as the Substance hierarchy.  The 
granularity of terms  in this branch is unaffected although 
interoperability improves, since the new naming 
conventions more closely match those used in other 
ontologies. 
The term Source has been replaced with two subtrees, 
Anatomy and Organism.   This allows the vacuous 
distinction between Natural_source and Artifical_source, 
which never appeared in textual annotations, to be 
replaced with natural/cultured distinctions on the frontier 
of the hierarchy, where they do appear in text.  Some 
examples are given in Table 4.   This change improves the 
granularity of the affected classes. 
Many of the class definitions in version 1.0 of the Genia 
ontology were inductive, providing example members 
and depending on the reader to infer a definition.  The 
revised class definitions are heavily borrowed from 
definitions of MeSH terms.  The change to declarative 
definitions makes the criteria for membership in Genia 
classes more clear.  In addition, domain experts carefully 
performed a mapping from Genia classes to MeSH terms 
during this process.  The small size of the Genia ontology 
(46 classes) makes this a task appropriate for human 
annotators, rather than machine learning tools.  As a 
result, meaningful correspondences between Genia and 
MeSH were identified, increasing interoperability of the 
Genia ontology. 
4.2    Genia 2.0 to Genia 2.1 
The designers of Genia have continued to refine the 
ontology since releasing version 2.0 in (Kim, Ohta et al. 
2007).  Current changes being considered include 
redefining the parent-child relation among classes and 
moving terms that refer to textual features or roles into a 
separate hierarchy. 
Section 2.3 describes the parent-child relationship in 
Genia version 1.0 as “specialization-of”, and this relation 
holds in version 2.0, as well.  This arrangement is most 
clearly seen in the subclasses of Protein.  In text, the same 
protein name can be used to refer to entities of very 
different types: sets of proteins (Genia class 
Protein_family_or_group), parts of proteins (Genia 
classes Protein_substructure and  
Protein_domain_or_region), and subclasses of proteins 
(Genia classes Protein_molecule and Protein_complex).  
Table 3 presents some examples. 
Although they do not represent entities that stand in a 
biological is-a relation, placing these terms under Protein 
in the Genia ontology, version 2.0 reflects the fact that, 
when none of these specializations applies, annotators 
should use the more general parent class to annotate a 
protein name in text.  
In the Genia term ontology, version 2.1, subclasses like 
Protein_family_or_group have been removed to a 
separate hierarchy of Expression_features.  The new 
relation has_text_feature is defined between a Genia term 
and an expression feature.  Using this relation, we can still 
create an annotation for a protein name that is used in text 
to refer to a family or group, but the connection between 
the protein and the family is clearly indicated as a product 
of textual usage, rather than biological inheritance.  This 
also applies to the subclasses of DNA and RNA from 
version 2.0 of the ontology.  The updated ontology is 
shown in Figure 2.     
Annotation now occurs at the same level of granularity as 
before, using this combination of Genia term and 
expression feature.  With Protein_family_or_group and 
its siblings removed, the remaining classes in the  Genia 
term ontology, version 2.1 refer to biological entities that 
stand in the traditional is-a relation to each other.  This 
structural consistency improves interoperability, 
according to our definition. 
The new structure also gives us a fresh perspective on 
how expression features interact with the biological 
entities.  We can observe that expression features are 
currently applied to instances of DNA, RNA, and Protein.  
Genia version 2.0 Term Example sentence 
Protein_molecule “We have detected a specific nuclear protein complex that binds to the element 
and show that NF-kappa B1 (p50) is a part of this complex.” 
“In contrast, NF-kappa B p50 alone fails to stimulate kappa B-directed 
transcription, and based on prior in vitro studies, is not directly regulated by I 
kappa B.” 
Protein_complex “Analysis of the nuclear extracts with antibodies directed against the major 
components of NF-kappa B the p50 and RelA (p65) proteins, indicated that the 
composition of NF-kappa B was similar in neonatal and adult cells.”  
“This was due to the presence of active NF-kappa B complexes in the nucleus of 
CD45- T cells.” 
Protein_domain_or_region “Does nucleolin bind the NF kappa B DNA binding motif?” 
Protein_family_or_group “Besides p50, 1,25(OH)2D3 decreased the levels of another NF-kappa B 
protein, namely c-rel.” 
“Fibrinogen activates NF-kappa B transcription factors in mononuclear 
phagocytes.” 
Table 3. Example annotations using subclasses of Protein from Genia 1.0/2.0.  Annotated strings are shown in bold. 
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The structure of the ontology suggests that there may be a 
more elegant compositional solution: allow all instances 
of Organic_compound to be modified by expression 
features.   In addition, the expression features themselves 
could be regrouped or subclassed to improve consistency.  
This type of compositional analysis, in the tradition of 
(Ogren, 2005), is the subject of our ongoing work on 
refining the Genia ontology.  
5. Conclusion 
The design strategies used in the most recent revisions of 
the Genia ontology are aimed at improving its 
interoperability while maintaining a level of granularity 
that supports term-level annotation of biological entities.  
A comparison of  MeSH, GO, and Genia revealed that 
these features can be used to characterize and compare 
structured knowledge resources, and that design choices 
can be motivated directly by the intended use of the 
resource. All three of these resources are the object of 
ongoing development and research.  Future releases of the 
Genia ontology will continue to bear these lessons in 
mind. 
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Abstract
We report on two large corpora of semantically annotated full-text biomedical research papers created in order to develop information
extraction (IE) tools for the TXM project. Both corpora have been annotated with a range of entities (CellLine, Complex, Developmental-
Stage, Disease, DrugCompound, ExperimentalMethod, Fragment, Fusion, GOMOP, Gene, Modification, mRNAcDNA, Mutant, Protein,
Tissue), normalisations of selected entities to the NCBI Taxonomy, RefSeq, EntrezGene, ChEBI and MeSH and enriched relations
(protein-protein interactions, tissue expressions and fragment- or mutant-protein relations). While one corpus targets protein-protein
interactions (PPIs), the focus of other is on tissue expressions (TEs). This paper describes the selected markables and the annotation
process of the ITI TXM corpora, and provides a detailed breakdown of the inter-annotator agreement (IAA).
1 Introduction
This paper describes two corpora constructed and annotated
for the TXM project. The aim of the TXM project was to
develop tools for assisting in the curation of biomedical re-
search papers. The ITI TXM corpora were used to train and
test machine learning based NLP components which were
interfaced with a curation tool.
There already exist several corpora of annotated biomedi-
cal texts (Section 2), all with individual design and annota-
tion characteristics. The ITI TXM corpora combine a num-
ber of attractive characteristics of such available corpora,
thus making them a valuable resource for NLP research.
We annotated full-text papers since our intended target ap-
plication (the curation tool) worked with such documents.
Furthermore, it has been shown in previous research that
there is valuable information in full-text articles that cannot
be obtained from their abstracts alone (e.g. by Shah et al.,
2003 and McIntosh & Curran, 2007). The markables used
in the ITI TXM corpora included not only a range of named
entities and relations, but also extensive, multi-species nor-
malisation of proteins, genes and other entities, to standard
publicly available databases.1 Furthermore, some of the re-
lations were enriched with additional biomedical informa-
tion enabling finer-grained classification, and connecting
the relations with other entities in the text. At around 200
full-text papers each, the corpora are relatively large in size.
In addition, we will release multiple annotations of many of
the papers, enabling the comparison of different annotators’
views of the corpus. The set of markables chosen for both
corpora arose out of extensive discussions between biolo-
gists managing the curation, and NLP researchers creating
the NLP components. The biologists were consulted to de-
termine what information they wanted to be extracted. At
the same time, their ideas had to be balanced against what
was possible using the state-of-the-art in NLP technology,
and what could be reliably annotated. The final set of mark-
ables resulted out of several iterations of piloting and mea-
surements of IAA.
This paper is organised as follows: after discussing related
1Normalisation refers to the task of grounding a biomedical
term in text to a specific identifier in a referent database. See
Table 3 for the publicly available databases used.
work on biomedical corpus design and annotation in the
next section, a description of how the documents were se-
lected for the corpora is provided in Section 3. An overview
of both corpora, a description of the markables, the annota-
tion process and details of the IAA are presented in full in
Section 4. Finally Section 5 offers some conclusions and
lessons learnt from the annotation project.
2 Related Work
In recent years, there have been numerous efforts in con-
structing and annotating biomedical corpora. Comprehen-
sive lists of publicly available corpora are maintained by
Cohen et al.2 as well as Hakenberg3. This related work
section does not provide an all-inclusive list of biomedical
corpora but rather presents different characteristics of cor-
pus design and annotation illustrated by typical examples.
Existing resources vary in size, type of data, markables and
levels of annotation, the way the annotation is applied, their
distributed formats and their domains. The GENIA cor-
pus (Ohta et al., 2002), for example, is one of the largest
and most widely used data sets in the text mining commu-
nity. It consists of 2,000 Medline abstracts and is manually
annotated with a series of semantic classes defined in the
GENIA ontology. Other corpora are made up of sets of
sentences from biomedical research articles, as is the case
for BioInfer (Pyysalo et al., 2007) and GENETAG (Tanabe
et al., 2005). The latter is a collection of 20,000 Medline
sentences annotated for gene and protein names in one se-
mantic class. Parts of this corpus were used in the BioCre-
AtIvE I and II competitions that, amongst other tasks, en-
abled different text mining research groups to evaluate how
well their systems perform at extracting gene/protein names
from biomedical literature.
Although there have been a series of corpus construction ef-
forts for the purpose of biomedical text mining, only a small
number of groups (e.g. Wilbur et al., 2006 and Krallinger
et al., 2006) report IAA figures. In other words, it is rare
to find information about how consistent two independent
2http://compbio.uchsc.edu/ccp/corpora/
obtaining.shtml
3http://www2.informatik.hu-berlin.de/
˜hakenber/links/benchmarks.html
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annotators are when marking up a representative sample of
a data set. The assumption is that the level of IAA pro-
vides insights into how challenging a particular task is to a
human expert, providing an upper bound for an automated
system is and how appropriate the task in itself is. Lu et
al. (2006) show an increase in IAA over time as annota-
tors become more familiar with their task of marking up
GeneRIFs with 31 semantic classes in the protein transport
domain. Figures of IAA also help to determine weaknesses
in the annotation guidelines. Mani et al. (2005) measured
IAA based on a first set of annotation guidelines for mark-
ing up protein names.4 After analysing the annotation dif-
ferences, they revised their guidelines which resulted in an
improvement of IAA in a second annotation round and si-
multaneously in better annotation quality overall. Alex et
al. (2006) have shown that consistency in the annotation
of named entity boundaries is crucial to obtain high accu-
racy for biomedical named entity recognition. The need
for both clear annotation guidelines to achieve such consis-
tency and comprehensive annotation guidelines to capture
complex information in unstructured text data is often high-
lighted (e.g. see Wilbur et al., 2006 and Piao et al., 2007).
Making such guidelines available to the research commu-
nity and publishing figures of IAA is recommended by Co-
hen et al. (2005) who analysed the characteristics of differ-
ent biomedical corpora. They also conclude that distribut-
ing data in standard formats (e.g. XML) is vital to guarantee
high corpus usage.
As mentioned earlier, publicly available corpora differ in
the type of textual data, i.e. a corpus can be made up of
sentences, abstracts or full-text papers. McIntosh & Cur-
ran (2007) and Shah et al. (2003) indicate a clear need
for biological IE from full-text articles. The former study
shows that only a small proportion of identified fact in-
stances appears in abstracts. The latter found that although
abstracts contain the best ratio of keywords, other sections
of articles are a better source of biologically relevant data.
As a result, they advocate IE systems that are tuned to spe-
cific sections. As much of the important information is
not present in the abstract but the main paper, Cohen et
al. (2005) suggest that abstracts and isolated sentences are
inadequate and unsuited to the opportunities that are avail-
able for text mining. Sometimes, the most relevant infor-
mation in a paper is found in figure captions (Shatkay and
Feldman, 2003). Currently, only few available resources
contain full-text publications, one example of such a cor-
pus being FetchProt (2005). Its annotation includes specific
experiments and results, the proteins involved in the exper-
iments and related information. Exploiting such full-text
resources is vital to develop text mining systems that will
be used in practice, e.g. by biologists, clinicians or curators.
Publicly available biomedical corpora also often differ in
their markables and levels of annotation. Some are an-
notated with part-of-speech tags (e.g. GENIA) and named
entities, most often gene/protein names (e.g. GENETAG)
that are sometimes normalised to identifiers (e.g. Fetch-
Prot). In other cases, the annotation includes binary rela-
tions between entities such as PPIs (e.g. AImed described
in Bunescu et al., 2005) or non-binary relations (e.g. BioIn-
fer). Several corpora are distributed with syntactic annota-
tion such as phrase-based or dependency-based structures,
4Mani et al. (2005) refer to IAA as inter-coder reliability.
e.g. BioIE (Kulick et al., 2004), GENIA treebank (2005),
LLL (Nedellec, 2005) and BioInfer.
In this paper, we introduce two large biomedical corpora in
the sub-domains of PPIs and TEs which will be distributed
in one collection as the ITI TXM corpora. Both corpora are
made up of full-text papers that are annotated with a series
of relevant named entities, some of which are normalised.
Furthermore, the annotations include various types of rela-
tions as well as relation attributes and properties (see Sec-
tion 4.2). Domain experts used extensive curation guide-
lines that were devised based on several rounds of piloting
(see Section 4.3). We provide figures of IAA for all types
of semantic annotation for a representative corpus sample
(see Section 4.4). Moreover, the data is distributed in XML
with semantic annotations in standoff format (Carletta et
al., 2005). In the future, the ITI TXM corpora will serve as a
valuable resource to train IE methods for mining facts from
biomedical literature.
3 Document Selection
Document selection for the PPI corpus was performed in
two stages. The initial plan was to annotate only full-text
articles available in XML. Therefore, 12,704 full-text XML
files were downloaded from PubMedCentral OpenAccess.5
The documents were filtered by selecting those articles that
contained at least 1 of 13 terms either directly associated
with PPIs or with biological concepts representative of typ-
ical curation tasks.6 The abstracts and, if necessary, full
texts of the remaining 7,720 documents were all examined
by trained biologists and selected if they contained inter-
actions that were experimentally proven within the paper,
resulting in a total of 213 documents.7 In order to ensure
that enough documents were available for annotation, the
same queries were performed against PubMed and addi-
tional documents were selected from the resulting list using
the same criteria.8 Several of the documents were excluded
from the final set because they were used during the pilot-
ing or were rejected by the annotators as not being suitable
for annotation. The resulting corpus consists of 217 doc-
uments, 133 selected from PubMedCentral and 84 docu-
ments selected from the whole of PubMed.
Document selection for the TE corpus was performed
against PubMed. This was partially to ensure that enough
documents were selected, and partially to address the con-
cern that in practice, many important documents would not
be available in XML and the annotations would be more
representative if they accounted for this reality. The ini-
tial pool of documents was selected from PubMed using
terms designed to capture documents representative of typ-
ical TE and PPI curation tasks.9 The abstracts of the re-
sulting 12,060 documents were randomised and examined
5http://www.pubmedcentral.nih.gov/
The 12,704 articles represented the complete set of available doc-
uments on 17/08/2005.
6The terms were: bind, complex, interact, apoptosis, ubiqui-
tination, mitosis, nuclear envelope, cell cycle, phosphorylation,
glycosylation, signal transduction and nuclear receptors.
7Clinical articles on drug or patient trials were excluded.
8http://www.ncbi.nlm.nih.gov/PubMed/
9The queries were: “Gene Expression Regulation”[MeSH],
Development, “Signal Transduction”[MeSH], “Protein Biosyn-
thesis”[MeSH], “Cell Differentiation”[MeSH], Apoptosis, Mito-
sis, Cell cycle and Phosphorylation
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PPI TE
Annotations TRAIN DEVTEST TEST All TRAIN DEVTEST TEST All
1 65 25 35 125 82 34 34 150
2 48 9 8 65 68 7 11 86
3 20 5 2 27 1 0 1 2
Total documents 133 39 45 217 151 41 46 238
Total annotations 221 58 57 336 221 48 59 328
Table 1: Counts of numbers of papers with 1, 2 or 3 annotations in each section of each corpus.
in order by a biologist and selected if they contained men-
tions of the presence or absence of mRNA or protein in any
organism or tissue. A total of 4,327 documents were exam-
ined of which 1,600 were selected for TE annotation. The
TE corpus is comprised of the first 238 of these documents
that were not used during piloting and not rejected by the
annotators.
In both phases, documents were split into TRAIN, DE-
VTEST, and TEST sets in a ratio of approximately 64:16:20
(see Table 1). TRAIN was to be used for training machine
learning models and deriving rules, DEVTEST for testing
during system development, and TEST for testing the final
system. The document selection methods were dictated,
in part, by the requirements of the industrial partner that
assisted in the annotation of the corpora. The terms used
were based on the queries used for selecting documents for
creating commercially viable curated databases. Further-
more, the results of document selection were used to create
training and testing corpora for a document retrieval system
designed to improve the document selection phase. These
corpora will be released at a future date.
4 Corpus Annotation
4.1 Overview
Documents were selected for annotation as described in
Section 3. The full-text papers were downloaded from
PubMed or PubMedCentral either as XML, or as HTML if
the XML version was not available, and then converted to
an in-house XML format using LT-XML2 tools.10 The LT-
XML2 and LT-TTT2 tools were also used to tokenise and in-
sert sentence boundaries into the text (Grover et al., 2006).
From each corpus a random selection of documents was
chosen for double or triple annotation in order to allow cal-
culation of IAA, which is used to track annotation quality
and to provide a measure of the difficulty of the task. The
counts of singly and multiply annotated documents in the
TRAIN, TEST and DEVTEST sections for both corpora are
shown in Table 1. Multiply annotated documents were left
in the corpus and not reconciled to produce a single, gold
standard version. It was found during piloting that recon-
ciliation could be very time-consuming so we decided to
focus our resources on obtaining a larger sample of papers.
During the annotation of the full-text papers, we did not
annotate sections that did not contain any relevant infor-
mation, e.g. contact details and reference sections, HTML
navigational text. Moreover, materials and methods sec-
tions were not annotated on the grounds that they would
be too time-consuming to annotate. The annotators marked
unannotated paragraphs during the annotation so that these
sections could be excluded from training and testing. Based
on the sentence splitting and tokenisation performed during
10http://www.ltg.ed.ac.uk/software/xml/
Entity type PPI TE
CellLine 7,676 —
Complex 7,668 4,033
DevelopmentalStage — 1,754
Disease — 2,432
DrugCompound 11,886 16,131
ExperimentalMethod 15,311 9,803
Fragment 13,412 4,466
Fusion 4,344 1,459
GOMOP — 4,647
Gene — 12,059
Modification 6,706 —
mRNAcDNA — 8,446
Mutant 4,829 1,607
Protein 88,607 60,782
Tissue — 36,029
Table 2: Entity types and counts in each corpus. A long
dash indicates that the entity was not marked in that corpus.
the pre-processing, the PPI corpus contains approximately
74.6K sentences and 2.0M tokens, and the TE corpus is
made up of around 62.8K sentences and 1.9M tokens.11
4.2 Description of Markables
In both corpora the markables, i.e. units of annotation, con-
sist of named entities, normalisations, relations, properties
and attributes.
Named entities are terms of interest to biologists which be-
long to pre-defined semantic classes. Table 2 shows the
named entity types marked and their counts in each corpus.
In the PPI corpus, the entities are either proteins and other
related entities involved in PPI relations (Protein, Complex,
Fusion, Fragment and Mutant) or attributes of PPI relations
(CellLine, DrugCompound, ExperimentalMethod, Modifi-
cation). Conversely, for the TE corpus, the entities are either
those that can be involved in TE relations (Tissue, Protein,
Complex, Fusion, Fragment, Mutant, Gene, mRNAcDNA
and GOMOP) or those that can be attributes of TE rela-
tions (DevelopmentalStage, Disease, DrugCompound, Ex-
perimentalMethod). All named entity types (except GO-
MOP) have intuitively obvious biological interpretations,
which are made precise in the annotation guidelines. For
example, the definition of DrugCompound is: “a chemical
substance of known composition used to affect the func-
tion of an organism, cell or biological process”. The GO-
MOP entity type was used in cases where the annotator felt
that the author was referring to a “Gene or mRNAcDNA or
Protein”. We felt that having a single entity type to repre-
sent this kind of ambiguity would be simpler than allowing
annotators to mark the same term as multiple entity types
(e.g. Protein and Gene).
11Note that all annotated versions of each paper are treated as
separate documents in this calculation.
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Database Url Prefix PPI TE
NCBI Taxonomy http://www.ncbi.nlm.nih.gov/Taxonomy/ ncbitaxon: Protein Gene, mRNAcDNA, Protein, GOMOP
RefSeq http://www.ncbi.nlm.nih.gov/RefSeq/ refseq: Protein Protein, mRNAcDNA
EntrezGene http://www.ncbi.nlm.nih.gov/entrez/ gene: Protein Gene, mRNAcDNA, Protein, GOMOP
ChEBI http://www.ebi.ac.uk/chebi/ chebi: — DrugCompound
MeSH http://www.nlm.nih.gov/mesh/ mesh: — Tissue
Table 3: Databases used for normalisations and the entities to which they are assigned in each corpus. A long dash indicates
that the database was not used in that corpus.
Corpus Relation type Count
PPI PPI 11,523
PPI FRAG 16,002
TE TE 12,426
TE CHILD-PARENT 4,735
Table 4: Relation types in each corpus.
When marking named entities, the annotators were permit-
ted to nest them, but entities were not allowed to cross. For
any pair of entities with a non-empty intersection, the inter-
section therefore had to coincide with at least one of the en-
tities. Entities were also required to be continuous. Discon-
tinuous coordinations such as “A and B cells” were anno-
tated as two nesting entities “A and B cells” and “B cells”,
indicating that the first was discontinuous using a flag in
the XML. Furthermore, annotators were able to override the
tokenisation if entity boundaries and token boundaries did
not coincide, by indicating the entity boundaries using char-
acter offsets. For example, in one annotated document, the
term “Cdt1(193-447)” is tokenised as a single token, but the
annotator decided that “Cdt1” was a Protein and “193-447”
was a Fragment. The Protein was therefore marked using
an end offset of -9, to indicate that the end of the Protein
name was 9 characters from the end of the token, and in a
similar way the Fragment had start offset 5 and end offset
-1. The XML representation of the data enables retokeni-
sation as proposed by Grover et al. (2006) to improve the
original tokenisation at a later stage while preserving the
entity annotation.
A number of types of entities were normalised to one
or more of the standard, publicly available biomedical
databases listed in Table 3. In general, for each entity term
that was normalised, an ID of the appropriate database was
assigned as the normalisation value with a prefix indicating
the source database. If no appropriate identifier existed, the
ID was left blank and only the database prefix was used as
the normalised value.
Normalisation of protein, gene and mRNAcDNA entities
was more complex. Two types of normalisations were
added to each occurrence of such entities: full normalisa-
tion and species normalisation, where the former involves
assigning RefSeq identifiers to protein and mRNAcDNA
terms and EntrezGene identifiers to gene terms; and the lat-
ter involves assigning NCBI taxonomy identifiers to pro-
tein, gene and mRNAcDNA terms. The project initially
aimed at providing full normalisation for both corpora.12
However, full normalisation turned out to be too time-
consuming. Given limited time and resources, only the
12In fact, both RefSeq and EntrezGene identifiers are species-
specific. When a term is “fully normalised” its host species can
therefore be identified without species normalisation.
TE corpus and the DEVTEST and TEST portions of the PPI
corpus were fully normalised, while the TRAIN portion of
the PPI corpus was only species-normalised. A few special
cases must be considered in the normalisation annotation:
• Species mismatch. For the term to be normalised,
there is an entry in the database (e.g. RefSeq) which
matches the specific entity but the entry does not
match the species of the term given the surrounding
context. In this case the term was only normalised for
its species (i.e. species normalisation).
• Several host species. The term to be normalised is dis-
cussed relative to several host species. In this case, the
term was normalised multiple times and each anno-
tated entity was assigned a unique identifier for each
species mentioned. In case of more than five possible
host species for the term, annotators followed the next
instruction.
• Host species not clear. The host species of a term to
be normalised cannot be determined from the text, be-
cause it is discussed in a general way rather than in
relation to one or more specific species, or the text
is unclear about the host species of the term. In this
case, the entity was normalised as if its species was
Homo sapiens, and the keyword “gen” (for “general”)
was added to any chosen identifier, e.g. “NP 004513
(gen)”, and at the same time the Taxonomy iden-
tifier for Homo sapiens together with the keyword
“gen” (e.g., “9606 (gen)”) were entered as the species-
normalisation. However, if Homo sapiens could not
possibly be the correct host species, due to the occur-
rence of a general species word, such as viral or bac-
terial, “gen” was entered for species normalisation.
In each corpus, two types of relations were marked (see
Table 4). In the PPI corpus, relations refer to interactions
between two proteins (PPI) and connect Mutants and Frag-
ments with their parent proteins (FRAG). In the TE corpus,
relations indicate when a gene or gene product is expressed
in a particular tissue (TE); relations also connect Mutants
and Fragments with their parent proteins (CHILD-PARENT).
Annotators were permitted to mark relations between enti-
ties in the same sentence (intra-sentential) and in different
sentences (inter-sentential). For the TE and PPI relations,
annotators also marked “link terms” used by the authors to
indicate a relation. Marked in the same way as entities,
these are called InteractionWord for PPI relations and Ex-
pressionLevelWord for TE relations.
The properties and attributes are extra pieces of informa-
tion added by the annotators to both PPI and TE relations.
A property is a name-value pair assigned to a relation to add
extra information, for example whether a PPI is mentioned
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Name Value PPI TE
IsPositive Positive 10,718 10,243
Negative 836 2,067
IsDirect Direct 7,599 —
NotDirect 3,977 —
IsProven Proven 7,562 9,694
Referenced 2,894 1,837
Unspecified 1,096 736
Table 5: Property names, values and counts in each corpus.
A long dash indicates that the property was not marked in
this corpus.
as being direct or indirect, or whether it was experimentally
proven in the paper. Both positive and negative TE and PPI
relations, i.e. statements asserting that an interaction or ex-
pression did or did not occur, were also marked, with prop-
erties used to distinguish between them. The names and
values for the properties were drawn from a small closed
list and annotators assigned at least one value to each name,
for each relation. Their counts in each corpus are listed in
Table 5.
Attributes are named links between relations and other enti-
ties, e.g. to indicate the experimental method used to verify
a PPI relation, or the cell line used to discover a TE relation.
In the PPI corpus, all attributes, except for MethodEntity,
are attached to entities. Conversely, all attributes are at-
tached to relations in the TE corpus. Attributes are also
used to link a relation to its link term and do not have to be
in the same sentence as the relation. The names and counts
of the attributes are listed in Tables 6 and 7.
Note that as well as being able to add multiple values for
each relation property, annotators were also permitted to
add multiple values for each attribute. They did this by
marking extra relation entries. For example, in a sentence
such as “Protein A interacts with B in the presence of Drug
C but not D.”, the annotators would mark two PPI relations
between “A” and “B”, one Positive with “C” as a Drug-
Compound attribute, and the other negative with “D” as a
DrugCompound attribute.
4.3 The Annotation Process
Annotation was performed by a group of nine biologists,
all qualified to PhD level in biology, working under the su-
pervision of an annotation manager (also a biologist) and
collaborating with a team of NLP researchers. At the be-
ginning of the annotation of each corpus, a series of discus-
sions between the biologists and the NLP team were held
with the aim of determining a set of markables. Since the
overall aim of the project was to build NLP tools for inte-
gration into a curation assistant, the markables suggested
by the biologists were those which they wished the cura-
tion assistant to aid them with. The NLP team provided in-
put as to which markables might be technically feasible and
what could be reasonably accomplished within the project
timescale.
A further consideration in selecting markables was how
well they could be annotated in practice. Markables which
could not be reliably annotated by humans would not pro-
duce good data, and as a result would be even more diffi-
cult for automated systems to extract. Using the initial list
of markables, several rounds of piloting were conducted to
determine the markables that could be annotated reliably.
For example, four piloting iterations were conducted be-
fore commencing the annotation of the PPI corpus. As a
result, it was decided to remove MutationType from the list
of originally proposed entity types as this information did
not occur frequently enough in the piloting documents. The
piloting process also helped to produce comprehensive an-
notation guidelines on all markables. During the piloting
phase, the same documents were annotated by two or three
annotators, IAA was computed for these documents, and
annotation differences were analysed. The annotators dis-
cussed points of difficulty and disagreement with the NLP
team and the annotation guidelines were clarified and ex-
tended wherever necessary.
At the end of the piloting phase a final set of markables
was agreed by all parties and the main body of annotation
commenced. During this phase weekly annotation meet-
ings were held to discuss the latest IAA measurements and
any other issues arising from the annotation, with all the an-
notators in attendance plus a representative from the NLP
team. IAA was measured using a sample of documents ran-
domly selected in advance for multiple annotation. The an-
notation was organised so that annotators were not aware
when they were assigned a document that was being an-
notated by someone else as well. When new annotators
joined the team they went through a training phase where
they annotated several documents, comparing their annota-
tions with those created by the existing team. This was done
to ensure that they were following the guidelines correctly
and were consistent with the other annotators.
For the annotation of the PPI corpus, an in-house annota-
tion tool was developed using FilemakerPro, with data be-
ing stored in a relational database before being exported to
XML for analysis by the NLP team. However, as this an-
notation tool did not scale well, a customised version of
Callisto13 was employed for the TE annotation project. Be-
fore the documents were presented to the annotators, they
were tokenised and had sentence boundaries inserted by
means of pre-processing steps implemented using the LT-
XML2 and LT-TTT2 tools. The original spacing in the docu-
ments was preserved so that it could be recovered from the
XML version simply by stripping off the word, sentence and
paragraph elements.
All annotated documents were converted to an in-house
XML format, for consumption by NLP applications. In the
XML, all annotations are placed in standoff, with the nor-
malisations included in the named entity annotation, and
the properties and attributes included in the relation anno-
tation. Listings 1, 2 and 3 show a sample of text, with its
standoff entity and relation annotation. The standoff entity
annotation uses word ids to refer to the start and end words
of the entity, and the standoff relation annotation uses entity
ids to refer to its entity pair. Note that the standoff markup
for a document and its text are contained within the same
file. An XML schema and format documentation will be
provided with the corpus release.
<s><w id=”A33864”>Rrs1p</w>
<w id=”A33870”>has</w> <w id=”A33874”>a</w>
<w id=”A33876”>two</w><w id=”A33879”>−</w>
<w id=”A33880”>hyb r i d</w>
<w id=”A33887”> i n t e r a c t i o n</w>
<w id=”A33899”>wi th</w> <w id=”A33904”>L5</w>
<w id=”A33906”> .</w></ s>
Listing 1: Extract from the text of an annotated document
(note the original does not contain the line breaks)
13http://callisto.mitre.org/
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Name Entity type Explanation Count
ModificationBeforeEntity Modification Any modification applied before the interaction. 240
ModificationAfterEntity Modification Any modification resulting from the interaction. 1,198
DrugTreatmentEntity DrugCompound Any drug treatment applied to the interactors. 844
CellLineEntity CellLine The cell-line from which the interactor was drawn. 2,000
ExperimentalMethodEntity ExperimentalMethod The method used to detect the interactor. 1,197
MethodEntity ExperimentalMethod The method used to detect the interaction. 2,085
InteractionWordEntity InteractionWord The term which indicates the interaction. 11,386
Table 6: Attributes in the PPI corpus.
Name Entity type Explanation Count
te rel ent-drug-compound DrugCompound Any drug compound applied. 1,549
te rel ent-exp-method1 ExperimentalMethod The method used to detect the expression participants. 1,878
te rel ent-disease DiseaseType Any disease affecting the tissue. 332
te rel ent-dev-stage DevelopmentalStage The developmental stage of the tissue. 327
te rel ent-expr-word ExpressionLevelWord A term indicating the level of expression. 2,815
Table 7: Attributes in the TE corpus.
<e n t i d =” e933262 ” norm=”NP 014937 ” t ype=” P r o t e i n ”
s p e c i e s =” 4932 ” sw=”A33864” ew=”A33864”>Rrs1p</ e n t>
<e n t i d =” e933263 ” norm=” ” t ype =” Exper imen ta lMe thod ”
sw=”A33876” ew=”A33880”>two−hyb r i d</ e n t>
<e n t i d =” e933264 ” norm=” ” t ype =” I n t e r a c t i o nWo r d ”
sw=”A33887” ew=”A33887”> i n t e r a c t i o n</ e n t>
<e n t i d =” e933265 ” norm=”NP 015194 ” con f=” 100 ”
t ype=” P r o t e i n ” s p e c i e s =” 4932 ” sw=”A33904”
ew=”A33904”>L5</ e n t>
Listing 2: Example of standoff annotation of entities
<r e l a t i o n t ype =” pp i ” i d =” r903106 ” I sP r ov en =” Proven ”
I s D i r e c t =” D i r e c t ” I s P o s i t i v e =” P o s i t i v e ”>
<argument r e f =” e933262 ”></ a rgument>
<argument r e f =” e933265 ”></ a rgument>
<a t t r i b u t e name=”Me thodEn t i t y ” r e f =” e933263 ” />
<a t t r i b u t e name=” I n t e r a c t i o nWo r dE n t i t y ”
r e f =” e933264 ” />
</ r e l a t i o n>
Listing 3: Example of standoff annotation of relations
4.4 Inter-annotator Agreement
We IAA for each corpus and each markable using the mul-
tiply annotated documents. For each pair of annotations on
the same document, IAA was calculated by scoring one an-
notator against another using precision, recall and F1. For
the PPI corpus, IAA was calculated on a total of 146 doc-
ument pairs. IAA for TE corpus, having fewer triple anno-
tations, was computed over a total of 92 document pairs.
An overall corpus IAA was calculated by micro-averaging
across all annotated document pairs.14 Micro-averaging
was chosen over macro-averaging, since we felt that the lat-
ter would give undue weight to documents with few or no
markables. We used F1 rather than Kappa (Cohen, 1960)
to measure IAA since the latter requires comparison with
a random baseline, which would not make sense for tasks
such as named entity recognition and normalisation.
For named entities, IAA was calculated using precision, re-
call and F1, defining two entities as equal if they had the
same left and right boundaries, and the same type. The IAA
14Micro-averaging means giving equal weight to each example,
as opposed to macro-averaging which would give equal weight to
each annotated document pair.
Type PPI TE
CellLine 81.6 (2,456) —
Complex 76.4 (2,243) 82.6 (886)
DevelopmentalStage — 72.7 (357)
Disease — 74.3 (435)
DrugCompound 76.4 (3,705) 84.9 (4,453)
ExperimentalMethod 74.0 (4,673) 76.7 (2,013)
Fragment 75.3 (3,985) 77.7 (1,179)
Fusion 78.5 (1,270) 73.9 (359)
GOMOP — 50.2 (655)
Gene — 77.7 (1,911)
Modification 87.6 (1,900) —
mRNAcDNA — 78.1 (1,768)
Mutant 60.4 (1,008) 63.9 (310)
Protein 91.6 (32,799) 90.3 (16,329)
Tissue — 84.1 (8,210)
All 84.9 (54,039) 83.8 (38,865)
Table 8: IAA for entities (in F1) in each corpus. The total
number of true positives is shown in brackets.
figures for named entities listed in Table 8 show that an-
notation consistency is generally high, with important and
frequently occurring entities scoring in the 80s or 90s. IAA
is low for entity types which occur infrequently such as
Mutant. It is particularly low for GOMOP, not only an
infrequent entity but also an artificially constructed class
designed to include cases of annotator uncertainty. The
overall IAA is lower than that normally reported for MUC
type entities, but fits with our observations that biomedical
named entity annotation is more difficult.
The IAA for normalisations was only calculated when both
annotators agreed on the entities. This means that the nor-
malisation IAA only reflects agreement on normalisation
annotation and is not affected by the level of agreement
on the entity annotation. In addition, all entities marked
as general were excluded from the IAA calculations (see
Table 9). For Protein and mRNAcDNA types, only those
entities that were normalised to RefSeq identifiers were
included in the IAA calculations while for Gene and GO-
MOP entities, only those entities normalised to EntrezGene
identifiers were included. The IAA was measured using F1
where two normalisations were considered equal if both an-
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Type PPI TE
DrugCompound — 97.7 (215)
GOMOP — 77.3 (214)
Gene — 95.1 (1,463)
mRNAcDNA — 88.0 (892)
Protein 88.4 (7,595) 90.0 (5,979)
Tissue — 82.9 (6,776)
All 88.4 (7,595) 83.8 (15,785)
Table 9: IAA for normalisation (in F1) in each corpus. The
total number of true positives is shown in brackets.
Type PPI TE
PPI 67.0 (2,729) —
TE — 70.1 (2,078)
FRAG 84.6 (3,661) 84.0 (1,012)
All 76.1 (6,390) 74.1 (3,090)
Table 10: The IAA for relations (in F1) in each corpus. The
total number of true positives is shown in brackets. Note
that FRAG relations are referred to as CHILD-PARENT in
the TE corpus.
notators selected the same ID.
When calculating IAA for relations, only those relations for
which both annotators agreed on the entities were included.
Relation IAA was also measured using F1, where relations
are counted as equal if they connect exactly the same en-
tity pair, and have the same type. The IAA for relations
shown in Table 10 is overall lower than that for entities and
normalisations, suggesting that this is a more difficult task.
Since relations can span across clauses and even across sen-
tences, the annotators need to perform a deeper analysis of
the text than for entity annotations.
For properties, IAA was calculated for each name-value
pair, again using precision, recall and F1. In cases where
the annotators had entered multiple relations of the same
type between the same entities, these sets of equivalent re-
lations were collapsed for the purpose of property and at-
tribute IAA calculation. The collapsed relation was given
the union of all the properties and attributes assigned to the
relations in the set. This collapsing is an approximation of
the annotator’s intentions, but the number of occurrences
of multiple equivalent relations is small so the collapsing
should not have a significant effect on the IAA. The IAA
for properties shown in Table 11 is generally very high, ex-
cept for the IsProven-Unspecified category which was used
infrequently by the annotators and suffers from being an
“other” category.
For attributes, IAA was again measured using precision, re-
call and F1. Two attributes were considered equivalent if
they had the same type and connected the same relation
and entity. Tables 12 and 13 show the IAA figures for at-
tributes. These are quite low in some cases, and so are the
total numbers of attributes assigned. Investigation of the
IAA suggests that annotators often disagreed about whether
to assign an attribute or not, but if they both assigned an
attribute then they generally chose the same one. The en-
tities used as attributes sometimes appeared at a distance
from the relation in the text. Therefore, it is not surprising
that annotators sometimes missed them, or assigned them
inconsistently.
Name Value PPI TE
IsPositive Positive 99.6 (2,553) 97.2 (1,807)
Negative 90.1 (155) 88.9 (280)
IsDirect Direct 86.8 (1,746) —
NotDirect 61.4 (449) —
IsProven Proven 87.8 (1,543) 92.8 (1,547)
Referenced 88.6 (626) 75.3 (204)
Unspecified 34.4 (448) 29.3 (38)
All 87.2 (7.165) 91.2 (3,779)
Table 11: IAA for properties (in F1) in each corpus. The
total number of true positives is shown in brackets.
Name IAA
ModificationBeforeEntity 65.3 (31)
ModificationAfterEntity 86.7 (248)
DrugTreatmentEntity 45.4 (61)
CellLineEntity 64.0 (244)
ExperimentalMethodEntity 36.9 (94)
MethodEntity 55.4 (274)
All 59.6 (952)
Table 12: IAA of attributes (in F1) in the PPI corpus. The
total number of true positives is shown in brackets.
Name IAA
te rel ent-drug-compound 77.9 (229)
te rel ent-exp-method1 81.3 (261)
te rel ent-disease 64.0 (16)
te rel ent-dev-stage 57.8 (13)
All 77.2 (521)
Table 13: IAA of attributes (in F1) in the TE corpus. The
total number of true positives is shown in brackets.
5 Discussion and Conclusions
In terms of the amount of text annotated, the ITI TXM cor-
pora are the result of one of the largest biomedical corpus
annotation projects attempted to date. The two domains
covered (protein-protein interactions and tissue expression)
are both of crucial importance to biologists. Although there
are several corpora already available with annotations of
PPI, most of these only include protein annotation, and do
not include the range of entities and normalisations avail-
able in the ITI TXM corpora. There are few available an-
notated corpora addressing tissue expression, and we are
unaware of any large-scale efforts whose main focus is that
domain.
Another interesting aspect of the ITI TXM corpora is the
annotation of normalisations for multiple types of entity
mentions, and for multiple species. This annotation was
motivated by the role of the NLP system, as an assistant to
curators, as it was suspected that mapping proteins, genes
and other terms to standard databases occupied a signifi-
cant proportion of curators’ time. The annotation of multi-
species normalisations was difficult in situations where it
was unclear which species was being referred to for a given
named entity mention. These issues were resolved by de-
riving a series of annotation guidelines, as detailed in Sec-
tion 4.2. The annotation guidelines were also reasonably
successful in ensuring annotator consistency, as evidenced
by the normalisation IAA provided in Section 4.4.
During the annotation we found that the interaction be-
tween the NLP team and the biologists was essential at all
17
stages. In the design phase, the biologists, as the domain
experts, provided insight into what information should be
annotated. At the same time, the NLP team were able to ex-
plain to the biologists what their technology is capable of.
However, although both parties have an insight into what
can be reliably annotated, the only sure way to determine
this is empirically through extensive piloting. The piloting
phase not only provided experimental data on annotation
agreement and timing, but also helped the NLP team and
the biologists to improve their shared understanding of the
annotation process and its difficulties. During the main an-
notation phase, it was helpful to have regular contact be-
tween the NLP and the annotation teams in order to ensure
that doubts and difficulties were noted, discussed and re-
solved as quickly as possible. The NLP team analysed the
data as it was produced by the annotators and drew their
attention to any recurring sources of disagreement.
We believe that measuring IAA is a crucial part of any cor-
pus annotation effort. It provides a check that the annotators
are producing a reliable and consistent corpus. It also gives
a measure of how difficult the task is and suggests how well
an automated system can be expected to perform. We took
steps to ensure that the IAA itself was reliable, by instruct-
ing annotators not to discuss papers whilst annotating them.
We also did not inform annotators in advance whether they
were working on a paper that was also being annotated by
another person. The IAA measurements for the final set
of markables shows that some proved difficult to annotate
reliably, for example the GOMOP entity and some of the
attributes. Annotating them was problematic in the piloting
phase, and whilst we attempted to tighten up the guidelines,
it was not sufficient to boost their IAA.
We hope that the two ITI TXM corpora, consisting of over
200 papers each, and with multiple types of semantic an-
notation, will provide a useful resource for the biomedical
text-mining community when released to the academic re-
search community later this year.
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Abstract 
A significant amount of important information in Electronic Health Records (EHRs) is often found only in the unstructured part of 
patient narratives, making it difficult to process and utilize for tasks such as evidence-based health care or clinical research.  In this 
paper we describe the work carried out in the CLEF project for the semantic annotation of a corpus to assist in the development and 
evaluation of an Information Extraction (IE) system as part of a larger framework for the capture, integration and presentation of 
clinical information. The CLEF corpus consists of both structured records and free text documents from the Royal Marsden Hospital 
pertaining to deceased cancer patients. The free text documents are of three types: clinical narratives, radiology reports and 
histopathology reports. A subset of the corpus has been selected for semantic annotation and two annotation schemes have been 
created and used to annotate: (i) a set of clinical entities and the relations between them, and (ii) a set of annotations for time 
expressions and their temporal relations with the clinical entities in the text. The paper describes the make-up of the annotated 
corpus, the semantic annotation schemes used to annotate it, details of the annotation process and of inter-annotator agreement 
studies, and how the annotated corpus is being used for developing supervised machine learning models for IE tasks. 
 
1. Introduction 
Although large parts of the patient electronic health care 
record exist as structured data, a significant proportion 
exists as unstructured free texts. This is not just the case 
for legacy records. Much of pathology and imaging 
reporting is recorded as free text, and a major component 
of any UK medical record consists of letters written from 
the secondary to the primary care physician (GP). These 
documents contain information of value for day-to-day 
patient care and of potential use in research. For 
example, narratives record why drugs were given, why 
they were stopped, the results of physical examination, 
and problems that were considered important when 
discussing patient care, but not important when coding 
the record for audit. Clinical researchers could be 
assisted in hypothesis formation (for subsequent 
verification in clinical trials) if they could get answers 
aggregated across all NHS patient records to questions 
such as:  
How many patients with stage 2 adenocarcinoma 
who were treated with tamoxifen were symptom-free 
after 5 years? 
Doctors could also benefit for treating individual patients 
if they could get concise summaries of patients' clinical 
histories or if they had access to histories of similar 
patients elsewhere.  
CLEF (Rector et al. 2003) uses IE technology to make 
information available for integration with the structured 
record, and thus to make it available for clinical care and 
research (Harkema et al. 2005). Although some IE 
research has focused on unsupervised methods of 
developing systems, as in the earlier work of Riloff 
(1996), most practical IE still needs data that has been 
manually annotated with events, entities and 
relationships. This data serves three purposes. Firstly, an 
analysis of human annotated data focuses and clarifies 
requirements. Secondly, it provides a gold standard 
against which to assess results. Thirdly, it provides data 
for system development: extraction rules may be created 
either automatically or by hand, and statistical models of 
the text may be built by machine learning algorithms. 
This paper reports on the construction of a gold standard 
corpus for the CLEF project, in which clinical 
documents are annotated both with multiple entities and 
their relationships. To the best of our knowledge, no one 
has explored the problem of producing a corpus 
annotated for clinical IE to the depth and to the extent 
reported here. Our annotation exercise uses a large 
corpus, covers multiple text types, and involves over 20 
annotators. We examine two issues of pertinence to the 
annotation of clinical documents: the use of domain 
knowledge; and the applicability of annotation to 
different sub-genres of text. Results are encouraging, and 
suggest that a rich corpus to support IE in the medical 
domain can be created. An earlier description of the 
CLEF corpus was reported in (Roberts et al. 2007). The 
current paper provides more details, including details of 
the temporal annotation (not reported at all earlier), 
figures on the distribution of entity and relation types 
across the corpus, and inter annotator agreement scores 
for the completed corpus. 
The next section of this paper summarises the literature 
about annotated biomedical corpora. The following 
section describes the design of the CLEF corpus, 
describing the selection of documents for gold standard 
semantic annotation and the entities and relationships 
with which the gold standard is annotated. Next the 
annotation methodology is described, including a 
discussion of the development of annotation guidelines 
and an assessment of the consistency of human 
annotations. The following sections present inter 
annotator agreement scores for the finished corpus, and 
figures on the distribution of entity and relation types by 
document type across the corpus. Finally we mention on- 
going use of the corpus for training and evaluation of our 
supervised machine learning IE system. 
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2. Annotated Corpora for Biomedical 
Research 
Semantically annotated corpora are becoming 
increasingly common within biomedical information 
extraction research, with annotation levels gradually 
expanding over the years. For example, the GENIA 
corpus of Medline abstracts has been annotated with 
information about biological entities (Kim et al. 2003) 
with annotations about biological events added to (part 
of) it at a later stage (Kim et al. 2008). Other 
semantically annotated corpora developed for the 
purpose of providing training and evaluation material for 
IE systems include: 
• The PennBioIE corpus of ~2300 Medline abstracts, 
in the domains of molecular genetics of oncology 
and inhibition of enzymes of the CYP450 class 
annotated for biomedical entity types and 
parts-of-speech, some of which have also been 
annotated for Penn Treebank style syntactic 
structure (Mandel, 2006); 
• The Yapex corpus of 200 Medline abstracts 
annotated for protein names (Franzén et al. 2002); 
• Those developed within the BioText project for 
disease-treatment relation classification (Rosario 
and Hearst, 2004) and protein-protein interaction 
classification (Rosario and Hearst, 2005).   
In addition corpora have been available in order to 
provide data sets for research competitions such as: 
• Biocreative (the GENETAG corpus containing 
15,000 sentences with gene/protein names annotated 
– Tanabe et al 2005)  
• the TREC Genomics Track, which ran from 
2003-2007 and for which a variety of datasets and 
tasks were developed (http://ir.ohsu.edu/genomics/). 
• the LLL05 challenge task, which supplied training 
and test data for the task of identifying protein/gene 
interactions in sentences from Medline abstracts 
(Nédellec, 2005). 
All of the above corpora consist of texts drawn from the 
research literature, in most cases from the biology 
research literature. This is due at least in part to the 
difficulty of getting access to clinical text for research 
purposes. To our knowledge the only other work in the 
area of corpus annotation for clinical information 
retrieval and extraction is: 
• The corpus prepared and released for the 
Computational Medicine Challenge (Pestian et al 
2007).  This corpus consists of 1954 (978 training, 
976 test) radiology reports annotated with 
ICD-9-CM codes, the challenge being the text 
classification challenge of automatically coding the 
unseen test data.  
• The ImageCLEFmed 2005 and 2006 image test 
collections which consist of ~50,000 images with 
associated textual annotations (case descriptions, 
imaging reports) and in some cases metadata (e.g. 
DICOM labels), together with query topics and 
relevance judgements (Hersh et al 2006; Müller et 
all 2007). While intended to support medical image 
retrieval research, the textual component of this 
resource could have purely language processing 
applications.  
• Ogren et al.’s (2006) work on annotating disorders 
within clinic notes; and 
• The I2B2 challenges, which have so far provided 
training and evaluation data for de-identification of 
discharge summaries and for the identification of 
smoking status from discharge summaries 
(challenge 1);  and for identification of obesity and 
co-morbidities from discharge summaries annotated 
at the document level  (https://www.i2b2.org/NLP/). 
What differentiates CLEF from the annotation exercises 
mentioned above is that (1) it is the only corpus 
annotated with information about clinical entities and 
their relations as well as with temporal information about 
the clinical entities and time expressions occurred in 
patient narratives and (2) it is the only corpus to contain 
clinic notes, radiology reports and histopathology reports 
together with associated structured data.  
3. Design of the CLEF Corpus 
Our development corpus comes from CLEF’s main 
clinical partner, the Royal Marsden Hospital, a large 
specialist oncology centre. The entire corpus consists of 
both the structured records and free text documents from 
20234 deceased patients. The free text documents consist 
of three types: clinical narratives (with sub-types as 
shown in Table 1); histopathology reports; and imaging 
reports. Patient confidentiality is ensured through a 
variety of technical and organisational measures, 
including automatic pseudonymisation and manual 
inspection. Approval to use this corpus for research 
purposes within CLEF was sought and obtained from the 
Thames Valley Multi-centre Research Ethics Committee 
(MREC).  
3.1 Gold Standard Document Sampling 
Given the expense of human annotation, the gold 
standard portion of the corpus has to be a relatively small 
subset of the whole corpus of 565000 documents. In 
order to avoid events that are either rare or outside of the 
main project requirements, it is restricted by diagnosis, 
and only considers documents from those patients with a 
primary diagnosis code in one of the top level 
sub-categories of ICD-10 Chapter II (neoplasms). In 
addition, it only contains those sub-categories that cover 
more than 5% of narratives and reports. The gold 
standard corpus consists of two portions, selected for 
slightly different purposes. 
3.1.1 Whole patient records 
Two applications in CLEF involve aggregating data 
across a single patient record. The CLEF chronicle 
builds a chronological model for a patient, integrating 
events from both the structured and unstructured record 
(Rogers et al 2006). CLEF report generation creates 
aggregated and natural language reports from the 
chronicle (Hallet et al 2006). These two applications 
require whole patient records for development and 
testing. Two whole patient records were selected for this 
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portion of the corpus, from two of the major diagnostic 
categories, to give median numbers of documents, and a 
mix of document types and lengths. Each record consists 
of nine narratives, one radiology report and seven 
histopathology reports, plus associated structured data. 
3.1.2 Stratified random sample 
The major portion of the gold standard serves as 
development and evaluation material for IE. In order to 
ensure even training and fair evaluation across the entire 
corpus, the sampling of this portion is randomised and 
stratified, so that it reflects the population distribution 
along various axes. Table 1 shows the proportions of 
clinical narratives along two of these axes. The random 
sample consists of 50 each of clinical narratives, 
histopathology reports, and imaging reports. 
Narrative 
subtype 
% of 
standard 
 Neoplasm  % of 
standard 
To GP 49  Digestive 26 
Discharge  17  Breast 23 
Case note 15  Haematopoetic  18 
Other letter 7  Respiratory etc 12 
To consultant 6  Female genital 12 
To referrer 4  Male genital 8 
To patient 3    
Table 1: % of narratives in random sample 
3.2 Annotation Schema: Clinical Information 
The CLEF gold standard is a semantically annotated 
corpus. We are interested in extracting the main semantic 
entities from text. By entity, we mean some real-world 
concept referred to in the text such as the drugs that are 
mentioned, the tests that were carried out etc. We are 
also interested in extracting the relationships between 
entities: the condition indicated by a drug, the result of 
an investigation etc.  
Annotation is anchored in the text. Annotators mark 
spans of text with a type: drug, locus and so on. 
Annotators may also mark words that modify spans 
(such as negation), and mark relationships as links 
between spans. Two or more spans may refer to the same 
thing in the real world, in which case they co-refer. 
Co-referring CLEF entities are linked by the annotators.  
 
 Figure 1: CLEF annotation schema. Rectangles: entities; ovals: 
modifiers; solid lines: relationships. 
The types of annotation are described in a schema, 
shown in Figure 1.  The CLEF entities and relations are 
also listed in Tables 2 and 3, along with descriptions and 
examples. 
The schema has been based on a set of requirements 
developed between clinicians and computational 
linguists in CLEF. The schema types are mapped to 
types in the UMLS semantic network, which enables us 
to utilize UMLS vocabularies in entity recognition. For 
the purposes of annotation, the schema is modeled as a 
Protégé-Frames ontology (Gennari et al. 2003). 
Annotation is carried out using an adapted version of the 
Knowtator plugin for Protégé (Ogren 2006). This was 
chosen for its handling of relationships, after evaluating 
several such tools.  
3.3 Annotation Schema: Temporal Information 
Information from structured data and clinical narratives 
is integrated to build a patient chronicle, i.e. a coherent 
overview of the significant events in the patients' 
medical history, such as their condition, diagnosis and 
treatment over the period of care. This process involves 
extracting temporal information about events from the 
narratives, and using this and other information to map 
the events extracted from the narratives onto their 
corresponding, time-stamped, events in the structured 
data wherever possible. The aim of the gold standard is 
to provide the temporal links (called CTlinks for CLEF 
Temporal link) between TLCs (Temporally Located 
CLEF entities, which comprise CLEF investigations, 
interventions and conditions) and temporal expressions. 
Temporal expressions include dates and times (both 
absolute and relative), as well as durations, as specified 
in the TimeML (2004) TIMEX3 standard. CTlinks types 
include, for example, before, after, overlap, includes (for 
a full list see Table 9). Our scheme requires annotation 
of only those temporal relations holding between TLCs 
and the date of the letter (Task A), and between TLCs 
and temporal expressions appearing in the same sentence 
(Task B). These tasks are similar to, but not identical 
with, those addressed by the TempEval challenge within 
SemEval 2007 (Verhagen et al. 2007).  
4. Annotation Methodology 
The annotation methodology follows established natural 
language processing standards (Boisen et al. 2000). 
Annotators work to agreed guidelines; documents are 
annotated by at least two annotators; documents are only 
used where agreement passes a threshold; differences are 
resolved by a third experienced annotator. These points 
are discussed further below.  
Negation 
Sub-location Laterality 
has finding 
has finding 
has indication 
has location 
has target has target 
has indication 
Drug Result 
Investigation 
Condition 
Intervention 
Locus 
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Table 2: CLEF Entities 
 
 
Relation type  1st arg type  2nd arg type  Description  Example  
has_target  Investigation, Intervention  Locus  
Relates an intervention or an investigation 
to the bodily locus at which it is targetted.  
This patient has had a [arg2 lymph node]  
[arg1 biopsy] 
… he does need a [arg2 groin] 
 [arg1 dissection] 
has_finding  Investigation  Condition, Result  
Relates a condition to an investigation that 
demonstrated its presence, or a result to 
the investigation that produced that result.  
This patient has had a lymph node [arg1 
biopsy] which shows [arg2 melanoma] 
Although his [arg1 PET] scan is 
 [arg2 normal] 
has_indication  
Drug or 
device, 
Intervention, 
Investigation  
Condition  
Relates a condition to a drug, intervention, 
or investigation that is targetted at that 
condition  
Her facial [arg2 pain] was initially relieved 
by [arg1 co-codamol] 
has_location  Condition  Locus  
Relationship between a condition and a 
locus: describes the bodily location of a 
specific condition. May also describe the 
location of malignant disease in lymph 
nodes, relating an involvement to a locus.  
… a biopsy which shows [arg1 melanoma] 
in his right [arg2 groin] 
It is clearly secondaries from the [arg1 
melanoma] on his right [arg2 second toe] 
Her[arg2  facial] [arg1 pain] was initially 
relieved by co-codamol  
Modifies  Negation signal  Condition  
Relates a condition to its negation or 
uncertainty about it  
There was [arg1 no evidence] of extra 
pelvic [arg2 secondaries] 
Modifies  Laterality signal  
Locus, 
Intervention  
Relates a bodily locus or intervention to 
its sidedness: right, left, bilateral.  
… on his [arg1 right] [arg2 second toe] 
[arg1 right] [arg2 thoracotomy]  
Modifies  Sub-location signal  Locus  
Relates a bodily locus to other 
information about the location: upper, 
lower, extra, etc.  
[arg1 extra] [arg2 pelvic] 
  
 
Table 3: CLEF Relations 
Entity type  Description  Example  
Condition  Symptom, diagnosis, complication, conditions, problems, functions and processes, injury  
This patient has had a lymph node biopsy which shows 
melanoma in his right groin. It is clearly secondaries from 
the melanoma on his right second toe. 
Intervention  
Action performed by doctor or other clinician targeted at a 
patient, Locus, or Condition with the objective of 
changing (the properties) of, or treating, a Condition.  
Although his PET scan is normal he does need a groin 
dissection 
We agreed to treat with DTIC, and then consider 
radiotherapy. 
Investigation  
Interaction between doctor and patient or Locus aimed at 
measuring or studying, but not changing, some aspect of a 
Condition. Investigations have findings or 
interpretations, whereas Interventions usually do not.  
This patient has had a lymph node biopsy …  Although his 
PET scan is normal he does need a groin dissection. We 
will perform a CT scan to look at the left pelvic side wall … 
 
Result  The numeric or qualitative finding of an Investigation, excluding Condition  
Although his PET scan is normal… 
Other examples include the numeric values of tests, such 
as "80mg".  
Drug or  
device  
Usually a drug. Occasionally, medical devices such as 
suture material and drains will also be mentioned in texts.  This (pain) was initially relieved by co-codamol 
Locus  Anatomical structure or location, body substance, or physiologic function, typically the locus of a Condition.  
This patient has had a lymph node biopsy which shows 
melanoma in his right groin … It is clearly secondaries 
from the melanoma on his right second toe. Although his 
PET scan is normal he does need a groin dissection. We 
will perform a CT scan to look at the left pelvic side wall 
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4.1 Annotation Guidelines 
Consistency is critical to the quality of a gold standard. It 
is important that all documents are annotated to the same 
standard. Questions regularly arise when annotating. For 
example, should multi-word expressions be split? Should 
“myocardial infarction” be annotated as a condition, or 
as a condition and a locus? To ensure consistency, a set 
of guidelines is provided to annotators. These describe in 
detail what should and should not be annotated; how to 
decide if two entities are related; how to deal with 
co-reference; and a number of special cases. The 
guidelines also provide a sequence of steps, a recipe, 
which annotators should follow when working on a 
document. This recipe is designed to minimise errors of 
omission. The guidelines themselves were developed 
through a rigorous, iterative process, which is described 
below. 
4.2 Double Annotation 
A singly annotated document can reflect many problems: 
the idiosyncrasies of an individual annotator; one-off 
errors made by a single annotator; annotators who 
consistently under-perform. There are many alternative 
annotation schemes designed to overcome this, all of 
which involve more annotator time. Double annotation is 
a widely used alternative, in which each document is 
independently annotated by two annotators, and the sets 
of annotations compared for agreement. 
4.3  Agreement Metrics 
We measure agreement between double annotated 
documents using inter annotator agreement (IAA, shown 
below).  
IAA = matches / (matches + non-matches) 
We report IAA as a percentage. Overall figures are 
macro-averaged across all entity or relationship types. 
Entity IAA may be either “relaxed” or “strict”. In relaxed 
IAA, partial matches, i.e. overlaps,  are counted as a half 
match. In strict IAA, partial matches do not count to the 
score. Together, these show how much disagreement is 
down to annotators finding similar entities, but differing 
in the exact spans of text marked. We used both scores in 
development, but provide a set of final strict IAAs for 
the corpus. Results given below explicitly state the score 
being used. 
Two variations of relationship IAA were used. First, all 
relationships found were scored. This has the drawback 
that an annotator who failed to find a relationship 
because they had not found one or both the entities 
would be penalized. To overcome this, a Corrected IAA 
(referred to as CIAA) was calculated, including only 
those relationships where both annotators had found the 
two entities involved. This allows us to isolate, to some 
extent, relationship scoring from entity scoring. 
4.4 Difference Resolution 
Double annotation can be used to improve the quality of 
annotation, and therefore the quality of statistical models 
trained on those annotations. This is achieved by 
combining double annotations to give a set closer to the 
"truth" (although it is generally accepted as impossible to 
define an "absolute truth" gold standard in an annotation 
task with the complexity of CLEF's). The resolution 
process is carried out by a third experienced annotator. 
All agreements from the original annotators are accepted 
into a consensus set, and the third annotator adjudicates 
on differences, according to a set of strict guidelines. In 
this way, annotations remain at least double annotated. 
4.5 Developing the Guidelines 
The guidelines were developed and refined using an 
iterative process, designed to ensure their consistency. 
This is shown in Figure 2. Two qualified clinicians 
annotated different sets of documents in 5 iterations 
(covering 31 documents in total). The relaxed IAA and 
CIAA for these iterations are shown in Table 4. As can 
be seen, entity relaxed IAA remains consistently high 
after the 5 iterations, after which very few amendments 
were required on the guidelines. Relation CIAA does not 
appear so stable on iteration 5. Difference analysis 
showed this to be due to a single, simple type of 
disagreement across a limited number of sentences in 
one document. Scoring without this document gave a 
73% CIAA. 
 
Figure 2: Iterative development of guidelines 
Debug iteration  
1 2 3 4 5 
Matches  244 244 308 462 276  
Partial match 2 6 22 6 1 
Non-matches  45 32 93 51 22 
En
titi
es 
Relaxed IAA 84 87 74 89 92 
Matches 170 78 116 412 170 
Partial match 3 5 14 6 1 
Non-matches 31 60 89 131 103 
Re
lat
ion
sh
i
ps
 Corrected IAA 84 56 56 75 62  
Table 4: Relaxed IAA and CIAA (%) for each 
development iteration. 
4.6 Annotator Expertise 
In order to examine how easily the guidelines could be 
applied by other annotators with varying levels of 
expertise, we also gave a batch of documents to our 
development annotators, another clinician, a biologist 
with some linguistics background, and a computational 
linguist. Each was given very limited training. The 
resultant annotations were compared with each other, 
Double annotate by 
guidelines 
Select small set of documents Draft guidelines 
Calculate agreement 
score 
Resolve differences 
Amend guidelines 
Annotate larger 
corpus 
Stable 
agreement? 
No 
Yes 
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and with a consensus set created from the two 
development annotators. The relaxed IAA matrix for this 
group is shown in Table 5. This small experiment shows 
that even with very limited training, agreement scores 
that approach acceptability are achievable. A difference 
analysis suggested that the computational linguist was 
finding more pronominal co-references and verbally 
signaled relations than the clinicians, but that 
unsurprisingly, the clinicians found more relations 
requiring domain knowledge to resolve. A combination 
of both linguistic and medical knowledge appears to be 
best. 
This difference reflects a major issue in the development 
of the guidelines: the extent to which annotators should 
apply domain specific knowledge to their analysis. Much 
of clinical text can be understood, even if laboriously and 
simplistically, by a non-clinician armed with a medical 
dictionary. The basic meaning is exposed by the 
linguistic constructs of the text. Some relationships 
between entities in the text, however, require deeper 
understanding. For example, the condition for which a 
particular drug was given may be unclear to the 
non-clinician. In writing the guidelines, we decided that 
such relationships should be annotated, although this 
requirement is not easy to formulate as specific rules. 
D2 77     
C 67 68    
B 76 80 69   
L 67 73 60 69  
Consensus 85 89 68 78 73 
 D1 D2 C B L 
Table 5: Relaxed IAA (%) for entities. D1 and D2: 
development annotators; C: clinician; B: biologist with 
linguistics background; L: computational linguist 
4.7 Annotation: Training and Consistency 
In total, around 25 annotators were involved in guideline 
development and annotation. They included practicing 
clinicians, medical informaticians, and final year medical 
students. They were each given an initial 2.5 hours 
training session.  
After the initial training session, annotators were given 
two training batches to annotate, which comprised 
documents originally used in the debugging exercise, and 
for which consensus annotations had been created. 
Relaxed IAA and CIAA were computed between 
annotators, and against the consensus set. These figures 
allowed us to identify and offer remedial training to 
under-performing annotators and to refine the guidelines 
further. 
4.8 Annotation of Temporal Information 
This work is still at a preliminary stage. To date ten 
patient letters (narrative data) for a number of patients 
have been annotated in accordance with the scheme 
described in Section 3.3 above, which we still view as 
under development. A second annotator is currently 
re-annotating as part of the guideline development phase 
(see Figure 2). Temporal annotation is done through a 
combination of manual and automatic methods. TLCs 
were imported from the part of the corpus already 
annotated with clinical entities. Temporal expressions 
were annotated and normalized to ISO dates by the 
GUTime tagger (Mani and Wilson 2000), developed at 
Georgetown University, which annotates in accordance 
with the TIMEX3 standard and also recognizes a variety 
of temporal modifiers and European date formats. After 
these automatic steps, we manually annotate the 
temporal relations holding between TLCs and the date of 
the letter (Task A), and between TLCs and temporal 
expressions appearing in the same sentence (Task B).   
5. Inter annotator agreement 
We have calculated IAA for the double annotations 
across the complete stratified random portions of the 
gold standard, for each document type. Table 6 shows 
the strict IAA for entities, and Table 7 shows both the 
IAA and CIAA for relationships. 
 
Entity Narratives Histopath. Radiology 
Condition 81 67 77 
Drug or device 84 59 32 
Intervention 64 57 43 
Investigation 77 56 70 
Locus 78 71 75 
Result 69 29 48 
Laterality 95 88 91 
Negation 67 71 65 
Sub-location 63 29 36 
Overall 77 62 69 
Table 6: Strict IAA (%) for entities across the stratified random 
corpus 
 
Note that the final gold standard consists of a consensus 
of the double annotation, created by a third annotator. 
Systems trained and evaluated with the gold standard use 
this consensus. The IAAs given do not therefore provide 
an upper bound on system performance, but an 
indication of how hard a recognition task is. Table 7 
illustrates that relation annotation is highly dependent on 
entity annotation: CIAA, corrected for entity recognition, 
is significantly higher than uncorrected IAA. 
 
Narratives Histopath. Radiology 
Relation IAA CIAA IAA CIAA IAA CIAA 
has_finding 48 76 26 69 33 55 
has_indication 35 51 15 30 14 22 
has_location 59 80 44 70 45 77 
has_target 45 64 20 47 67 81 
laterality_mod 70 93 70 89 55 80 
negation_mod 63 90 67 100 51 94 
sub_loc_mod 52 98 29 100 32 93 
Overall 52 75 36 72 43 76 
Table 7: IAA and corrected IAA (%) for relationships across 
the stratified random corpus 
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6. Distribution of semantic annotations 
The distribution of annotations for CLEF entities and 
relations in the stratified random portion of the corpus 
(50 documents of each type) is shown in Table 8. 
CLEF stratified random corpus 
Entity 
Narra- 
tives 
Histopath- 
ology 
Radiol- 
ogy Total 
Condition 429 357 270 1056 
Drug or device 172 12 13 197 
Intervention 191 53 10 254 
Investigation 220 145 66 431 
Laterality 76 14 85 175 
Locus 284 357 373 1014 
Negation 55 50 53 158 
Result 125 96 71 292 
Sub-location 49 77 125 251 
Relation     
has_finding 233 263 156 652 
has_indication 168 47 12 227 
has_location 205 270 268 743 
has_target 95 86 51 232 
laterality_mod 73 14 82 169 
negation_mod 67 54 59 180 
sub_loc_mod 43 79 125 247 
Table 8: Distribution of annotations by document type 
for entities and relations (clinical IE). 
The distribution of annotations for the different subtypes 
of CTLinks, TLCs and time expressions for the ten 
development documents annotated so far are shown in 
Tables 9 and 10. Note that some TLCs are marked as 
hypothetical. For example in “no palliative 
chemotherapy or radiotherapy would be appropriate” the 
terms chemotherapy and radiotherapy are marked as 
TLCs but clearly have no “occurrence” that can be 
located in time and hence will not participate in any 
CTLinks.  
CTLink Task A Task B 
After 5 18 
Ended_by 3 0 
Begun_by 4 0 
Overlap 7 26 
Before 5 135 
None 4 8 
Is_included 31 67 
Unknown 6 14 
Includes 13 137 
Total 78 405 
Table 9: Distribution of CTLinks by type for tasks A & B. 
 
Not hypothetical 243 
hypothetical 16 
TLCs 
Total 259 
Duration 3 
DATE 52 
Time 
Expression 
Total 55 
Table 10: Distribution of TLCs and temporal expressions. 
 
7. Using the Corpus 
The gold standard corpus is used as input to train an IE 
system based on SVM classifiers for recognizing both 
entities and relations. Preliminary results, with models 
evaluated on a narrative corpus comprising the combined 
stratified random and whole patient portion, achieve 
average F-measure 71% for entity extraction over 5 
entity types (Roberts et al. 2008). Preliminary results for 
relation extraction trained with the same corpus, achieve 
an average F-measure of 70% over 7 relation types, 
where gold standard entities are provided as input. 
8. Conclusion 
We have described the CLEF corpus: a semantically 
annotated corpus designed to support the training and 
evaluation of information extraction systems developed 
to extract information of clinical significance from free 
text clinic notes, radiology reports and histopathology 
reports. We have described the design of the annotated 
corpus, including the number of texts it contains, the 
principles by which they were selected from a large body 
of unannotated texts and the annotation schema 
according to which clinical and temporal entities and 
relations of significance have been annotated in the texts. 
We also described the annotation process we have 
undertaken with a view to ensuring, as far as is possible 
given constraints of time and money, the quality and 
consistency of the annotation, and we have reported 
results of inter-annotator agreement, which show that 
promising levels of inter-annotator agreement can be 
achieved. We have examined the applicability of 
annotation guidelines to several clinical text types, and 
our results suggest that guidelines developed for one type 
may be fruitfully applied to others.  We have also 
reported the distribution of entity and relation types, both 
clinical and temporal, across the corpus, giving a sense 
of how well represented each entity and relation type is 
in the corpus. 
The annotated CLEF corpus is the richest resource of 
semantically marked up clinical text yet created. Our 
work has faced several challenges, such as achieving 
consistent annotation, particularly of relations, across 
annotators and co-ordinating the work of many 
annotators at several sites. We do not as yet have 
persmission to release these materials to the wider 
language processing community for research purposes. 
However, we are currently preparating an application 
requesting this release, to be submitted shortly to the 
appropriate UK Multi-centre Research Ethics 
Committee. We are optimistic of success.  
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Abstract  
The accurate recognition of modal information is vital for the correct interpretation of statements. In this paper, we report on the 
collection a list of words and phrases that express modal information in biomedical texts, and propose a categorisation scheme 
according to the type of information conveyed.  We have performed a small pilot study through the annotation of 202 MEDLINE 
abstracts according to our proposed scheme. Our initial results suggest that modality in biomedical statements can be predicted fairly 
reliably though the presence of particular lexical items, together with a small amount of contextual information.
1.  Introduction 
Text processing systems tend to focus on factual 
language (Hahn & Wermter, 2006; McNaught & Black, 
2006).  However, modality is a common phenomenon 
which must be taken into account to correctly interpret 
text. Modality is concerned with the opinion and attitude 
of the speaker (Lyons, 1977). Palmer (1979) 
distinguishes three types of modality: epistemic (making 
judgements about the truth of a proposition), deontic 
(concerned with permission) and dynamic (concerned 
with the potential of a situation to occur).  
Our concern here is epistemic modality in biomedical 
text, which covers the expression of the author’s level of 
confidence towards a proposition, but may also indicate 
the type of knowledge, assumptions or evidence on 
which the proposition is based (Coates, 1995).    
It also covers speculation. Light et al. (2004) and 
Medlock & Briscoe (2007) show that successful 
classification of biomedical sentences for speculation  
depends on the presence or absence of  speculative cue 
words or phrases. Whilst more complex syntactic 
contexts, e.g. conditional clauses, are a possible way 
express modality in texts (Sauri et al, 2006), corpus-
based studies of hedging (i.e. speculative statements) in 
biological texts by Hyland (1996a, 1996b) reinforce the 
above experimental findings: 85% of hedges were 
realised lexically, rather than through more complex 
means.  
Previous efforts at annotating modal information in 
biomedical texts (e.g. Light et al., 2004; Wilbur et al. 
2006; Medlock & Briscoe, 2007) have been at the 
sentence or sentence fragment level only, without 
explicit annotation of the modal cue words. Given the 
importance of these cue words, a list of modal lexical 
items used within the field, categorised according to the 
information they express, would be a useful resource for 
the automatic processing of biomedical texts.  
Previous lists (e.g. Hyland, 1996a; Rizomiliti, 2006) 
suffer from being either incomplete or coarse-grained. 
Here, we describe the collection and multi-dimensional 
classification of a preliminary set of words and phrases 
that express modality within biomedical texts. We then 
report on initial validation of our classification, via 
annotation of modal information that modifies 
previously-annotated gene regulation events in a small 
corpus of MEDLINE abstracts. 
Although oriented towards biological events, our 
proposed categorisation could be equally valid for other 
applications, e.g. helping to determine intent of citations, 
as suggested by DiMarco & Mercer (2004). 
2.  Modality in Scientific Texts 
Hyland (1996a; 1996b) shows that modals such as may, 
could, would etc., play a relatively minor role in 
expressing modality in biological texts. This is evident 
when the proportions of word categories occurring in 
such texts are compared to those calculated by Holmes 
(1988) on general academic articles from the Brown 
corpus of American English and the LOB corpus of 
British English. See Table 1. 
 
 
Hyland 
(Biology) 
Holmes (gen. 
academic) 
Lexical verbs  27.4% 35.9 % 
Adverbials  24.7% 12.8 % 
Adjectives  22.1  % 6.6 % 
Modal verbs  19.4 % 36.8 % 
Nouns  6.4 % 7.7 % 
 
Table 1: Comparison of modal items in different text 
types 
 
It is the lexical (i.e. non-modal) verbs, adjectives and 
adverbs that dominate in expressing modality in 
biological research articles. Thus, we collected a set of 
modal words and phrases that are relevant within the 
biomedical domain. 
3.  Collecting Modal Items from Biomedical 
Texts 
Rizomilioti (2006) provides a comprehensive base list of 
modal lexical items drawn from academic research 
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articles in biology, archeology and literary criticism 
(200,000 words each).  
As we hypothesised that modal lexical items can vary 
amongst text genres, we eliminated any items with no 
modal sense within the biomedical literature.   
113 abstracts were taken from a corpus of MEDLINE 
abstracts on E. Coli (approximately 30,000 abstracts). 
Within these, any additional lexical markers of modality 
not present on Rizomilioti’s list were identified. 
Examples included evidence, observe, predict, imply, be 
consistent with and potential.  
For each item in the resulting combined list, we 
calculated its frequency within the complete E. Coli 
corpus, and discarded 26 items occurring fewer than 10 
times (9 had zero occurrence). Discarded words included 
those indicating a high degree of confidence (e.g. surely, 
patently, admittedly, attest, emphasise) and those 
expressing doubt (e.g. alledgedly, improbable, doubtful, 
ostensibly). 
We examined the usage of each remaining word in 
context within the corpus using a concordancer from the 
Multilingual Corpus Toolkit1, and discarded any words 
not having a modal meaning in any contexts within the 
corpus. Examples included the verb stress and the adverb 
naturally, both of which Rizomilioti judged to indicate a 
high degree of confidence. In our corpus, stress almost 
always occurs as a noun, e.g. oxidative/environmental 
stress, whilst naturally most commonly occurs in phrases 
such as naturally occurring.  Following this step, 90 
lexical items remained.  Table 2 shows the most 
frequently occurring of these in the E. Coli corpus, 
which correspond well with the highest ranked terms 
identified by Hyland and Rizomilioti.   
 
show (17836) may (5826) 
suggest (11850) demonstrate (4817) 
indicate (8511) reveal (4467)  
observe (6177) could (4247) 
identify (5494) appear (4212) 
 
Table 2: Most frequent modal words in the E.Coli corpus 
4.  Classifying Modality in Scientific Texts 
To propose a categorisation model for our list of modal 
lexical items, we considered a number of existing models 
and annotation schemes. Light et al. (2004) and Medlock 
& Briscoe (2007) are concerned primarily with the 
speculative/non-speculative distinction; other models are 
more complex and include multiple “dimensions”. Rubin 
et al. (2005) annotate certainty in newspaper articles 
along 4 separate dimensions: a) degree of certainty; b) 
focus, i.e. whether the statement is abstract (opinions, 
beliefs, assessments) or factual; c) perspective, i.e. the 
writer’s or a reported point of view; and d) time, i.e. 
whether the reported event is in the past, present or 
future. Lexical markers are explicitly annotated to give 
evidence for the value assigned to each attribute, 
suggesting that separate sets of words or phrases are used 
to express these different dimensions.  
Although newspaper articles are very different from 
biomedical texts, the certainty, focus and perspective 
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dimensions also seem relevant for us. The following 
corpus sentence illustrates the possibility of identifying 
these different dimensions through separate words or 
phrases: 
 
We suggest that these two proteins may form a complex 
in the membrane which acts at late steps in the export 
process 
 
The word we shows that the perspective is the authors’ 
own, suggest provides focus information (i.e. this is a 
speculation rather than a definite fact) whilst may 
conveys the author’s level of certainty.  
4.1  Evidence Underlying Statements 
An aspect not covered by Rubin et al.’s model, and yet 
highly relevant in scientific literature, is the source or 
type of evidence underlying a statement. The importance 
of this within the biomedical field is illustrated in 
annotation  using the Gene Ontology (GO) (Ashburner et 
al, 2000). This requires gene associations to be attributed 
to the literature through the assignment of evidence 
codes, which denote the type of evidence available, e.g. 
experimental evidence, evidence through citations, or 
evidence inferred by the curator from other GO 
annotations. 
Wilbur et al.’s annotation scheme also uses evidence; 
some of the possible values correspond closely to the 
main evidence categories used by GO curators, thus 
reinforcing that this type of information is important to 
domain experts. Sentences or sentence fragments are 
annotated for evidence as follows: a) no evidence, b) 
claim of evidence without verifying information, c) 
citation of other papers or d) explicit reference to 
experimental findings or results described within the 
paper.  
4.2  Interpretation of Evidence 
Certain verbs, like see, indicate and find, can help to 
identify statements containing reference to evidence. 
Wilbur et al.’s scheme determines the value of the 
evidence attribute largely from  the type of subject taken 
by the verb, or the presence of citations. A subject such 
as our results provides explicit reference to results within 
the paper, whilst previous studies makes a claim of 
evidence, which may or may not be backed up by a 
citation.  
Whilst the type of evidence behind a statement is 
important within the domain, another relevant type of 
information is how that evidence is to be interpreted. The 
choice of verb (or other modal lexical item) is important 
for this: whilst a statement beginning “we see that …” 
normally expresses an observation based on 
experimental findings or results, a sentence of the form 
“Previous experiments indicate that…” would imply that 
reasoning has taken place to arrive at the statement that 
follows.  
Palmer’s (1986) model for the 4-way classification of 
non-factual statements takes such distinctions into 
account, yielding   speculative, deductive (derived from 
inferential reasoning or conclusions), quotative 
(specifying and acknowledging previous findings) and 
sensory (referring to apprehending, sensing or 
observing).  
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This model has been analysed for biological texts by 
Hyland (1996a). It has similarities with Wilbur et al.’s 
evidence attribute, in that the quotative category 
encompasses statements that cite other works. However, 
other types of statements backed by evidence are divided 
into sensory and deductive, according to whether they 
are based on observations or reasoning. Hyland’s 
examples suggest that lexical items themselves can be 
used to distinguish between the speculative, deductive 
and sensory categories. For example, appear and seem 
are sensory verbs, whilst the verbs propose, believe and 
speculate fit well into the speculative category. Likewise, 
the verbs infer, indicate and imply are typical indicators 
of the deductive category. 
5.   Proposed Categorization Scheme 
We conclude that the following factors are important to 
the interpretation of statements in scientific literature: 
a) whether the statement is a speculation or based 
on factual data (e.g. experimental findings or 
results) 
b) the type/source of the evidence 
c) the interpretation of the evidence 
d) the level of certainty towards the statement 
We take Palmer’s model as a starting point for our own 
proposed categorisation, as it covers the above factors a), 
b) and c), at least to a certain extent.  Ad factor a), 
sensory, deductive and quotative statements are normally 
based on factual data, whilst speculations fall into the 
speculative category. Ad factor b), Palmer’s categories 
allow different types of evidence to be distinguished. So, 
a speculative statement is not normally backed by 
evidence, whilst sensory and deductive statements would 
normally contain claims of evidence or reference to 
experimental findings.  Meanwhile, quotative statements 
normally provide evidence through citation of other 
papers. Finally, ad factor c), different interpretations of 
evidence may be distinguished according to whether the 
statement is sensory or deductive.   
Arguably, Palmer's categories implicitly encode certainty 
level information. A speculation is, for example, 
normally a less confident assertion than one backed by 
evidence of some sort. However, this does not 
necessarily follow: deductions and experimental 
observations may be made with varying degrees of 
confidence through the use of explicit certainty markers 
like may or probably.  Thus, we follow Rubin et al. 
(2005) and Wilbur et al. (2005), in categorising certainty 
level as a separate dimension.    
We further observed that quotative does not form a 
distinct category of statements. Consider: “Trifonov [38] 
has suggested that…”. Here, the cited work speculates 
about the statement that follows, and so the sentence is 
both quotative and speculative. We thus classify the 
point of view of the statement (i.e. that of the author or a 
cited work) as a separate dimension. Whilst this does not 
correspond to modal information per se, its identification 
is important for correct interpretation of certain 
sentences containing modal lexical items, e.g. in 
determining the source of evidence presented.  A 
sentence beginning Our data implies that …is the 
author’s point of view, indicating that the experimental 
findings discussed are drawn from the current paper 
rather than another source. 
Our categorisation scheme for modality in biomedical 
texts thus consists of the following 3 “dimensions” of 
information: 
1) Knowledge Type, encoding the type of 
“knowledge” that underlies a statement, 
encapsulating both whether the statement is a 
speculation or based on evidence and how the 
evidence is to be interpreted. 
2) Level of certainty, indicating how certain the 
author (or cited author) is about the statement.  
3) Point of View, indicating whether the statement 
is based on the author’s own or a cited point of 
view or experimental findings.      
Recognition of the Point of View level is aided through 
finding strings such as we and our (corresponding to the 
author’s point of view), or various forms of citations for 
cited points of view. According to our scheme, the 
possible values for the Point of View dimension are 
writer or other. The other two dimensions can be 
recognised largely through the presence of lexical items 
such as the ones collected from our corpus of E. Coli 
abstracts.  
5.1  Knowledge Type 
The majority of lexical items within our list have been 
categorised under Knowledge Type. Three of the 
subclasses we use are taken from Palmer’s model: 
speculative, deductive and sensory. To these, we add a 
fourth category of words whose members explicitly mark 
a statement as describing experimental results or 
findings, rather than observations or deductions made 
from them.  Such statements are marked by words such 
as show, reveal, demonstrate or confirmation. As 
experiments are normally carried out to prove or 
demonstrate a hypothesis, we label this class of words 
demonstrative. 
The largest category of items is the speculative one, 
containing 30 members from our preliminary list. These 
include not only verbs or their nominalised equivalents 
such as predict, prediction, hypothesize, hypothesis, etc., 
but also other nouns such as view and notion, adjectives 
like conceivable and phrases such as in theory and to our 
knowledge. Other categories are smaller, ranging from 8-
12 items, consisting mainly of verbs and nominalised 
forms. So, a deductive statement can be denoted by 
interpret, indication or deduce, whilst sentences with 
sensory evidence can be marked with words such as 
observation, see or appear. 
However, context may be required to correctly determine 
the category of statements denoted by certain Knowledge 
Type words: suggest, when used with a human subject, 
e.g. We suggest … or in the passive voice, e.g. It is 
suggested…, denotes a speculation; however, when the 
subject is inanimate, e.g. The results suggest …, there is 
an implication that a deduction has been carried out. 
5.2  Level of Certainty 
The partitioning of lexical items or statements into 
various degrees of certainty has been extensively studied, 
but little consensus has been reached. Rubin (2007) notes 
an ongoing discussion about whether they should be 
arranged on a continuum or into discrete categories.  
Hoye (1997) proposes that there are at least three 
articulated points on the epistemic scale: certainty, 
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probability and possibility. However, recent works have 
suggested more fine-grained partitions, with either 4 
distinct levels (Rubin et al, 2005; Wilbur et al. 2006) or 
even 5 levels (Rubin, 2007). Annotation experiments 
according to this 5 level system (i.e. absolute certainty, 
high certainty, moderate certainty, low certainty and 
uncertainty) suggested that English may not be precise 
enough to distinguish so many shades between certainty 
and doubt. However, a 4-level distinction appears more 
feasible, with successful application in both the 
newspaper (Rubin et al., 2005) and biomedical domains 
(Wilbur et al., 2006). In the latter case, inter-annotator 
agreement rates of approximately 80% were reported.  
Thus, we derived a four-way classification of lexical 
items denoting certainty: Absolute, High, Moderate and 
Low.  
Within the scientific literature, a statement marked as 
known is normally an accepted fact within the field, and 
so is assigned the Absolute certainty value. Statements 
marked with words such as probable, likely or clearly 
express a high degree of confidence. Words such as 
normally and generally are also placed in this category, 
denoting that a specified event takes place most of the 
time, and thus expressing a high degree of confidence 
that the statement is true. Also within the High category 
are words and phrases that only express certainty when 
combined with certain Knowledge Type items.  Strongly 
can be used in sentences of the following form: The 
results strongly suggest that …. Here, suggest has a 
deductive meaning, and strongly indicates a high degree 
of confidence towards this deduction. Words and phrases 
such as support, in agreement with and consistent with 
can be used with speculative nouns (e.g. theory, notion or 
view) to lower the speculation (and hence increase the 
certainty) of the statement.  
Moderate items specify a more “neutral” certainty level, 
without strong indication of whether the statement is 
more likely to be true than false. Examples include 
possibly and perhaps, as well as some modal auxiliary 
verbs like may and could. Finally, low certainty level 
items have more negative undertone, signaling little 
confidence in the statement they modify, e.g. unlikely.  
6.   Testing the Classification Scheme 
Our work has been carried out in the context of the 
BOOTStrep project (FP6 - 028099), aimed at building a 
bio-lexicon and bio-ontology for biomedical text mining.  
As part of the project, we have been creating a corpus of 
E. Coli abstracts annotated with gene regulation bio-
events (Thompson et al., 2008). Events are centred 
around verbs (e.g. regulate) or nominalised verbs (e.g. 
expression), and event annotation consists of identifying 
and classifying the semantic arguments or participants in 
the event. Note that event annotation was carried out on 
top of shallow parsed (pos-tagged and chunked) texts2: 
the advantages of such a choice range from practical 
ones, i.e. annotated corpora can be produced with much 
less work, to more substantial ones, i.e. previous levels 
of annotation can drive the annotation process, thus 
resulting in an increase in efficiency and consistency for 
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  Each abstract to be annotated with gene regulation bio-
events was first pre-processed with the GENIA tagger 
(Tsuruoka et al, 2005). 
any new annotation. 
From the annotated events, patterns (i.e. semantic 
frames) relating to the behaviour of each verb and 
nominalised verb can be learnt and included within the 
bio-lexicon; these can help in the automatic extraction of 
facts from biomedical texts. As the annotated events 
correspond to facts of biomedical interest, we considered 
them a useful starting point for the verification of our 
proposed modality classification.   
Thus, we carried out a small experiment, in which 
modality was annotated within a small set (i.e. 202) of 
these event-annotated abstracts, using WordFreak,a Java-
based linguistic annotation tool (Morton & LaCivita, 
2003), which was customized to the task.  
Due to the linguistically-driven purposes as well as the 
small size of the corpus exploited in this feasibility study, 
annotation was carried out by a single annotator with 
linguistic expertise. However, extensive support was 
provided by two researchers, one with a background in 
linguistics, and the other one in biology, to discuss open 
issues raised during the annotation process in order to 
improve the semantic stability and reliability of the 
annotations produced. 
6.1  Annotation process 
Each sentence containing a previously-annotated gene 
regulation event was studied, and modality annotation 
was performed only on those sentences in which the 
description of the event contained explicit expression of 
modal information: modal information was only 
annotated if it was within the scope of the gene 
regulation event described. Let us consider, for example, 
the derepress bio-event, described in the sentence “We 
suggest that overproduction of SlyA in hns(+) E. coli 
derepresses clyA transcription by counteracting H-NS”, 
which was annotated as follows:  
 
VERB: derepresses 
AGENT: overproduction 
THEME: clyA transcription 
MANNER: counteracting 
 
The modality annotation process started from the event 
anchor, i.e. the verb derepress. Words or phrases 
expressing modal information and linguistically bound to 
the event anchor were searched for within the sentence’s 
span. If such items were found, values from the proposed 
sets were selected for one or more of the three 
dimensions of the annotation scheme, i.e. Point of View, 
Knowledge Type and Certainty Level. For the Knowledge 
Type and Certainty Level attributes, a value was only 
selected if there was explicit lexical evidence in the 
sentence. In the case at hand, suggest was annotated as 
the lexical modality marker conveying information about 
Knowledge Type, whose associated value is deductive. 
The word We was interpreted as lexical evidence that the 
reported Point Of View was that of the writer. 
Each piece of lexical evidence (i.e. lexical modality 
marker) could only be used to assign a value to one of 
the annotation dimensions. Thus, it was not possible to 
use a single word or phrase to assign values to both the 
Knowledge Type and Certainty Level dimensions.  
If one or both the Knowledge Type or Certainty Level 
attributes were assigned, the Point of View attribute was 
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also instantiated. If no explicit lexical evidence was 
available for the assignment of this attribute, a “default” 
value of writer was assigned, i.e. it was assumed that the 
Point of View was expressed implicitly. 
The annotator used the preliminary categorisation of 
modal lexical items as a starting point for the annotation 
of the Knowledge Type and Certainty Level attributes, 
although she was not bound by this categorisation, nor 
was her annotation limited to only those items on the list: 
part of the purpose of the annotation was to discover the 
semantic stability of the lexical items within our 
proposed categories, as well as to discover other 
modality markers missing from the preliminary list.  
7.   Results 
The 202 MEDLINE abstracts annotated for modal 
information contained a total of 1469 gene regulation 
events. 249 of these events (i.e. 16.95%) were annotated 
with modality information. Table 3 shows general 
statistics about the dimensions of the modal markers that 
were present in the description these events, whilst Table 
4 shows the distribution of the annotations amongst the 
various values within each dimension of the scheme. 
The number of modality annotations may at first seem 
rather low, with an average of 1.31 annotations per 
abstract. However, a number of points should be noted. 
Firstly, lexical markers of modality are generally quite 
sparse within texts. Secondly, as pointed out above, 
modality annotations have only been carried out on top 
of previously annotated bio-events, and there was an 
average of 6.05 bio-event annotations per abstract. 
Rather than aiming to annotate all modal information 
expressed within the abstracts, our case study is firstly 
aimed at verifying whether the modality classification 
scheme is suitable for a corpus of biomedical texts, and 
secondly, it is focused on the discovery of the main 
domain-relevant problems and features involved, as well 
as clues which can drive future work.  
There follows a number of annotation examples. In each 
case, the modality marker(s) and the Point Of View 
marker (if present) have been underlined, with the 
corresponding category placed in brackets. The verb 
which forms the focus of the associated bio-event is 
emboldened.  
 
a) Therefore, we [WRITER] suggest [DEDUCTIVE] that 
overproduction of SlyA in hns(+) E. coli derepresses 
clyA transcription by counteracting H-NS. 
b)We [WRITER] have shown [DEMONSTRATIVE] that 
the open reading frame ybbI in the genomic sequence of 
Escherichia coli K-12 encodes the regulator of 
expression of the copper-exporting ATPase, CopA 
c)We [WRITER] speculate [SPECULATIVE] that the 
product of this gene is involved in the attachment of 
phosphate or phosphorylethanolamine to the core and 
that it is the lack of one of these substituents which 
results in the deep rough phenotype. 
 
A single modality marker may also express the same 
information relative to more than one bio-event in the 
case of a coordinated structure, e.g. : 
 
Band shift experiments showed [DEMONSTRATIVE] 
that AllR binds to DNA containing the allS-allA 
intergenic region and the gcl(P) promoter and its binding 
is abolished by glyoxylate. 
 
Modal marker(s) present Count % of total 
events 
Knowledge Type only 192 77.11 % 
Certainty Level only 40 16.07% 
Knowledge Type + 
Certainty Level 
17 6.83% 
 
Table 3: Distribution of modality markers within 
annotated events  
 
Dimension Value 
Count % of 
annotations 
within  
dimension 
DEMONSTRATIVE 110 52.63% 
DEDUCTIVE 56 26.79% 
SENSORY 25 11.96% 
Knowledge 
Type 
SPECULATIVE 18 8.61% 
ABSOLUTE 4 7.01% 
HIGH 15 26.31% 
MODERATE 34 59.64% 
Certainty 
Level 
LOW 2 3.50% 
WRITER 213 92.20% Point Of View OTHER 18 7.79% 
 
Table 4: Distribution of modality annotations within the 
different dimensions 
 
7.1  Knowledge Type Information 
The Knowledge Type dimension is the most frequently 
annotated (77.11% of annotations). The most common 
value for this dimension is demonstrative (52.63% of 
Knowledge Type annotations), whilst the least 
widespread type of knowledge is speculative (8.61%).  
These statistics are perhaps unsurprising, given that the 
current pilot study has been carried out on abstracts. 
Demonstrative events are explicitly marked as describing 
experimental results, particularly those which prove 
hypotheses or predictions.  These are exactly the sorts of 
events that we can expect to occur most frequently in 
abstracts; within the short amount of space available, 
authors normally aim to emphasize the definite results 
that their experiments have produced.  
The annotation experiment has highlighted a potential 
need to add an additional value for the Knowledge Type 
dimension. Consider the following examples:  
 
a) The model states that the lex (or exrA in E. coli B) 
gene codes for a repressor. 
b) Mutations in yjfQ allowed us to identify this gene as 
the regulator of the operon yjfS-X (ula operon), reported 
to be involved in L-ascorbate metabolism. 
 
Events that are introduced by verbs such as state or 
report do not fit well into one of our other four 
Knowledge Type categories. They are used to introduce   
facts, either cited from previous work or earlier in the 
paper, but without taking a particular stance to them, i.e. 
there is no speculation or deduction involved, and there 
is no reference to active proof or demonstration that an 
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assertion or hypothesis is true.  
Statements such as the above fit into Hyland’s (1996a) 
description of the quotative category, i.e. specifying and 
acknowledging previous findings. Thus, the quotative 
label can apply to a wider range of statements than just 
those that contain citations. Therefore, we propose to 
introduce the quotative category into our classification as 
a further Knowledge Type category to cover statements 
that specify or acknowledge previous findings through 
explicit lexical items.  
Our annotation also revealed that, whilst the majority of 
Knowledge Type items are fairly stable semantically 
within their assigned categories, a small number of items 
do not fit neatly within a single category. The verb seem 
was originally placed within the sensory category, 
following Hyland. However, there is often a speculative 
aspect to its meaning, as confirmed by Dixon (2005): 
seem is used “when there is not quite enough evidence” 
(p. 205). The degree of speculation conveyed may vary 
according to the context: this is an area for further 
research.      
7.2  Certainty Information 
Certainty level markers are considerably less common 
than Knowledge Type markers, representing 16.07% of 
the modality annotations. The most widespread value 
among these annotations is moderate (59.64%). 
The high percentage of moderate markers can again be 
explained by the text type, i.e. abstracts. The results 
concerning Knowledge Type illustrated that 
demonstrative statements are most common: authors are 
keen to emphasize the experimental results that they 
have produced. If there is doubt about these results, this 
can be indicated thought an explicit certainty level 
marker. A moderate (and hence neutral) certainty level 
marker may be the “safest” choice here. 
Certainty Level markers occur most commonly without 
an accompanying Knoweldge Type marker, as in: 
 
EvgA is likely [HIGH] to directly upregulate operons in 
the first class, and indirectly upregulate operons in the 
second class via YdeO. 
 
As mentioned previously, Knowledge Type markers 
implicitly encode certainty level information. Thus, 
when a statement is explicitly marked as a speculation or 
deduction, the use of an explicit marker of certainty may 
be unnecessary, except for emphasis, or to alter the 
“default” certainty level associated with the Knowledge 
Type item.  
Nevertheless, our annotation has served to identify a 
small number of cases (6.83%) that contain explicit 
markers of both Knowledge Type and Certainty Level 
information. Such cases provide evidence that our 
proposed separate dimensions of annotation are indeed 
well motivated. Some examples are shown below:  
 
a) No reverse transcriptase PCR product could be 
detected for hyfJ-hyfR, suggesting [DEDUCTIVE] that 
hyfR-focB may [MODERATE] be independently 
transcribed from the rest of the hyf operon. 
b) We [WRITER] suggest [SPECULATIVE] that these 
two proteins may [MODERATE] form a complex in the 
membrane which acts at late steps in the export process. 
 
A large number of certainty level markers are fairly 
stable in terms of semantics, particularly adjectives and 
adverbs such as probable, possibly or likely. Another 
category of words that play a central role in expressing 
certainty in our corpus is the modal auxiliaries (e.g. can, 
may or could), which represent 40.35% of the total 
number of Certainty Level markers. However, their 
interpretation is more problematic than adjectives and 
adverbs like those listed above. In general, can, may and 
could can have the following senses:  
 
1) Moderate level of certainty 
2) Theoretical possibility (indicating that an event 
has the potential to occur) 
3) Ability 
4) Permission 
 
Whilst the permission sense is rarely relevant within 
biomedical texts, examples of the other three senses can 
be readily identified within our corpus. Some examples 
involving may are shown below: 
 
1) Certainty level marker 
The DNA-binding properties of mutations at positions 
849 and 668 may [MODERATE] indicate 
[DEDUCTIVE] that the catalytic role of these side 
chains is associated with their interaction with the DNA 
substrate. 
2) Theoretical possibility marker  
The expression of nifC may be coregulated with nitrogen 
fixation because of the presence of nif-distinctive 
promoter and upstream sequences preceding nifC-nifV 
omega-nifV alpha. 
3) Ability marker 
Results obtained indicate that the nrdB gene has a 
promoter from which it may be transcribed 
independently of the nrdA gene. 
 
Thus, the presence of these modal auxiliaries does not 
guarantee that certainty level is being conveyed. 
Determining the correct sense can be a difficult task, 
which requires in-depth knowledge of the domain, and 
often requires examining a wider context than just the 
sentence itself.  
Whilst this could prove problematic in the automatic 
recognition of modality, Collins (2006) suggests that for 
each verb, one sense is usually more likely than the 
others. In his study of can and may in various spoken and 
written sources, he found that may was used as a 
certainty level marker in 83.5% of cases, whilst only 
1.1% of occurrences of can concerned certainty level. A 
default interpretation of each modal could thus be used. 
Further study of the context of these items may reveal 
clues that could determine when a non-default value 
should be assigned.    
Our studies have shown that the meaning of can mainly 
corresponds to the “ability” sense, although “theoretical 
possibility” is also possible, as shown in the following 
examples: 
 
a) The enhanced expression of tac-dnaQ reduces 10-fold 
the frequency of UV-induced Su+ (GAG) mutations in 
the CCC phage and nearly completely prevents 
generation by UV of Su+ (GAG) mutations in the GGG 
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phage, in which UV-induced pyrimidine photo-products 
can be formed only in the vicinity of the target triplet. 
b) These results indicate that OmpR stabilizes the 
formation of an RNA polymerase-promoter complex, 
possibly a closed promoter complex, and that a 
transcription activator can  serve not only as a positive 
but also as a negative regulator for gene expression. 
 
Whilst the “ability” sense is not central to the 
interpretation of modality, the recognition of “theoretical 
possibility” may be more important: stating that an event 
has the potential to happen is different from stating that 
it does (always) happen. Thus, further investigation of 
lexical markers of theoretical possibility will help to 
build upon our current categorisation model. 
7.3  Point Of View Information 
Although we suggested that there are a number of textual 
clues that can be used to determine the Point of View of a 
statement, our annotation experiment revealed that such 
explicit evidence is quite sparse, at least in abstracts. 
Occasionally, the sentence contains words or phrases 
such as we, our results, in this study, etc. allowing the 
Point Of View to be determined as the author(s) of the 
abstract. In other cases, looking at the wider surrounding 
context, i.e. in neighbouring sentences or even within the 
whole abstract, is necessary. Although our annotation 
assumes the lack of an explicit Point of View marker to 
indicate the writer point of view, further analysis of these 
cases must be carried out. 
During annotation, however, we identified some 
potential additional clues that can help to determine the 
value of this dimension.  
Consider the phrase these results. On its own, this 
provides no explicit information about the point of view 
of the accompanying statement. However, when 
occurring as the subject of suggest (especially in the 
present tense), it is normally the case that the deduction 
has been carried out by the author(s), as illustrated in the 
following example: 
 
These results [WRITER] suggest [DEDUCTIVE] that 
both locally and regionally targeted mutagenesis is 
affected by overproduction of the epsilon subunit. 
  
The writer value can also be assumed in such contexts 
when other verbs in the deductive and sensory categories 
are used, e.g. indicate, imply, appear, etc, particularly 
when in the present tense with an inanimate subject. An 
exception is when there is explicit reference to another 
author or work. If there is an impersonal subject, e.g. It is 
suggested, then greater contextual evidence would be 
required, as the point of view is ambiguous.  
A further example concerns Certainty Level markers 
within the absolute category, which generally denote 
well-established facts within the community. When such 
a certainty level marker is present, we can assume that 
the statement does not correspond only to the author’s 
personal point of view. An example is shown below:  
 
Near the amino terminus is the sequence 35GLSGSGKS, 
which exemplifies a motif known [ABSOLUTE] to 
interact with the beta-phosphoryl group of purine 
nucleotides. 
8.   Conclusion 
We have presented a scheme for classifying modality in 
biomedical texts according to three different dimensions, 
namely Knowledge Type, Certainty Level and Point of 
View. In many cases, textual clues can be used fairly 
reliably to determine the correct classification of 
statements according to these dimensions. The results 
from a preliminary annotation experiment based on this 
scheme confirm this hypothesis.  
Contextual information surrounding modal lexical items 
can also be important in determining the correct modal 
value of statements. Shallow parsing (i.e. chunking), on 
the top of which event annotation and modality 
annotation are carried out, can help to identify such 
information. This is in agreement with Medlock & 
Briscoe (2006), who suggest that linguistically-motivated 
knowledge may help to boost the performance of an 
automatic hedge classification system. 
Our preliminary results suggest that many modal items in 
our list are fairy stable semantically when modifying bio-
events. However, the correct interpretation of modal 
auxiliaries within the domain is more problematic, and is 
thus an area for further research. Our experiment also 
served to highlight certain weaknesses in the original 
model, e.g. the lack of a Knowledge Type category 
corresponding to reported facts. A further potential 
weakness in our results is that, whilst examples 
supporting all of our proposed categories were found, 
there is a strong bias towards certain categories. This 
may be because our preliminary study was based only on 
abstracts.  
In the future, we plan to carry out further experiments to 
reinforce the validity of our proposed classification. 
These include involving multiple annotators (including 
biologists) to provide inter-annotator agreement 
statistics, as well as applying our scheme to full texts, 
where we can expect a greater variability of modal 
expression to be encountered.  
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Appendix A:  Lexical Modality Markers 
Knowledge Type Markers 
Speculative - assume, assumption, belief, believe, claim, 
conceivable, estimate, expect, expectation, hypothesise,  
hypothesis, hypothetical, in principle, in theory,  judge, model, 
notion, predict, prediction, proposal, propose, speculate, 
suggest3, suggestion, suppose, suspect, theory, think,  to our 
knowledge, view.  
Deductive – argue, argument, deduce, imply, indicate, 
indication, infer, interpret, interpretation, suggest4.  
Demonstrative - conclude, conclusion, confirm, confirmation, 
demonstrate, find, finding, proof, prove, report, reveal, show.  
Sensory - apparent, apparently, appear, observation, observe, 
evidence, evident, seem, see. 
 
Certainty markers 
Absolute - certainly, known. 
High - consistent with5, clear, clearly, generally, in agreement 
with5, likelihood, likely, normally, obviously, probability, 
probable, probably, strongly6, support5, would. 
Medium – can, could, feasible, may, might, perhaps, 
possibility, possible, potential, potentially. 
Low – unlikely, unknown. 
                                                          
3
   with a human subject, e.g. We suggest that … or in the 
passive voice, e.g. It is suggested that… 
4
  with an inanimate subject, e.g. The results suggest that 
… 
5
  Often used to lower the speculation (and hence increase 
the certainty) of a speculative statement, e.g. These results are 
consistent with the view that … 
6
  Often used to strengthen the certainty of deductive or 
speculative propositions, e.g. The results strongly suggest that 
… 
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Abstract
In this paper we investigate the manual subclassification of chemical named entities into subtypes representing whole compounds, parts
of compounds and classes of compounds. We present a set of detailed annotation guidelines, and demonstrate their reproducibility by
performing an inter-annotator agreement study on a set of 42 chemistry papers. The accuracy and κ for the annotating the subtypes of
the majority named entity type were 86.0% and 0.784 respectively, indicating that consistent manual annotation of these phenomena is
possible. Finally, we present a simple system that can make these judgments with accuracy of 67.4% and κ of 0.470.
1. Introduction
Pyridines are chemical compounds that contain a pyridine
ring, and the simplest pyridine is pyridine itself.1 Here we
see an ambiguity whereby a chemical name can be used
to refer to a specific compound, a class of compounds, or
a part of compound. This is not unique to pyridine; it
is a form of regular polysemy which applies to almost all
names of chemical compounds. This is a significant prob-
lem for chemical named entity recognition,2 and is not ad-
dressed by the annotation guidelines for existing corpora
that mark up chemical names, such as the BioIE P450 cor-
pus (Kulick et al., 2004), Genia (Kim et al., 2003) or our
own chemical-focused corpus and annotation scheme (Cor-
bett et al., 2007). The aim of our current work is to build
on our existing annotation scheme for chemistry named en-
tities in a way which captures this systematic ambiguity.3
The compound/class of compounds polysemy is an ex-
ample of autohypernymy (or autosuperordination (Cruse,
2004)), and the (class of) compound/part of compound pol-
ysemy is an example of automeronymy, similar to certain
sorts of metonymy. Examples of similar phenomena can be
found in other domains. For example, in animals it is com-
mon to have a word that refers to both an animal of unspec-
ified gender and a specific gender of that animal (for exam-
ple, “cow” can mean a female bovine or any bovine), and in
some cases a word can refer to different taxonomic levels
(for example, “cat” can refer both to the domestic cat Felis
silvestris catus or to the Felidae in general). Food and drink
provide further examples of this; one can distinguish be-
tween “Merlot” as a mass noun, denoting the wine, and “a
Merlot” as a count noun, denoting a particular sort of Mer-
lot wine, and also “Merlot grapes”. For people, one may
1A pyridine ring is five carbon atoms and one nitrogen atom
in a ring, linked by alternating single and double bonds as in ben-
zene. In pyridine (C5H5N) each carbon atom is bonded to a hy-
drogen atom. In other pyridines one or more of these hydrogens
are substituted by a different atom or group.
2For a review of chemical named entity recognition, see
Banville (2006) and the introduction to Corbett et al. (2007).
3We do not consider non-systematic ambiguity in this paper,
which for chemistry named entities chiefly arises from acronyms.
say “a Kennedy” to mean a member of the Kennedy family,
and “Kennedy” to mean some specific member of that fam-
ily (usually JFK)—thus it may be said that Kennedy was a
Kennedy. Nevertheless the regular polysemy of chemical
names is particularly interesting, not least because the dis-
tinctions between the different senses can be mapped onto
well-defined notions in the domain of chemical structure.
In many cases the compound, class-of-compounds and part-
of-compound senses are grammatically marked in a regular
fashion: exact compounds tend to occur as singular bare
noun phrases, as mass (or maybe proper) nouns; classes
of compounds tend to occur in the plural or with a deter-
miner, as count nouns; parts of compounds tend to occur in
noun–noun compounds, with a head noun such as “ring”,
“chain”, “group”, “moiety”, “substituent” or “subunit”.4
However these patterns are frequently violated. For exam-
ple, a compound with a pyridine ring may be described as
being “pyridine-containing” or “bearing a pyridine”. These
sense distinctions are defined in terms of chemical struc-
ture, and may be highly correlated with grammatical cues,
but they are not fundamentally grammatical distinctions.
It should be noted that the compound/class of compound
distinction cuts across distinctions between kind-referring
and substance- or specimen-referring uses. For example,
“pyridine has a boiling point of 115 ◦C” can be consid-
ered as kind-referring,5 whereas “the laboratory had to be
evacuated because pyridine had been spilled on the floor”
refers to a specific specimen of pyridine. However, there is
4In “pyridine ring”, the part-of-compound sense applies to the
whole noun–noun compound. The sense of the word “pyridine”
itself within the compound is harder to define: it may be argued
that it is ambiguous between the exact-compound sense (“the ring
found in pyridine”), the class-of-compounds sense (“the ring that
defines pyridines”) and possibly the part-of-compound sense (in
a redundant construction similar to “pine tree”). However, if we
need to annotate individual words, it makes sense from a practi-
cal point of view to annotate the word with the part-of-compound
sense.
5Carlson et al. (1995) make the same point about “gold is a
precious metal”, with the footnote: “We say ‘can be considered’
because we do not wish to prejudge the final semantic analysis to
be given.”
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a common factor in both these cases: the complete chem-
ical structure of pyridine, C5H5N. This factor also applies
in the cases of pyridine as part of a mixture of solvents,
pyridine molecules diffusing through a membrane, the ab-
stract pyridine molecule and a computer simulation of pyri-
dine. By contrast, this factor is not present in class-of-
compound uses. For example, “pyridines such as pentaflu-
oropyridine”, where the pyridine ring is present, but the five
hydrogen atoms are not. It is even possible to use the class-
of-compound use to refer to a specimen: “Yesterday I syn-
thesised pentafluoropyridine and tetrafluoropyrrole. Today
I spilled the pyridine but I still have the pyrrole.”
Regular polysemies also exist for other types of chemi-
cal named entities. Some are traditionally regarded as the
names of classes of compounds, for example “alkene” or
“ester”. These do not have an exact-compound sense but
they do possess a part-of-compound sense as well as their
class-of-compound sense. Underspecified names (Reyle,
2006) such as “dimethylpyridine” (which does not say
where the methyl groups are attached to the pyridine ring)
also have this property. Other names, such as “methyl”,
are most commonly used for parts of compounds; how-
ever these may also be used to refer to specific entities (in
compounds such as “methyl radical” or “methyl ion”) or to
classes of compounds (for example “methyl compounds”).
The names of chemical elements display an extended form
of this regular polysemy. For example, “carbon” has a bulk-
substance sense similar to the exact-compound sense for
“pyridine” and an atom sense similar to the part-compound
sense “pyridine ring”. The class sense also exists in the
form of “carbon compounds”. Finally there is arguably a
fourth sense that is unique to elements. One may, for ex-
ample, talk of “atmospheric carbon”. This is not a syn-
onym for soot particles, but refers to all of the carbon atoms
in atmospheric carbon dioxide, carbon monoxide, methane
and other carbon compounds as if they could some single
substance. Note that this is not synonymous with “atmo-
spheric carbon compounds”: one tonne of atmospheric car-
bon dioxide accounts for only 0.27 tonnes of atmospheric
carbon. This sense is unusual, as chemically it is like the
part-of-compound sense, but it typically has the grammati-
cal markings of the exact-compound sense, and is typically
substance-referring, rather than kind-referring.
Other forms of chemical nomenclature, such as chemical
formulae and acronyms, may also participate in these sys-
tems of exact-compound, part-of-compound and class-of-
compound senses. A few of these entities may be regarded
as monosemous. For example, “–CH3” unambiguously
refers to a methyl group, a part of a compound.
We present an approach to disambiguation which involves
both (i) determining which senses are available for a given
named entity, and then (ii) disambiguating the entity based
on its context. We collapse these into a single classification
task, where a single list of senses, or “subtypes”,6 is used
as the set of possible classifications for all chemical names.
This formulation as a classification problem follows Mark-
ert and Nissim (2002) and SemEval 2007 Task #8 (Markert
6We refer to subtypes rather than senses, and in general speak
of subclassification or subtyping rather than disambiguation, due
to the presence of occasional monosemous cases.
and Nissim, 2007) in their approach to metonymy.
These subtype distinctions could be used for a number of
purposes. Subtype information could be included in pat-
terns for information extraction. For example, in the ex-
traction of “A is-a B” relations, the precision could be in-
creased by only allowing relations where A is EXACT or
CLASS, and B is CLASS. Subtypes could also be useful in
an information retrieval context. For example a user could
seach for “pyridine” as EXACT only, and get only mentions
to the specific compound, and not to other pyridines.
Another use for subtypes is the assignment of identifiers
to named entities. The chemical ontology ChEBI (Degt-
yarenko et al., 2008) contains entries for specific com-
pounds, classes of compounds and parts of compounds.
These may have the same or closely related names. For ex-
ample there is an entry for “thiol group” (CHEBI:29917),
corresponding to the part-of-compound subtype, which
is part of “thiols” (CHEBI:29256), corresponding to
the class-of-compounds subtype.
Furthermore, with chemicals it is often possible to con-
cisely annotate a chemical name with the structure of the
chemical compound that it represents. There are a variety
of useful formats for storing the structures of specific com-
pounds, some of which (such as SMILES and InChI) have
useful advantages in terms of conciseness and canonicali-
sation, whereas there are fewer formats for storing classes
of compounds, and to the best of our knowledge none of
these are canonicalisable. Thus, a system of subtypes could
act in a manner analogous to the type systems used in com-
pilers, specifying what sort and format of data is needed to
represent a particular entity.
In this paper we briefly mention related work in the
gene/protein domain (section 2), describe an annotation
scheme for disambiguating these regular polysemies of
chemical named entities (section 3) and then describe an
interannotator agreement experiment (section 4). We illus-
trate the task with some examples drawn from the corpus
(section 5). Finally we present some simple systems for
automated annotation of these subtypes (section 6) and sug-
gest some directions for further work (section 7).
2. Related Work
We know of no other detailed work on this issue of ex-
act/class/part distinctions of chemical names. However
there are a few publications that touch on related issues for
gene and protein named entities.
Vlachos and Gasperin (2006) divide noun phrases that con-
tain gene names into gene mentions and other mentions. It
has been shown that these distinctions can be made with
78.6% accuracy using SVMs and syntactic parsing (Ko-
rkontzelos et al., 2007). Gasperin et al. (2007) then
classify their gene NPs as gene, product, subtype,
part-of, supertype or variant.
In the Genia ontology (Kim et al., 2003), which provides
the type system for the Genia corpus, there are subtypes
of nucleic acids and proteins, dealing with both parts and
classes of these biomacromolecules. However, there is no
such subtyping for their more chemical named entity types,
we are unaware of any inter-annotator agreement studies
44
for these distinctions, and much of the named-entity recog-
nition work based on the Genia corpus ignores these dis-
tinctions entirely, as it uses the simplified version of the
corpus used in the JNLPBA evaluations.
3. Annotation Guidelines
The work presented in this paper is based upon the named
entity annotation scheme of Corbett et al. (2007) (hence-
forth, “the named entity guidelines”), which has five classes
of named entity. These guidelines were applied to a cor-
pus of 42 chemistry papers, three each from fourteen jour-
nals covering most of chemistry (henceforth “the corpus”),
and it was shown that the guidelines could be applied with
93% inter-annotator agreement. The majority class, CM
(“chemical”), accounted for 94.1% of the named entities
in the, and includes specific chemicals, parts of chemicals
and some classes of chemicals7 with no disambiguation be-
tween them. The second most common class, RN (“reac-
tion”), was intended to mainly cover words that denoted (a
subset of) chemical reactions; however, it also included in-
stances of these words that were used to describe chemicals,
or denote the bulk movement of chemicals.
The subtypes annotation task consists of taking a corpus
that has previously been annotated for named entities ac-
cording to the named entity guidelines, and assigning one
and only one subtype to each entity that belongs to the type
CM (“chemical”), RN (“reaction”), CJ (“chemical adjec-
tive”) or ASE (“enzyme”). There are no subtypes for the
type CPR (“chemical prefix”). Each type has its own list of
available subtypes, and the subtype OTHER was available
for exceptionally difficult cases (it is expected that the use
of OTHER will occur less than once per paper).
We have developed a set of annotation guidelines (hence-
forth “the guidelines”), specifying the subtypes available
for each named entity type, and providing advice on diffi-
cult distinctions. These were developed in an iterative pro-
cess, where a proposed set of guidelines were used in an
informal inter-annotator agreement study on a batch of test
papers, and experience from that study was used to inform
the refinement of the guidelines. None of the 42 papers in
the corpus was used or referred to in this process.
The subtypes annotation applies to the named entities them-
selves, and not in general to the noun phrase that contains
them. This makes annotation easier and allows the scheme
to remain agnostic about linguistic issues surrounding the
structure of noun phrases. However in many cases the
guidelines allow head words in noun-noun compounds to
be used as cues; for example in “pyridine ring”, “ring” is a
cue that “pyridine” should be given the subtype PART.
The predominant named entity class in the corpus is CM
(chemical), encompassing 95% of the entities. We divide
this into six subtypes: three major subtypes, EXACT (for
specific compounds), CLASS (for classes of compounds)
and PART (parts of compounds, and classes of those parts),
to deal with a large majority of the named entities, and three
7The classes of chemicals had to be those that could be defined
at least partially in terms of structure (e.g. “pyridines”) and/or
elemental composition (e.g. “hydrocarbons”): classes that were
purely based on origin (e.g. “natural product”) or activity (e.g.
“antioxidant”) were excluded.
minor subtypes, SPECIES (corresponding to the fourth
subtype identified for elements in the introduction, the
sense of “atmospheric carbon”), and SURFACE (for sur-
faces) and POLYMER (for polymers), to deal with special
cases that did not fit well with the major classes.
3.1. EXACT, CLASS and PART
We distinguish EXACT from PART according to whether
the author was talking about an entity as some free item
that had an existence of its own right, rather than making a
judgement according to what sort of chemical bonds there
were inside and outside of the entity.
Our distinction between EXACT and CLASS is different
from the issue of genericity and specificity, for example as
discussed by Herbelot and Copestake (2008). Our CLASS
subtype deals with situations where the named entity itself
does not specify a specific compound. CLASS applies both
to terms denoting entire classes of chemicals and to mem-
bers of that class that are not specified by the named entity
itself, including anaphoric and deictic uses. So “pyridines”
would typically be CLASS, as would “pyridine” in “The
Hantzsch pyridine synthesis is the formation of a pyridine
from an aldehyde, a ketoester and a nitrogen donor” and in
“the pyridine 6” (where 6 is a reference to a structural dia-
gram denoting a specific pyridine). EXACT is used for the
pyridine that is called “pyridine”, as in “dissolved in pyri-
dine.” Genericity annotations in the style of Herbelot and
Copestake could conceivably be applied to entities of type
CLASS as an additional stage of processing.
3.2. SPECIES, SURFACE and POLYMER
The minor subtypes were introduced to cover particular dif-
ficulties caused by the major subtypes not entirely fitting
the domain. These subtype distinctions take precedence
over the distinctions between major subtypes: for example,
in “sodium halide surface” and “sodium chloride surface”,
“sodium chloride” and “sodium halide” are annotated as
SURFACE, even though “sodium chloride” would normally
be EXACT and “sodium halide” CLASS.
The subtype SPECIES (which is often easier to annotate
than to concisely explain or come up with a good name for),
exemplified by “atmospheric carbon”, arises from the fact
that the number of atoms of a given element is usually con-
served. In essence, SPECIES is considering atoms as part
of a bulk sample, rather than as part of the structure of a
compound, which would warrant the use of PART. There
are a number of contexts that are particularly associated
with SPECIES, for example environmental or metabolic
processes associated with a particular element, toxic metals
such as lead, mercury or polonium, and elemental analysis
techniques such as ICP. The name SPECIES derives from
the fact that in these cases the atoms of the element are of-
ten said to belong to different chemical species.
The subtype SURFACE was added because surfaces intro-
duce a confounding part-of relation. A surface is a part of
a specimen of bulk material but not a part of a chemical
structure in the way that for example a pyridine ring might
be. Also, there are forms of notation for specific types of
surface that are included within some named entities. For
example “Ag(111)” represents a specific surface of a crys-
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tal of silver with a specific arrangement of silver atoms.
This arrangement of atoms, different from the arrangement
in Ag(110), gives the Ag(111) surface different properties
from Ag(110), even though the two surfaces may be differ-
ent faces of the same specimen of silver.
Polymers are particularly difficult, hence the POLYMER
subtype. Many polymer samples consist of a mixture of
polymer molecules of varying sizes and shapes, so we could
imagine several different part-of and class-of subtypes for
polymers. As polymers are moderately rare in general
chemistry corpora it makes sense to group all of these to-
gether as POLYMER to avoid too many complications.
3.3. RN, CJ and ASE
The types other than CM accounted for only 5.9% of the
named entities in the corpus between them, and so less at-
tention was devoted to them. Briefly:
The type RN (“reaction”) was divided into three subtypes:
REACT (actual reactions), DESC (descriptions of com-
pounds), and MOVE (bulk movements of compounds). For
example, the word “chlorinated” would be REACT in “ben-
zene was chlorinated to give chlorobenzene”, DESC in
“chlorobenzene is a chlorinated compound” and MOVE in
“We chlorinated the swimming pool”.
The type CJ (‘chemical adjective’) had subtypes EXACT,
CLASS and PART, by analogy with CM, and also ACID,
SOLUTION and RECEPTOR. The names of many acids
are of the form “<something>ic acid”. Sometimes the
“<something>ic” word gets detached from its “acid”, for
example one could talk about “citric acidity”. In this case
“citric” would get the subtype ACID. SOLUTION is used
for words such as “aqueous” or “ethanolic” when they are
used to describe solutions, and RECEPTOR is used for
words such as “nicotinic” and “adrenergic” that are used
to describe types of receptors.
The type ASE, which covers words derived from chemical
names that end in -ase, has two subtypes, PROTEIN, where
the word, for example “demethylase”, refers to a protein,
and ACTIVITY, where the word refers to the ability of a
protein to perform the function of, say, a demethylase - i.e.
to catalyse demethylation reactions. Although ASE was
rare (0.7% of entities) in the corpus, we observe that the
ACTIVITY subtype is common in some subdomains. For
example, in the cytochrome P450 literature, it is common
to refer to the enzymatic demethylation of aminopyrine as
“aminopyrine demethylase activity”, even though at least
five different enzymes have this activity.
4. Inter-annotator Agreement
To test the annotation guidelines, we performed an inter-
annotator agreement study. We used the corpus of 42 chem-
istry papers of Corbett et al. (2007). These papers had
been selected from those published by the Royal Society of
Chemistry in January 2004, randomly selecting 3 full pa-
pers or short papers from each non-review journal. Those
papers had then been annotated for named entities. The
named entities in that work had been assigned to five cat-
egories, CM, RN, CJ, CPR and ASE. Only 14 papers had
been annotated by all three annotators, whereas all 42 had
been annotated by their Subject A, who is our annotator A
and the first author of this paper (Corbett). They did not
produce an adjudicated annotation.
We subclassify Subject A’s CM, RN, CJ and ASE annota-
tions with the subtype scheme described above. There were
two subjects, annotators A and B, who are the first two
authors of this paper (Corbett and Batchelor) and the au-
thors of the guidelines.8 They are both trained chemists and
were Subjects A and B in Corbett et al. (2007). We anno-
tated the papers with a custom-made software tool tool that
presented the annotators with a drop-down menu which al-
lowed them to select exactly one subtype for each of the
named entities.
During annotation the subject were allowed to refer to the
annotation guidelines, to reference sources, to their domain
knowledge as chemists, and to the original chemistry pa-
pers (including the figures). They were not allowed to con-
fer with anyone over the annotation, nor to refer to texts
annotated during development of the guidelines.
We use two metrics to assess interannotator agreement; ac-
curacy and κ (kappa). Accuracy is simply the proportion
of named entities for which both annotators gave the same
type. The κ metric is a more sophisticated measure which
factors out random agreement. We use Cohen’s κ (Cohen,
1960), where the distribution of categories is calculated in-
dependently for each annotator.
4.1. Results and Discussion
Class N n Accuracy κ (k = 2)
CM 6865 6 86.0% 0.784
RN 288 3 95.5% 0.828
CJ 60 6 75.0% 0.363
ASE 31 2 90.3% −0.045
Table 1: Inter-annotator agreement by named entity class.
N is the number of entities. n is the number of available
subtypes (excluding OTHER). k is the number of annota-
tors.
In Table 1 we can see that the κ values are acceptable
(above 0.67) for both CM and RN, whereas CJ and ASE
were not reproducibly annotated. However, between them,
CJ and ASE accounted for only about 1% of the named en-
tities in the corpus, and so this is not a major issue. Note
that the results in this table represent four essentially inde-
pendent experiments, one per named entity class.
The results for RN are very encouraging - it was easy to
annotate in the original named entity task too (F = 94%).
REACT was the majority subtype (84% by annotator A;
85% by B), with all but one of the remaining named entities
being annotated as DESC. MOVE was not adequately tested
in this exercise - a corpus from more biological domains,
such as physiology and cell biology might be a better test
of this subtype.
CJ proved to be problematic during the original named-
entity annotation too (inter-annotator F = 56%), suggesting
8This may have resulted in slightly inflated scores for inter-
annotator agreement, due to tacit understandings being developed
during guidelines development. This has been demonstrated pre-
viously, for example Corbett et al. (2007)
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that CJ represents a rather ill-defined collection of phenom-
ena. Most examples of CJ (68% by annotator A; 88% by
B) were of the subtype SOLUTION.
ASE was reliably (F = 96%) annotated in the original
named entity task. Almost all incidences of ASE were an-
notated as PROTEIN, there was two cases where one an-
notator chose ACTIVITY, one case where the other anno-
tator chose it, and no cases where both annotators chose
ACTIVITY. The subtypes of ASE would most likely be
better tested in a corpus such as the PennBioIE P450 cor-
pus (Kulick et al., 2004).
For CM, the median accuracy was 90.7%, the minimum ac-
curacy was 61.1%, and two papers (one containing 2 CM
entities, one containing 86) were annotated with 100% ac-
curacy. This concurs with the annotators’ experiences that
the subject matter and writings styles encountered in some
papers presented particular difficulties.
Subtype N % N % F (%)
EXACT 3402 49.5 3246 47.3 89.9
CLASS 1114 16.2 1125 16.4 81.7
PART 1982 28.9 2118 30.9 84.3
SPECIES 233 3.4 194 2.8 77.3
SURFACE 73 1.1 131 1.9 63.7
POLYMER 58 0.8 49 0.7 74.8
OTHER 3 0.04 2 0.03 0.0
Table 2: Breakdown of subtypes of CM. Columns 2 and 3
show numbers of entities found by annotator 1, columns 4
and 5 show annotator 2.
Table 2 shows a breakdown of the results for CM. 95% of
the entities fell into one of the three major subtypes, with
slightly less than half being EXACT. There was little need
to resort to using OTHER. In general, the ease of annotating
a subtype, as measured by the F score, appears to correlate
quite well with how common the subtype is. This is unsur-
prising, as the minor subtypes were invented as a means of
dealing with tricky cases.
None of the F scores seen here are as high as the 93%
that was achieved for the original named entity annotation,
which suggests that the subtypes task is a harder task (at
least for human annotators) than named entities.
Table 3 shows the confusion matrix for CM. Intuitively one
might have expected a large confusion between CLASS and
PART, owing to the ambiguous use of terms to mean both
functional groups and compounds possessing them, but this
is not especially marked. Evidently the guidelines were
largely sufficient to address this issue. EXACT/PART ambi-
guity appears to be a larger issue, with one annotator having
a bias towards EXACT and another towards PART.
5. Examples
In these examples, named entities of type CM are under-
lined.
5.1. EXACT, CLASS and PART
Corbett et al. (2007) draw an example from the corpus
which is worth repeating here:
In addition, we have found in previous stud-
ies that the Zn2+–Tris system is also capable of
efficiently hydrolyzing other β-lactams, such as
clavulanic acid, which is a typical mechanism-
based inhibitor of active-site serine β-lactamases
(clavulanic acid is also a fairly good substrate of
the zinc-β-lactamase from B. fragilis).
In this example, “clavulanic acid” is obviously EXACT, and
“β-lactams” is very strongly marked as CLASS. “Zn2+–
Tris” was annotated as a whole named entity, and refers to
a specific complex, and so is also EXACT. More interest-
ing is the mention of “serine”, as part of the name of the
enzyme family “serine β-lactamases”. Here, background
knowledge is required to know that the serine is mentioned
as the catalytic amino acid residue, rather than as the sub-
strate of the enzyme. As such, it is referring to a serine
residue as part of a protein, and is annotated as PART; ser-
ine as a free amino acid would be annotated as CLASS.
Another, more difficult, example can be taken from the
same source text:
[. . . ] it has been proposed that the metal
ions bind to the β-lactam carboxylate group, pro-
moting the attack of external hydroxide on the
β-lactam carbonyl group.
“Carbonyl” and “carboxylate” are both clearly PART here.
“Hydroxide” presumably means a hydroxide ion. The neg-
ative charge of the hydroxide ion makes it impossible to get
a bottle of hydroxide ions, and hydroxide is often a part of
salts such as sodium hydroxide; however, in this case it is a
free species, independent of any positive ion, and so can be
annotated as EXACT.
The real difficulty concerns “β-lactam”, where we must
disambiguate CLASS from PART (there is no such com-
pound as “β-lactam”, so EXACT is inappropriate). Here,
we need background knowledge to know that β-lactam
rings contain carbonyl groups, they do not contain carboxy-
late groups, and that the β-lactams studied in the paper do
not contain carboxylate groups directly attached to the β-
lactam ring system. It is also useful to know that carboxy-
late groups themselves contain carbonyl groups. Given this
knowledge, we can deduce that the first β-lactam must be
CLASS, and the second PART. In the second case, there are
at least two carbonyl groups to consider: the carbonyl group
in the β-lactam ring, and the carbonyl group in the car-
boxylate group. The authors disambiguate between these
carbonyls, specifying the former of the two, with “the β-
lactam carbonyl” where “β-lactam” specifies the location
of the carbonyl group. However, in the case of the car-
boxylate group, it is neither a part of the β-lactam ring nor
attached to it, so the PART reading is inappropriate and the
“β-lactam” therefore must specify the whole molecule, so
CLASS is the correct annotation.
In another paper, we encounter the following exam-
ple, where “FA” stands for “fatty acid” and “LPS” for
lipopolysaccharide (a biomacromolecule; not a chemical
named entity according to the guidelines):
After 2h of hydrolysis, 14:0 3-OH FA, the
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EXACT CLASS PART SPECIES SURFACE POLYMER OTHER
EXACT 2988 92 258 10 52 2 0
CLASS 87 915 90 14 8 0 0
PART 136 102 1729 5 4 4 2
SPECIES 27 11 28 165 2 0 0
SURFACE 3 0 2 0 65 3 0
POLYMER 3 5 10 0 0 40 0
OTHER 2 0 1 0 0 0 0
Table 3: Confusion matrix for subtypes of CM.
only 3-OH FA in the LPS of E. coli, was detected
in GC-MS analysis.
Here, “3-OH FA” refers to a fatty acid as part of a larger
biomacromolecule, much like the “serine” in the first ex-
ample, and is clearly PART. However, “14:0 3-OH FA” ap-
pears to be referring to the fatty acid once it has been hy-
drolysed from the LPS and become a free fatty acid, and
thus is annotated as EXACT. This reading is further rein-
forced by background knowledge of GC-MS, an analyti-
cal technique that is well-suited to the detection of small
molecules but which is unlikely to be useful for the detec-
tion of whole biomacromolecules.
5.2. SPECIES, SURFACE and POLYMER
Selenized yeast contains a large number of
water-soluble selenium compounds but most of
the selenium is incorporated into sparingly solu-
ble bio-molecules that are difficult to extract.
The first “selenium” is part of the phrase “selenium com-
pounds”, and therefore is annotated as CLASS, whereas the
second “selenium” is annotated as SPECIES.
In the cases of sulfate surfaces previously
studied, the frictional asymmetry was detected at
monatomic steps where the tilt directions of the
sulfate ions were reversed.
Here the first “sulfate” takes CLASS, as the paper had men-
tioned minerals such as calcium sulfate and strontium sul-
fate; however, in this case SURFACE is required. The sec-
ond case is clearly not talking about a whole surface, and
so one annotator chose PART and the other EXACT.
Both of the separations make use of resin-
based anion exchange columns with quater-
nary ammonium fuctional (sic) groups. The
PRP-X100 column (Separation 1) utilizes a
poly(styrene–divinyl)benzene polymeric support
while the IC-Pak A HR column (Separation 2) is
based on a polymethacrylate resin.
The last two entities here are both POLYMER. Nei-
ther “poly(styrene–divinyl)benzene” nor “polymethacry-
late” fully describe the polymeric compounds used; in both
cases, the compounds incorporate some monomeric build-
ing blocks bearing ammonium groups.
6. Automated Systems
In this section we discuss some simple automated systems
for assigning subtypes. These systems are intended to pro-
vide a simple measure of the difficulty of the problem, and
to set a baseline for future systems. This section focuses
exclusively on CM as the named entity type of interest, and
uses the annotations produced by annotator A.
The simplest baseline is to annotate everything as EXACT.
This achieves an accuracy of 49.5% against annotator A but
a κ of zero.
To improve on this, we make use of a simple machine learn-
ing system based on a maximum-entropy classifier9. We
evaluate the classifier using three-fold cross validation, with
each fold consisting of one-third of the papers (one from
each journal). We explore several possible features, con-
sidering each feature both in isolation and in combination
with the other features.
For simplicity, we consider only features that are easy
to obtain; we use the tokeniser described by Corbett et
al. (2007) (and combine multi-token named entities into a
single token, converting whitespace within them to under-
scores) and no other NLP components such as POS tag-
gers or parsers. This is useful as we do not know of any
of these which have been specifically trained for chemistry
text. Furthermore, in the scenario where an NER system is
run prior to parsing, as a method for unknown word iden-
tification, it seems likely that the extra information from
subtype classification will be useful for a parser.
We use two types of feature, name-internal and name-
external. Name-internal features often determine what sub-
types are possible for a name and their probability distri-
bution, and name-external features can be used to disam-
biguate these possibilities.
The two name-internal features are (“name”), the unmodi-
fied name itself which when used alone implements a first
sense heuristic (see McCarthy et al. (2007) for a discussion
of this heuristic in general WSD), backing off to the most
common subtype if the name has not been seen in the train-
ing corpus, and (“suffix”), which is the last four characters
of the name, or the whole name if it is shorter than that.
The suffixes of chemical names are often informative; for
9We use the OpenNLP MaxEnt classifier,
http://maxent.sourceforge.net/. If it is required to classify
an instance with no features, it returns a uniform probability
distribution. To fix this, and get a probability distribution
representative of the training data as a whole, all training and test
instances are given a single “bias” feature.
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example, names ending in “yl” are likely to prefer PART
(e.g. “methyl”), whereas names ending in “oid” are likely
to be CLASS (e.g. “alkaloid”). A small amount of experi-
mentation shows that four is the best number of characters
to use. Finally, we can detect whether or not a name is plu-
ral (“plural”) by looking for a terminal “s”; irregular plurals
are very rare in chemical names, and singular names ending
in “s” (e.g. “chlorpyrifos”) are uncommon.
We propose two simple name-external features; the previ-
ous token (“previous”) and the next token (“next”). These
tokens may include punctuation tokens. The XML format
that is used for our tokens marks up citation references
(which appear as numbers in superscript) - if the next or
previous token is one of these, we skip it and take the next
next token or previous previous token instead. Furthermore,
if the next token is a hyphen, we skip over the hyphen. As
such, “pyridine-based” and “pyridine based” are treated the
same by our system.
The “next” feature is expected to detect many of the
head words in noun–noun compounds. Often they imply
PART (e.g. “group”, “ring”, “bond”), or spectroscopic fea-
tures that derive from parts of compounds (e.g. “peak”,
“stretch”). Some head words typically signify EXACT (e.g.
“molecules”), whereas others typically specify CLASS (e.g.
“compounds”). Furthermore the presence of punctuation or
a common verb is likely to indicate the name is the head of
its noun phrase, weighing against PART.
The previous token feature in effect combines several forms
of evidence. For example, the presence of a determiner sig-
nifies that EXACT is unlikely.10 Conversely, a preposition
helps to indicate a bare noun phrase and is thus likely to
constitute evidence in favour of EXACT. Some premodifiers
can distinguish bulk elements from atoms of that element
(e.g. “elemental”, “molecular”, “dry”), and some others
are likely to be good indicators of SPECIES (e.g. “atmo-
spheric”, “dietary”, “total”). Some premodifiers are also
useful as evidence of PART, (e.g. “bridging”, “terminal”).
We test the system with several feature sets. The fea-
ture set “all” contains all of the features, and “none” is
a feature-free setup that always selects the most common
subtype. The feature set “name” only uses the name fea-
ture, “−name” uses all of the features except for the name
feature. The other feature sets follow this naming scheme,
except for “internal”, which is a combination of “name”,
“suffix”; “plural”, and “external”, which is a combination
of “next” and “previous”; and “p+p+n”, which combines
“plural”, “previous” and “next”.
Table 4 shows the influence of the various features. It is
clear that all five features are useful in this task, with “next”
being particularly important. Interestingly, the features
“plural” and “previous” can be contrasted with “name” and
“suffix”, in that the former pair seem to be more impor-
tant as part of a large feature collection, whereas the lat-
ter pair work quite well on their own but are less impor-
tant in the combined feature set. This observation inspired
the “p+p+n” feature set, which showed that removing both
“name” and “suffix” had a much larger effect than remov-
10Markert and Nissim (2005) find that the presence of a de-
terminer is a good feature for identifying org-for-product
metonymy, as is a word being plural.
Feature set Accuracy κ
none 49.5% 0.0
name 56.2% 0.213
suffix 59.2% 0.303
plural 53.4% 0.114
previous 54.2% 0.208
next 61.0% 0.311
internal 60.9% 0.334
external 61.9% 0.364
p+p+n 65.6% 0.434
−name 67.3% 0.468
−suffix 67.0% 0.459
−plural 66.1% 0.447
−previous 66.7% 0.452
−next 62.0% 0.372
all 67.4% 0.470
Table 4: Automated results for CM by feature set
ing either one of them, demonstrating a large amount of
redundancy between them.
Subtype Precision Recall F
EXACT 70.9% 83.4% 76.7%
CLASS 65.6% 46.1% 54.2%
PART 62.0% 57.8% 59.8%
SPECIES 53.6% 48.5% 50.9%
SURFACE 94.1% 21.9% 35.6%
POLYMER 71.4% 8.6% 15.4%
Table 5: Automated results for CM by subtype. The com-
puter did not assign OTHER to any name.
Table 5 shows the breakdown for the “all” feature set,
by subtype. The more common subtypes are more easily
recognised, with recall being bad for the rare subtypes.
Overall, it is clear that the problem is at least partly
tractable, but also that considerable improvements will have
to be made to get good accuracy.
It is obvious that there are a number of directions in which
this baseline system could be extended. As well as experi-
menting with different machine-learning techniques, an ob-
vious approach is to use a parser rather than simple prox-
imity to generate context features. It may also be possi-
ble to look at the larger context; for example, the mention
of elemental analysis techniques such as ICP may indicate
an increased likelihood of SPECIES. Additional name-
internal features could also be useful. For example, there
are a number of class terms available which can be in-
cluded in systematic names, such as “alkyl”, “acyl” and
“halo”, the presence of which could be used to rule out
EXACT. Furthermore, the parsing and interpretation of sys-
tematic names could be helpful (Reyle, 2006). For exam-
ple, “dimethylpyridine” is ambiguous; there are several dif-
ferent ways to put two methyl groups on a pyridine ring.
This ambiguity means that EXACT is not likely to be ap-
propriate in this case.
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7. Further Directions
The obvious next steps with this system of annotations
are to experiment with greater quantities and other gen-
res of chemical text, and to explore more sophisticated ap-
proaches to the automation of the annotation. However
there are a few areas in which the annotation scheme itself
could be extended.
It is clear that some of the subtypes could themselves be
divided up into subsubtypes. PART is the most obvious
of these, covering functional groups, rings, chains, atoms,
bonds, ligands in complexes, amino acid residues in pro-
teins and a few other systems. Furthermore it would be
useful to distinguish between precisely-specified parts (e.g.
“methyl”) and classes of parts (e.g. “alkyl”). For CLASS it
would be useful to distinguish truly generic uses from uses
that mention a specific compound but not by name. For
EXACT, there are cases where there is not quite enough in-
formation in the named entity itself to make a full distinc-
tion. For example, in both “sodium metal” and “sodium
ion”, the named entity (according to the annotation guide-
lines) is “sodium”, and the subtype in both cases is EXACT.
Resolving these cases to point to the correct entries in a
database will require more information than the named en-
tity itself and the subtype.
There are also cases where what is understood by “a spe-
cific compound” is variable. For example, lactic acid is a
chiral molecule which has left- and right-handed forms, L-
lactic acid and D-lactic acid. A mention of “lactic acid”
in text may indicate either form, a mixture of the two, or
that the author did not remember, care or know that the two
forms of the compound existed.
8. Conclusion
We have identified subtypes of the chemical named enti-
ties defined by Corbett et al., and have produced extensive
annotation guidelines for them. We have shown that the
inter-annotator agreement is acceptable for the named en-
tity types CM and RN across the major genres of chemistry
papers. Furthermore we have demonstrated a simple sys-
tem for automatically making these assignments, showing
that the problem is both tractable and non-trivial, and set-
ting a baseline for future systems. These annotations will
assist in the assignment of ontology identifiers to chemical
named entities, and should be useful in information extrac-
tion and information retrieval systems.
The annotation guidelines are available by contacting the
first author.
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Abstract
Chemical compounds like small signal molecules or other biological active chemical substances are an important entity class in life
science publications and patents. The recognition of these named entities relies on appropriate dictionary resources as well as on training
and evaluation corpora. In this work we give an overview of publicly available chemical information resources with respect to chemical
terminology. The coverage, amount of synonyms, and especially the inclusion of SMILES or InChI are considered. Normalization of
different chemical names to a unique structure is only possible with these structure representations. In addition, the generation and
annotation of training and testing corpora is presented. We describe a small corpus for the evaluation of dictionaries containing chemical
enities as well as a training and test corpus for the recognition of IUPAC and IUPAC-like names, which cannot be fully enumerated in
dictionaries. Corpora can be found on http://www.scai.fraunhofer.de/chem-corpora.html
1. Introduction
In life science and chemical research a huge amount of
new publications, research reports and patents is produced
every year. High efforts were made to improve named entity
recognition (NER) to support researchers to cope with the
growing amount of publications. Analysis of the quality of
developed methods have been focused to a great extend on
the recognition of gene and protein names. Corpora for the
main model organisms have been annotated and different
systems have been evaluated in international assessments.
The identification of protein and gene names is still a chal-
lenge but as a result of the mentioned efforts, dictionary and
rule based methods as well as machine learning techniques
are now well established for protein and gene mentions
in text. The Proceedings of the BioCreative II challenge
(Hirschmann et al., 2007) give a good overview about the
state-of-the-art methods and their performance.
A further important entity class is composed of small chemi-
cal compounds, for instance artificial substances, like drugs,
or the organism’s own biomolecules like metabolites or
small signaling molecules. They are analyzed in many bio-
logical, medical or pharmacological studies to clarify their
effect onto biological systems or to study the biological
systems on its own.
In contrast to genes coded through a nucleotide sequence
and protein macromolecules coded through amino acid se-
quences these small chemical molecules are represented in
structures. InChI and SMILES are chemical structure descrip-
tions that have been developed to refer to a compound with
a unique textual compound identifier. In addition the largest
commercial chemical database (CAS) provide for its whole
chemical compound content unique CAS registry numbers
(e.g. 50-78-2 for Aspirin). These numbers are are often used
for normalization in the chemical community but they are
proprietary and contain no structural information. Because
of a limited readability of such specifications for humans,
trivial names or drug trade names and the nomenclature
published by the International Union of Pure and Applied
Chemistry (IUPAC, (McNaught and Wilkinson, 1997)) is
commonly applied (Eller, 2006) in text. Also combinations
of the different types of names as well as abbreviations,
especially of often used substances, are in use.
A number of systems deal with the entity class of chemical
names, spanning from manually developed sets of rules
(Narayanaswamy et al., 2003; Kemp and Lynch, 1998),
grammar or dictionary-based approaches (Anstein et al.,
2006; Kola´rˇik et al., 2007; Rebholz-Schuhmann et al., 2007)
to machine learning based systems (Sun et al., 2007; Corbett
et al., 2007).
Semantic search, classification of recognized names, or
structure and substructure searches are improved by normal-
izing the names to the corresponding structure. Chemical
dictionaries containing structural representation allows for
direct mapping of recognized names to the corresponding
structure at the same time. Therefore one main task during
the development of dictionary based systems is the genera-
tion of comprehensive resources providing synonyms and
unique identifiers for the normalization of the entities of
interest.
For other representations of chemical structures like
SMILES, InChI or IUPAC names such an enumeration is
only possible for the most common substances. The full
chemical space cannot be enumerated. Therefore dictionary
independent systems are necessary for the recognition of
these names. For machine learning based systems as well
as for system evaluation, the annotation of text corpora is
another main challenge.
To our knowledge, no general overview or evaluation on pub-
licly available terminology resources, like databases, cover-
ing chemical entities is available. In this work, we give a sur-
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vey of different data sources, and evaluate the general usabil-
ity of the contained chemical terminology for Named Entity
Recognition. Unfortunately, none of the corpora used for the
existing approaches mentioned above is publicly available
for the evaluation and development of new methods. There-
fore, we annotated new corpora and provide them publicly
together with the annotation guidelines on http://www.
scai.fraunhofer.de/chem-corpora.html.
IUPAC and IUPAC-like names have been identified with a
machine learning approach that is based on Conditional
Random Fields (Lafferty et al., 2001). Beside trivial names,
these are used most often in publications and cannot be
enumerated fully in dictionaries (more details can be found
in (Klinger et al., 2008)). We discuss our experiences in the
generation and annotation of the corpora and give a short
overview on the results.
2. Terminological Resources
Entity recognition approaches that are based on dictionaries
rely on comprehensive terminology resources containing
frequently used synonyms and spelling variants. An example
excerpt of an extracted dictionary is given in Table 1. As for
proteins and genes, databases could be a valuable resource
to obtain chemical named entities and their synonyms. In
this section we give an overview on available data sources.
Until recently, when the academic community started to
build information sources for biologically relevant chemical
compounds, chemical information was only available from
commercial databases. The most important and largest re-
sources not freely available are the CAS REGISTRY1, the
CrossFire Beilstein2 database, and the World Drug Index3.
For a deeper analysis we focus on freely available resources
basically used in biomedicinal research. These are databases
with public chemical content, thesauri and an ontology that
have been growing over the last years. We concentrate on
entities belonging to the class of small organic molecules
and drugs from the context of human studies. Some of them
contain very specific information and others cover a broad
chemical space. The database PubChem4 (Wheeler et al.,
2008), the ChEBI ontology5 (Degtyarenko et al., 2008), and
MeSH6 represent sources for a broad chemical space.
The more specialized data sources DrugBank7(Wishart et al.,
2008) and KEGG Drug8 (Kanehisa et al., 2008) were con-
sidered as drug terminology resources. KEGG Compound9
and the Human Metabolome Database (HMDB)10 (Wishart
et al., 2007) have been chosen as terminology resources for
metabolic substances.
1http://www.cas.org/expertise/cascontent/
registry/index.html
2http://www.beilstein.com/
3http://scientific.thomson.com/products/
wdi/
4http://pubchem.ncbi.nlm.nih.gov/
5http://www.ebi.ac.uk/chebi/init.do
6http://www.nlm.nih.gov/mesh/meshhome.
html
7http://drugbank.ca/
8http://www.genome.jp/kegg/drug
9http://www.genome.jp/kegg/compound
10http://hmdb.ca/
This survey does not claim to give a complete overview of all
available chemical information resources. There is a number
of other databases and resources covering specialized chem-
ical information and a broader chemical space, e.g. UMLS11
(Nelson et al., 2002) implying MeSH, MedlinePlus12, and
ChemIDplus13 (Tomasulo, 2002).
2.1. Commercial Databases
CrossFire Beilstein database is a large repository for in-
formation of over 10 million organic compounds, determin-
ing their bioactivity and physical properties, ascertaining the
environmental fates and their reactions. Beside structural
information the entities are associated with chemical and
physical facts, bioactivity data, and literature references.
CAS REGISTRYSM provided by CAS, is one of the
largest databases of chemical substance providing infor-
mation about more than 33 million organic and inorganic
substances as well as over 59 million sequences. To each
substance, a unique ID (CAS Registry Number) is assigned,
generated by CAS to link between the various nomenclature
terms as a kind of normalization. These IDs have long been
used as reference to chemicals in other databases as well as
in text.
The World Drug Index contains chemical and biomedi-
cal data for over 80,000 marketed and development drugs
with internationally recognized drug names, synonyms,
trade names, and trivial names. Each record has a chemi-
cal structure and is classified by drug activity, mechanism
of action, treatment, manufacturer, synonyms, and medical
information.
2.2. Freely available Resources
From all resources introduced in this section individual dic-
tionaries have been created and evaluated on the EVAL cor-
pus (see Section 5.1).
PubChem consists of three linked databases – PubChem
Substance, PubChem Compound, and PubChem BioAssay.
They are part of the NCBI’s Entrez information retrieval sys-
tem14. PubChem Compound contains 18.4 million entries
of pure and characterized chemical compounds, structure
information, SMILES, InChI, and IUPAC but no further syn-
onyms. PubChem Substance provides 36.8 million entries
with information about mixtures, extracts, complexes, and
uncharacterized substances or proteins. It comprises syn-
onyms in the form of trivial names, brand names, IUPAC,
but no SMILES, and only few mappings to InChI names. For
the chemical dictionary names and synonyms as well as the
chemical structure information are needed. Therefore a Pub-
Chem subset dictionary was generated with all PubChem
Substance entries containing names, synonyms and links to
corresponding entries of PubChem Compound (5,339,322
records).
Chemical Entities of Biological Interest (ChEBI) is a
freely available controlled vocabulary of small molecular
11http://www.nlm.nih.gov/research/umls/
12http://medlineplus.gov/
13http://chem.sis.nlm.nih.gov/chemidplus/
14http://www.ncbi.nlm.nih.gov/
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i idi Si
1 DB06151 CC(=O)NC(CS)C(=O)O; InChI=1/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-
/m0/s1/f/h6,8H; Acetylcysteine; ACC; Mucomyst; Acetadote; Fluimucil; Parvolex; Lysox; Mucolysin;
(2R)-2-acetamido-3-sulfanylpropanoic acid; . . .
2 DB05246 CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2; InChI=1/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-
10(14)13(2)11(12)15-/h3-7H,8H2,1-2H3; Methsuximide; Petinutin; Celontin; 1,3-dimethyl-3-
phenylpyrrolidine-2,5-dione; . . .
Table 1: Example for a dictionary based on DrugBank, usually incorporated in rule based Named Entity Recognition systems.
The identifier (in this case a DrugBank identifier) is denoted with idi, the set of synonyms with Si.
entities that intervene in the processes of living. Entities are
organized in an ontological classification and are grouped
by their chemical structure and functional properties. Gen-
eral chemical class terms, biological and pharmacological
functions, and compounds with general names are covered
as well as synonyms of the form of trivial name, IUPAC, and
sum formula. For most of the chemical compounds SMILES
and InChI names are given. We used the release version 35
of ChEBI provided in the OBO-format.
Medical Subject Headings (MeSH) is a controlled vo-
cabulary thesaurus from the National Library of Medicine
(NLM)15. It is used by NLM for indexing articles from the
MEDLINE PubMED database as well as a catalog database
for other media of the library. The terms are organized in
a hierarchy to which synonyms as well as inflectional term
variants are assigned. A subset of the MeSH thesaurus (ver-
sion 2007 MeSH) covering the chemical category of MeSH
(tree concepts with node identifiers starting with ’D’) was
extracted to give one dictionary of MeSH (referenced further
as MeSH T). Furthermore, NLM provides a compound list
with over 175,000 entries containing synonyms like triv-
ial and brand names, IUPAC and abbreviations which was
used to generate another dictionary, referenced further as
MeSH C.
Kyoto Encyclopedia of Genes and Genomes (KEGG)
is a composite database that integrates genomic, chemical,
and systemic functional information. Two sub-databases –
KEGG COMPOUND and KEGG DRUG – are considered
to be terminology resources for the dictionary creation. The
types of compounds provided by KEGG COMPOUND span
from single ions (e.g. Mg2+), simple compounds (like differ-
ent sugars or cofactors of enzymes, metabolites, products of
microorganisms, or nuclear receptor compounds like GW
6471) to peptides and basic RNAs – all essential endogenous
molecules of cells. KEGG DRUG covers all approved drugs
in the United States of America and Japan. Every entry of
both databases is linked to a unique chemical structure and
to standard generic names that could be of the type IUPAC
and trivial name. For the creation of the two dictionaries
KEGG C and KEGG D the fields ‘NAME’, ‘FORMULA’,
and ‘DBLINKS’ of the KEGG proprietary format files com-
pound and drug have been used.
DrugBank is a specific database about pharmaceuticals,
that combines detailed chemical, pharmacological, and phar-
maceutical information with drug target information. It
15http://www.nlm.nih.gov/
Resource Number of entries
CrossFire Beilstein 10 mio.
CAS 33 mio.
World Drug Index 80,000
PubChem C; PubChem S 18.4 mio.; 36.8 mio.
MeSH T 8,612
MeSH C 175,136
ChEBI 15,562
KEGG (K-C; K-D) 21,498 (15,033; 6,834)
DrugBank 4,764
HMDB 2,968
Table 2: Total number of entities contained in chemical in-
formation resources (PubChem C: PubChem Com-
pound; PubChem S: PubChem Substance; K-C:
KEGG-compound; KEGG-Drug)
provides trivial, brand, and brand mixture names, IUPAC
and a structure for almost every entity as SMILES or InChI.
DrugBank is available as a single file in a proprietary format.
Following fields have been extracted: ‘Name’, ‘Synonyms’,
‘Brand Names’, ‘Brand Mixtures’, ‘Chemical IUPAC Name’,
‘Chemical Formula’, ‘InChI Identifier’, ‘Isomeric SMILES’,
‘Canonical SMILES’, and ‘CAS Registry Number’.
Human Metabolome Database (HMDB) is a freely
available database containing detailed information about
small molecule metabolites found in the human body. The
focus lies on quantitative, analytic or molecular scale infor-
mation about metabolites, their associated enzymes or trans-
porters and their disease-related properties. The database
currently contains nearly 3000 metabolite entries, like hor-
mones, disease-associated metabolites, essential nutrients,
and signaling molecules as well as ubiquitous food additives
and some common drugs. HMDB is downloadable as a
single file with a similar proprietary format as DrugBank.
Following fields have been extracted: ‘Name’, ‘Common
Name’, ‘Synonyms’, ‘Chemical IUPAC Name’, ‘Isomeric
SMILES’, ‘Canonical SMILES’, ‘InChI Identifier’, and ‘CAS
Registry Number’.
3. Analysis of the Chemical Information
Resources
In this section we discuss the general usability of the above
mentioned resources for dictionary based named entity
recognition approaches. The resources were analyzed with
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Figure 1: Plot of the synonym count distribution for the analyzed databases
PubChem subset MeSH T ChEBI DrugBank HMDB MeSH C KEGG
SMILES 4,080,909 — 8,371 4,489 2,881 — —
InChI 4,080,909 — 8,280 4,486 2,859 — 17,021
CAS 397,858 — 4,566 2,223 2,527 175,136 13,545
Percentage of synonyms 100 % 22 % 56 % 66 % 54 % 28 % 79 %
covered by PubChem
Cross references yes — yes yes yes — yes
Total No. of entries 5,339,322 8,612 15,562 4,764 2,968 175,136 21,498
Table 3: Overview of the linkage of the entities to structure information in the analyzed data sources. For PubChem only
PubChem Substance entries containing a PubChem Compound link were included. For KEGG the respective values
of the drug and compound sub-databases were unified. For the PubChem coverage all synonyms of all entries are
compared.
regard to following properties:
• Total number of entries,
• Provided number of synonyms,
• Linkage to a structure, and
• Cross linkage to other databases.
Table 2 gives an overview about the total amount of the
entities provided by the analyzed sources. All commercial
databases contain a huge number of chemical entities, re-
flecting their growth for a long time. In comparison to them,
PubChem is the biggest collection of public chemical data,
followed by MeSH compounds. The remaining specialized
resources, like DrugBank or HMDB, contain fewer enti-
ties but highly comprehensive biomedical information about
them. Figure 1 reflects the distribution of the occurrences
of synonyms for every analyzed resource. Most entries con-
tain only few synonyms. Entries of PubChem, both MeSH
dictionaries, and DrugBank as well as HMDB contain a
high amount of synonyms. A high number of provided
synonyms is of high value for the creation of the dictionar-
ies. A comprehensive coverage of the chemical terms and
their synonyms used in text leads to a good performance
of a dictionary-based NER approach by avoiding a high
false negative rate. Comparison of the synonyms contained
in PubChem to the other databases (cf. Table 3) showed
that there are differences in the synonym coverage in the
analyzed resources. About 79 % of the KEGG synonyms
are included in PubChem and 55 % of the CheBI entities
but only 22 % of the MeSH tree synonyms could be found.
Combining all analyzed dictionaries, 69 % of the synonyms
are not from PubChem but from the other resources. Hence,
it is meaningful to use an all-integrating dictionary. instead
of incorporating only PubChem.
Table 3 presents the number of the resource which are
mapped to InChI, SMILES or CAS. Unique representations
are relevant for the mapping and normalization of the identi-
fied chemical names from text to a chemical structure. All
entries in the selected PubChem subset contain InChI infor-
mation and two third of the entries contain the CAS registry
number. Most entries in DrugBank, HMDB, ChEBI are
mapped to all three chemical representations and in KEGG,
InChI and CAS registry numbers are included. All entries
of MeSH C are mapped to CAS identifiers but no other
chemical representations like InChI is given.
In addition no cross references to other data sources are
included. The other sources contain a high number of cross
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references and references to PubChem, KEGG and ChEBI
are given in all databases. PubChem contains the highest
number of cross references and in addition links to MeSH.
4. Annotation and Corpus Generation
For evaluation purposes of NER-systems as well as for the
training of machine learning based methods annotated cor-
pora are needed. Corbett et al. (2007) describe a corpus
annotation, but the corpus as well as the annotation guide-
lines are not publicly available. Because annotated corpora
for the chemical domain are not public available yet, we
describe three corpora consisting of MEDLINE abstracts. A
small evaluation corpus (EVAL corpus) containing entities of
all classes described in Tables 3 and 4.1 has been annotated
to give an overview of the different chemical name classes
found in MEDLINE text. This corpus will be used for a first
assessments of chemical dictionaries and for the evaluation
of methods for chemical name recognition. In addition, a
training and a test corpus was generated for the machine
learning based recognition of IUPAC and IUPAC-like names
and has been annotated with the classes IUPAC and PART. In
the following sections our assignment of chemical terms to
various defined annotation classes and the corpus annotation
is described.
4.1. Chemical Entity Classes used for the Annotation
To allow an annotation even for non-chemical experts a
simplified classification schema with respect to chemical
classification was developed. The defined classes are IU-
PAC, PART, TRIVIAL, ABB, SUM, and FAMILY, shown
in Table 3 with descriptions and examples. The separa-
tion between TRIVIAL and IUPAC names is based on the
term length, names with only one word were classified as
TRIVIAL even if they were IUPAC names. Multi word sys-
tematic and semi-systematic names are always annotated
as IUPAC. This includes names that imply only a IUPAC-
like part (e.g. 17-alpha-E) or names including a labeling
(e.g. 3H-testosterone). This does not follow strictly the
definition of IUPAC, but such terms are less likely contained
in databases and cannot be found with a pure dictionary-
based approach. For the correct resolution of enumerations,
partial chemical names have been annotated separately as
PART, but chemical names were not tagged in other entities
(e.g. in protein names). Names were only tagged as FAM-
ILY if they describe well defined chemical families but not
pharmacological families (e.g. glucocorticoid was labeled
but not anti-inflammatory drug). Substances used as base
for building various derivates and analogs were tagged as
IUPAC, not as FAMILY (e.g. 1,4-dihydronaphthoquinones).
More examples and their labels used for the annotation are
provided for clarification in Table 4.1. All defined classes
were used for the annotation of the evaluation corpus. This
annotation allows the assessment of distribution of chemical
names in MEDLINE text and the coverage of the different
dictionaries and recognition approaches. We do not imply to
use this classification as final annotation scheme for chem-
ical name annotation. Further iterations of evaluation and
annotation are necessary and are work in progress including
more chemical experts.
4.2. Corpus Selection for the Annotation and
Evaluation of all Chemical Classes
Based on the assumption that abstracts containing IUPAC
names also contain other nomenclatures, a preliminary sys-
tem for detecting IUPAC names as described in Section 4.3
(Klinger et al., 2008) was applied to select abstracts from
MEDLINE containing at least one found entity. Next to
abstracts selected with this procedure, we selected abstracts
containing problematical cases as well as those containing
no entities. This procedure formed a corpus of 100 abstracts
containing 391 IUPAC, 92 PART, 414 TRIVIAL, 161 ABB,
49 SUM, and 99 FAMILY entities.
4.3. Corpus Generation for the Recognition of IUPAC
and IUPAC-like Entities
As a training corpus for a Conditional Random Field (CRF),
463 abstracts have been selected from 10,000 sampled ab-
stracts from MEDLINE. It was annotated by two indepen-
dent annotators. A conclusive training corpus was generated
using a combination of both annotations by an independent
person. This resulted in a corpus containing 161,591 tokens
with 3,712 IUPAC annotations. Here, the class PART was
included in the class IUPAC due to morphological similarity
of these classes which is important for the machine learning
approach described in Section 5.2.
A test corpus was selected to test the system trained on
the above described training corpus. For that, 1000 MED-
LINE records with 124,122 tokens were sampled equally
distributed from full MEDLINE and has been annotated. It
comprises 151 IUPAC entities. The sampling process ensures
to have representative text examples of the full MEDLINE.
This is especially beneficial for a correct analysis of the false
positives.
4.4. Inter-Annotator Agreement
For the corpus with all chemical entities described in Sec-
tion 4.2 and the training corpus described in Section 4.3, the
inter-annotator agreement was evaluated.
Recognizing the boundaries without considering the differ-
ent classes on the test corpus described in Section 4.2, the
inter-annotator F1 is 80 % and for the IUPAC entity in the
training corpus, the F1 measure is 78 %. For both corpora
conclusive corpora were generated. The conclusive train-
ing corpus and the first-annotated corpus differ to a lower
degree, the inter-annotator F1 measure is 94 %. In contrast
Corbett et al. (2007) claimed 93 % for the training corpus
for the system OSCAR. One reason for the lower F1 measure
in the first annotation in comparison to the result of Corbett
and his colleagues is our differentiation of the IUPAC entity
to other chemical mentions. The appropriate usage of those
is not always easy to decide, while all chemical mentions in
the corpus generated by Corbett are combined in one entity
(see Section 5.2 for more details). Another reason is the
different experience level of our annotators. One annotator
participated in the development of the annotation rules. The
corpus was annotated partly by this person more than once
during this process. The second person annotated the whole
set based on the annotation guideline without an interme-
diate revision. Therefore, we propose a two step process
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Chemical Class Description Example Annotation
IUPAC IUPAC names, IUPAC-like names, systematic, and semi-systematic names 1-hexoxy-4-methyl-hexane
PART partial IUPAC class names 17beta-
TRIVIAL trivial names aspirin, estragon
ABB abbreviations and acronyms TPA
SUM sum formula, atoms, and molecules, SMILES, InChI KOH
FAMILY chemical family names disaccaride
Table 4: Chemical entity classes used for the corpora annotation
Name Labeled Sequence Label Explanation
Acetylsalicylate Acetylsalicylate TRIVIAL
elaidic acid elaidic acid IUPAC multi word systematic and semi
systematic names are labeled as IUPAC
testosterone testosterone TRIVIAL
3H-testosterone 3H-testosterone IUPAC contains part IUPAC-like structure (3H-);
17-alpha-E 17-alpha-E IUPAC E = chemical abbreviation
17beta-HSD — — HSD = protein name
N-substituted-pyridino[2,3-f] N-substituted-pyridino[2,3-f]
indole-4,9-dione indole-4,9-dion IUPAC
2-acetyloxybenzoic acid 2-acetyloxybenzoic acid IUPAC
Ethyl O-acetylsalicylate Ethyl O-acetylsalicylate IUPAC
pyrimidine pyrimidine FAMILY
1,4-dihydronaphthoquinones 1,4-dihydronaphthoquinones IUPAC
Ca(2+) Ca(2+) SUM
(14)C (14)C SUM
Table 5: Annotation examples
for further annotations. In a first step an inter-annotator
agreement should be build only on a small set of annotated
abstracts and discrepancies could be reviewed with all an-
notators. Then the larger set of abstracts could be annotated
with higher confidence.
5. Recognition of Chemical Names
5.1. Dictionary-based Recognition of Chemical
Compounds
Dictionaries built from the different terminological re-
sources were used to recognize chemical entities in the EVAL
corpus. Following constraints were used for all searches:
• No curation of the created raw dictionaries was done,
which means that no names were removed, added or
changed.
• All synonyms were searched with a simple case insen-
sitive string search, dashes were ignored.
• No control of the correct association of the found
names to the corresponding entry was performed.
The results with uncurated dictionaries and such a simple
search strategy should only give a rough estimate of the
coverage of different sources and the efforts which have to
be invested in curation and search strategies.
The search results obtained with every individual dictio-
nary and a combination of the results of all dictionaries are
provided in Table 6. The first two rows show precision and
recall on a combination of all annotation classes. The rates in
brackets were obtained when also partial matches were con-
sidered as true positives. The highest precision rates were
achieved by the KEGG Drug dictionary (59 %) followed
by the MeSH C dictionary (44 %). The lowest precision
of 13 % and 15 % was obtained by ChEBI and PubChem
respectively. Many unspecific terms are contained in ChEBI
(e.g. groups or inhibitors), and also terms that have not been
annotated as a chemical family term (e.g. enzyme inhibitors
or adrenergic agonist). Such terms were considered to be
pharmaceutical property terms. Additionally, many other
names are unspecific, like one-character tokens (e.g. D,
J) and common word names (e.g. at, all). Therefore, we
conclude that curation processes are necessary to achieve
a higher performance with the dictionaries. Experiences
with the gene and protein name recognition (Hirschmann et
al., 2007) let us assume that the precision could be highly
enhanced through dictionary curation and more elaborate
named entity recognition techniques.
The recall of the dictionary based named entity recognition
is low. The highest recall was obtained with the PubChem
dictionary identifying 33 % of all entries, followed by the
ChEBI and the MeSH T dictionary (both 27 %). The con-
flation of all search results enhances the recall to 49 %, but
decreases the precision to 13 %. The participation of the dif-
ferent dictionaries on the combined result has to be checked
further for recall and precision.
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Class PubChem ChEBI MeSH C MeSH T HMDB KEGG C KEGG D DrugBank Combined
ALL 0.15 (0.26) 0.13 (0.34) 0.44 (0.64) 0.34 (0.42) 0.21 (0.44) 0.30 (0.54) 0.59 (0.76) 0.33 (0.43) 0.13 (0.22)
(1206) 0.33 (0.60) 0.27 (0.68) 0.10 (0.15) 0.27 (0.34) 0.16 (0.33) 0.24 (0.43) 0.12 (0.16) 0.13 (0.17) 0.49 (0.85)
IUPAC 0.16 (0.69) 0.08 (0.85) 0.09 (0.21) 0.05 (0.29) 0.06 (0.44) 0.07 (0.51) 0.03 (0.17) 0.01 (0.17) 0.23 (0.94)
(391)
PART 0.04 (0.32) 0.13 (0.72) 0.00 (0.05) 0.00 (0.01) 0.04 (0.32) 0.05 (0.24) 0.00 (0.00) 0.00 (0.00) 0.13 (0.75)
(92)
SUM 0.31 (0.73) 0.31 (0.88) 0.04 (0.08) 0.00 (0.00) 0.00 (0.30) 0.12 (0.46) 0.00 (0.00) 0.00 (0.00) 0.31 (0.88)
(49)
TRIV 0.66 (0.82) 0.52 (0.78) 0.18 (0.19) 0.64 (0.65) 0.36 (0.42) 0.57 (0.64) 0.35 (0.36) 0.40 (0.41) 0.88 (0.97)
(414)
ABB 0.49 (0.72) 0.23 (0.55) 0.09 (0.11) 0.2 (0.23) 0.15 (0.34) 0.15 (0.32) 0.03 (0.03) 0.03 (0.03) 0.58 (0.83)
(161)
FAM 0.18 (0.5) 0.42 (0.69) 0.05 (0.09) 0.42 (0.42) 0.08 (0.13) 0.19 (0.35) 0.17 (0.03) 0.00 (0.03) 0.71 (0.89)
(99)
Table 6: Comparison of the entities found in the evaluation corpus with dictionaries based on the analyzed resources. All
annotation classes are considered. (The total number of the annotated entities per class are given in brackets.)
Precision (slanted) and recall are given for an exact match of an entity and a match where the identification of a
subset of the term is sufficient (values behind the recall values in brackets).
The analysis of the recall for every single annotation class
confirms our hypothesis that names belonging to the TRIV-
IAL class could be found with the highest recall. The search
with the PubChem dictionary identified 66 %, followed by
MeSH T with 64 % and KEGG C with 57 %. The com-
bination of the results lead to a promising recall of 88 %.
Considering the recognition of family names by the ChEBI
and the MeSH T dictionary obtained the highest value (both
42 %). This is not very remarkable, because only those
two resources contain general chemical group and family
terms in their hierarchy. Sum formulas (mainly annotated
as shown in Table 4.1) were only recognized to a certain
degree by ChEBI, PubChem (both 31 %), and KEGG C dic-
tionary (12 %). The recognition rate of the ABB class has to
be taken with caution because abbreviations are often short
names, sometimes only one character long and therefore
highly ambiguous.
As we previously assumed, IUPAC names have been rec-
ognized with a low recall by all tested dictionaries. The
partial match rate is high, especially for the PubChem and
ChEBI dictionary. Some partial matches, e.g. ’testosterone’
in ’3H-testosterone’, could be accepted, but many terms,
e.g. diethyl or benzoyl being part of ’diethyl N-[2-fluoro-4-
(prop-2-ynylamino)benzoyl]-L-glutamate’, increase the rate
of false positive partial matches. Therefore, strategies need
to be integrated for an efficient recognition system to avoid
such problems.
In summary we can conclude from this experiment that the
recall of a simple search strategy that uses the individual un-
cured dictionaries is low. The combination of all dictionaries
leads to an acceptable rate for TRIVIAL and FAMILY names
but not for IUPAC and PART names. For the recognition of
the latter two a machine learning approach might be advan-
tageous compared to a dictionary approach. Thus a machine
learning based strategy for the IUPAC name recognition is
Precision Recall
IUPAC tagger on test corpus
sampled from MEDLINE
(IUPAC + PART entities)
86.50 84.80
IUPAC tagger on EVAL corpus
(all entities)
91.41 29.04
IUPAC tagger on EVAL corpus
(IUPAC + PART entities)
81.38 73.18
IUPAC tagger on EVAL corpus
(IUPAC entities)
— 77.11
IUPAC tagger on EVAL corpus
(PART entities)
— 41.18
IUPAC tagger on EVAL corpus
(TRIVIAL entities)
— 8.42
OSCAR on EVAL corpus with
all entities
52.09 71.86
Table 7: Results of the machine learning-based tagger and
of the system OSCAR for IUPAC entities and all
entities on the EVAL corpus and on the test corpus
sampled from MEDLINE (in %).
described in the next section.
5.2. CRF-based IUPAC Name Recognition
To improve the recognition of IUPAC names, the training
corpus described in Section 4.3 was used to train a Condi-
tional Random Field. Due to the morphological similarity of
IUPAC and PART entities they have been combined leading
to a system that does not separate these two classes. The
parameter optimization (e.g. feature selection) is described
in detail in Klinger et al. (2008).
An evaluation on the sampled test corpus of 1000 abstracts
from MEDLINE shows an F1 measure of 85.6 % with a pre-
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cision of 86.5 % and a recall of 84.8 %. Applying this tagger
on the EVAL corpus with several entity classes described in
Section 4.2, it recognizes 73.18 % of the IUPAC and IUPAC-
like names with a precision of 81.38 % (considering only
IUPAC and PART names as true positive hits). The recall on
the separated classes IUPAC and PART (namely 77.11 % and
41.18 %) on the EVAL corpus motivates the combination of
these classes for machine learning purposes.
The precision of 91.41 % on all entities is much higher than
only on the IUPAC entities due to the recognition of 8.42 %
of the TRIVIAL class names. They are frequently used
within IUPAC terms and cannot be easily separated by the
system. A separation from the other classes ABB, SUM, and
FAMILY is perfectly given.
It needs to be analyzed if trivial names could be recognized
with a machine learning based method with similar perfor-
mance to enhance the recall of the system which is now at
29 % considering all chemical classes. Here, an additional
annotation of the training set is necessary.
To compare the OSCAR software, this approach was also
used for the recognition of all entities in the EVAL corpus.
OSCAR has an overall high recall of almost 72 % accom-
panied with a precision of 52 %. The recall is similar to
the reports in (Corbett et al., 2007) (73.5 % recall, 75.3 %
precision) but the precision is lower. We did not analyze the
results in detail but certainly one reason for the lower pre-
cision can be found in the different annotation of chemical
entities underlying the training corpus used in OSCAR. One
difference is for example the annotation of more general
annotation of chemical names (e.g. dry ice).
6. Conclusion
To a certain amount, trivial names and family names but
not IUPAC like names are covered by the different chemical
resources analyzed in this paper. PubChem, as the largest
resource, does not include all names covered by the smaller
sources. Hence, the combination of the search results from
all terminologies lead to a high increase in recall, especially
for family and trivial names. The development of a training
corpus for IUPAC like entities lead to a performant CRF-
based IUPAC tagger.
These results are motivating for further investigations in the
generation of dictionaries as well as testing different anno-
tation classes to be used for training and the combination
of machine learning based chemical name recognition and
dictionary based normalization of chemical names.
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Abstract  
Human anatomy knowledge is an integral part of radiological information, which is necessary for image annotation in a semantic 
cross-modal image and information retrieval scenario. Anatomy and radiology related concepts and relations can be discovered from 
an anatomy corpus, which can be build up from Wikipedia as reported here. An ontology of human anatomy and a controlled 
vocabulary for radiology are used as knowledge resources in the search of significant concepts and relations. Our ultimate goal is to use 
the concepts and the relationships discovered in this way to identify potential query patterns. These query patterns are the abstractions 
of the actual queries that radiologists and clinicians would typically pose to a semantic search engine to find patient-specific sets of 
relevant images and textual data. 
 
Introduction 
This paper describes ongoing work towards the 
development and use of a human anatomy data set based 
on Wikipedia and domain semantic resources in human 
anatomy and radiology. In particular, we are using the 
Foundational Model of Anatomy1 or ‘FMA’ (Rosse and 
Mejino, 2003) and the Radiology Lexicon2 or ‘RadLex’ 
(Langlotz, 2006) for this purpose.  
Ultimately we aim at using the data set that we are 
constructing for the derivation of query patterns that 
would typically be used by clinicians and radiologists to 
find patient-specific sets of relevant images, i.e. images 
that show similar conditions and/or symptoms. The 
context of our work is in the Theseus-MEDICO3 project, 
which has a focus on cross-modal image and information 
retrieval in the medical domain.  
The focus of the work reported here is on setting up a 
Wikipedia-based corpus of human anatomy texts and the 
statistical profiling of FMA (human anatomy) and 
RadLex (radiology) terms on the basis of this resource. 
Using this information we will then be able to extract 
relations that are likely to occur between statistically 
relevant terms - and the concepts they express. The final 
goal of our work will be to derive potential query patterns 
from the extracted set of relations that can be used in the 
MEDICO semantic-based image retrieval application. 
The remainder of this paper is organized as follows. The 
                                                          
1
 http://sig.biostr.washington.edu/projects/fm/ 
2
 http://www.rsna.org/radlex/ 
3
 http://theseus-programm.de/scenarios/en/medico 
first section outlines the context of our work in the 
MEDICO project. In section 2 we compare some related 
work, while in the third section we describe the two 
domain specific semantic resources used, i.e. the FMA 
and RadLex. Here we also describe the human anatomy 
corpus that we derived from Wikipedia and the steps 
taken to construct it. Section 4 provides details on the 
statistical profiling of the FMA and RadLex terms on 
basis of the corpus, including the correspondence of terms 
from both resources. The final section includes the 
conclusions and our plans for future work. 
1. MEDICO 
MEDICO - Towards Scalable Semantic Image 
Semantics - is an application scenario of the THESEUS 
Program funded by the German Federal Ministry of 
Economics and Technology. MEDICO addresses the need 
for advanced image searching technologies enabling the 
direct access to and seamless integration of image 
semantics. Through the rapid advances in imaging 
technologies, more and more medical image data is 
generated by hospitals, pharmaceutical companies, and 
medical research.  
There exist a wide range of different imaging 
technologies and modalities, such as 4D 64-slice 
Computer Tomography (CT), whole-body Magnet 
Resonance Imaging (MRI), 4D Ultrasound, and the fusion 
of Positron Emission Tomography and CT (PET/CT) 
providing detailed insight into human anatomy, function, 
and disease associations. Moreover, advanced techniques 
for analyzing imaging data generating additional 
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quantitative parameters pave the way for improved 
clinical practice and diagnose. However, for advanced 
applications in Clinical Decision Support and Computer 
Aided Diagnoses the comparative exploration of similar 
patient information is required. The missing link here fore 
is a flexible and generic image understanding. Currently, 
the large amounts of heterogeneous image data are stored 
in distributed and autonomous image databases being 
indexed by keywords without capturing any semantics.  
The objective of MEDICO is to build the next generation 
of intelligent, scalable and robust search engine for the 
medical imaging domain. By integrating higher level 
knowledge represented by ontologies, the different 
semantic views of the same medical images, such as 
structural aspects, functional aspects, and disease aspects, 
can be reflected and integrated. Combining semantics 
with image understanding facilitates the formal 
description of bridges between different domains that can 
be used for comparative patient data exploration. The 
overall goal of MEDICO is to empower the imaging 
content-stakeholders, i.e. clinicians, pharmaceutical 
specialists, patient citizens, and policy makers, by 
providing flexible and scalable semantic access to 
medical image databases. 
For a beneficial integration of external semantics within 
advanced image search, one has to decide which external 
knowledge resources are appropriate for the purpose in 
mind, i.e. which external knowledge source captures the 
relevant knowledge in an appropriate level of detail for a 
particular context. Within the MEDICO project, one of 
the selected use case scenarios aims for improved image 
search in the context of patients suffering of lymphoma in 
the neck area. Lymphoma, a type of cancer originating in 
lymphocytes, is a systematic disease with manifestations 
in multiple organs.  
As imaging is done several times through the course of 
disease and different imaging modalities are used, 
scalable and flexible image search for lymphoma is of 
particular relevance: scalable image search functionalities 
can be easily extended to other body regions and 
flexibility achieved by incorporating semantics allows to 
use all the heterogeneous patient information, such as 
imaging features, symptoms, or lab results, for diagnosis 
and prediction of disease development. 
To enable improved image search and advanced medical 
applications, it is relevant to find out what kind of 
knowledge the clinician, e.g. a lymphoma expert, wants to 
know or the queries that clinicians are interested in. 
Existing methodologies for knowledge engineering, such 
as (Schreiber et al., 2000) and (Sure et al., 2002), 
following systematic interview-based approaches for the 
analysis of knowledge requirements were not suitable for 
our task in mind. As clinicians speak (and think) a very 
different language than computer scientists and as they 
are always in lack of time, the analysis of knowledge 
requirements by interviews were not feasible.  
Moreover, as we are aiming to develop next generation 
image search facilities, there was the danger that our 
addressed users are too constrained in their imagination 
by familiar, existing systems. For example, it is not 
possible for the current pattern recognition algorithms to 
produce image annotations that express the Lymph node 
as located_in the Neck that has_dimension X. In real life 
however, clinicians and radiologists look for information 
and images that report “an enlargement in the dimension 
of the lymph node in the neck”, which is an essential 
radiological pattern to re-stage a certain type of 
lymphoma in the head and neck region. Therefore, within 
our approach, we first establish, semi-automatically, 
hypotheses about possible user queries that are the so 
called query patterns. These patterns are derived from a 
combination of certain constraints and joint view of 
anatomy and radiology. More concretely, the joint view 
corresponds to the anatomical structures found on 
radiology images e.g. the CT scan of the neck region. The 
constraints are e.g. the spatial relations such as located_in 
that constrain the model by asserting that certain 
anatomical structures are (only) expected to be in certain 
other ones. For example, only a certain kind of lymph 
node will be found in the neck region. Accordingly, an 
example query pattern might look like this: 
 
[ANATOMICAL 
STRUCTURE] located_in 
[ANATOMICAL 
STRUCTURE] 
 
AND 
 
[ANATOMICAL 
STRUCTURE] has_dimension [DIMENSION] 
 
Once an initial set of similar patterns has been 
established in this way, they will be evaluated by 
clinicians for their validity and relevance. 
2. Related work 
As far as we know the data set that we are developing 
will be the first one based on a text corpus specifically on 
human anatomy, in particular from the viewpoint of 
radiology. Anatomy data sets that do exist are 
image-centered and consist of collections of radiology 
images without associated textual data, such as the 
Visible Human Project data set4. A future outcome of our 
research could in fact be the compilation of a multimedia 
data set consisting of the text-based data set introduced 
here in combination with radiology images of associated 
anatomic features - current work in the context of 
MEDICO on semantic annotation of anatomy images is 
described in (submitted). 
Biomedical data sets5 that are somewhat related to the 
one we are describing here include ‘i2b2’ on clinical data6 
next to the GENIA7, BioText8 and PASbio9 corpora, all 
three of which have been designed for the extraction of 
terms/concepts and relations between them - see e.g. 
(Ciaramita et al., 2008) on relation extraction from the 
GENIA corpus. Importantly all of the corpora mentioned 
include manual annotation of term/concept/relation 
information, which is foreseen also in our work but is not 
yet discussed here.  
Finally, more general work with Wikipedia as a data 
source is reported for instance in (Ruiz-Casado et al., 
2006), (Strube and Ponzetto, 2006), (Völkel et al. 2006), 
all of which are more concerned with the extraction of 
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 http://www.nlm.nih.gov/research/visible/ 
5http://biocreative.sourceforge.net/bio_corpora_links.htm 
6
 https://www.i2b2.org/NLP/ 
7
 http://www-tsujii.is.s.u-tokyo.ac.jp/GENIA 
8
 http://biotext.berkeley.edu/data/dis_treat_data.html 
9
 http://research.nii.ac.jp/~collier/projects/PASBio/ 
60
relation instances rather than relation types as is the topic 
or our work reported here. 
3. Data Sources 
In this section we describe the different data sources we 
used in setting up the human anatomy data set: the FMA 
ontology, the RadLex terminological resource and the 
Wikipedia pages on human anatomy. As the FMA was 
developed to fulfill the requirements of a formal ontology, 
whereas RadLex only a uniformed terminology, we will 
henceforth refer to the entities of the FMA ontology as 
concepts and to those of the RadLex as terms 
3.1 Foundational Model of Anatomy (FMA) 
As MEDICO targets semantic medical image retrieval, 
we use anatomical information to inform the system of 
concepts and spatial or partonomical relationships that are 
otherwise not obtained by the image parsing algorithms. 
The Foundational Model of Anatomy (FMA) that we use 
for this purpose is developed and maintained by the 
School of Medicine of the University of Washington and 
the US National Library of Medicine (Rosse and Mejino, 
2003). Besides the specification of anatomy taxonomy, 
i.e. an inheritance hierarchy of anatomical entities, the 
FMA provides definitions for conceptual attributes, 
part-whole, location, and other spatial associations of 
anatomical entities. By additionally allowing for 
attributing relations (i.e. relations can be described in 
more detail by attaching additional attributes) FMA is 
particularly rich with respect to the specification of 
relations and, thus, can cope with the requirements for the 
precise and comprehensive capturing of the structure of 
the body.  
FMA covers approximately 70,000 distinct anatomical 
concepts and more than 1.5 million relations instances 
from 170 relation types. The FMA is freely available as a 
Protégé 3.0 project or can be accessed via the 
Foundational Model Explorer 10 . There also exist 
conversions of the frame-based Protégé version of FMA 
to the OWL DL format (Goldbreich, Zhang, and 
Bodenreider, 2006), which version we use in the 
MEDICO project. 
From the linguistic perspective the FMA ontology is 
complex in that the terms form cascaded structures. Often 
one term occurs within another such as in  
 
Abdominal aorta 
Abdominal aortic lumen 
Abdominal aortic plexus 
Abdominal aortic nerve plexus 
… 
 
Tunica media of abdominal aorta 
Tunica intima of abdominal aorta 
Lumen of abdominal aorta 
… 
 
A common structure is the following: 
 
modifier [ANATOMICAL STRUCTURE] 
 
                                                          
10
 http://fme.biostr.washington.edu:8089/FME/ 
where the modifier is one of the following: 
 
modifier = {left, right, upper, lower, inferior, superior, 
lateral, anterior anterolateral, antero-inferior, 
anteromedial, anterovential, posterior, ascending, 
descending, atrial, lower, upper}  
 
as in  
 
Left neck of mandible 
Right neck of mandible 
Anterior part of neck 
Inferior part of back of neck 
Lower lip skin 
Upper trunk 
Inferior ventricular vein 
Superior vesical artery 
Lateral aortic lymph node 
Anterior body wall 
Anterolateral central artery 
Antero-inferior surface of body of pancreas 
Anteromedial bronchial wall  
Anteroventral nucleus  
Posterior auricular vein  
Ascending aorta  
Descending aorta 
Atrial cavity 
Lower limb 
Upper limb 
 
Additionally, these modifiers share a common semantic 
characteristic in that they refer to anatomical locations. In 
this respect, the FMA is rich in morphological 
information that can be exploited to discover further 
domain relevant information such as the spatial 
information in anatomical locations.  
Another example of linguistic richness (and source for 
ambiguity) is the use of prepositions such as of. In FMA 
terms, of is often used in the sense of part_of indicating a 
meronymy relationship as in wall of pharynx. However, 
this meronymy relationship cannot be assumed for each 
occurrence of of, as it can also occur in the sense of matter 
of or tree of. This complexity of FMA terms makes it hard 
to define regular patterns as exceptions occur quite often.  
To address multilinguality, the FMA provides synonym 
information for almost every concept in languages as 
French, Italian, German, Spanish etc. However, also here 
ambiguities are present with respect to translations. For 
example, the German term Öffnung (opening in English) 
is listed as a synonym for the English term mouth. 
However, the term Mund, which is the actual German 
equivalent of mouth is not included.  
Nevertheless, FMA is a valuable, and the most 
comprehensive machine-readable anatomical resource for 
medical information management and retrieval in the 
anatomy domain. Moreover, its complex terminological 
structure makes FMA a rich information source for 
linguistic analysis on our way to discover anatomy 
relevant relations and eventually to query patterns. 
3.2 Radiology Lexicon (RadLex) 
A major objective of the MEDICO project is to explore 
techniques for enhancing cross-modal medical image 
retrieval through automatic semantic annotation of 
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domain-specific terms and relations. For this purpose, the 
publicly available Radiology Lexicon, or RadLex, is used. 
RadLex is a controlled vocabulary developed and 
maintained by the Radiological Society of North America 
(RSNA) for the purpose of uniform indexing and retrieval 
of radiology information, including images.  
RadLex contains over 8,000 anatomic and pathologic 
terms, also those about imaging techniques, difficulties 
and diagnostic image qualities. It is available in a 
frame-based Protégé version. 
As RadLex is thought of as a unified lexicon for 
capturing radiology information, it contains not only 
domain knowledge but also lexical information such as 
synonymy. Hence, entries such as RadLex term, RadLex 
synonym and RadLex attribute are present next to 
domain-specific information such as drug-induced 
disorder. Two different terms can be related to each other 
through various relationships. For example, at the lexical 
level the Synonym of relationship links the Schatzki ring 
and the lower esophageal mucosal ring to each other. 
Additionally, synonymy in natural language expressions 
is considered, so that the two expressions, may be present 
and possibly present, are also related to each other with 
the Synonym of relationship. Thus, using either one of 
these terms, it is possible to make assertions about the 
(un)certainty of an imaging observation. Examples of 
radiology specific relationships are thickness of projected 
image or radiation dose.  
For the purpose of establishing a unified vocabulary, 
references are made to other medical controlled 
vocabularies such as the SNOMED-CT 11  via the 
SNOMED_ID or SNOMED_Term attributes. This way, 
RadLex enables the incorporation of the widely used 
SNOMED vocabulary in our relation extraction activities 
as an additional information resource Furthermore, 
(Marwede et al, 2007) reports on work about relating the 
RadLex terminology to the FMA by means of creating an 
intermediary ontology. 
3.3 Wikipedia Anatomy Corpus 
A central aspect of the query pattern mining task is the 
statistical analysis of the FMA and RadLex terms in 
relevant text collections, in order to assign relevance to a 
more precise set of terms and to investigate the most 
likely expressed (and hence queried) relations between 
them. For this purpose we need access to a representative 
corpus of anatomy texts, which could not be readily 
acquired as such data sets do not exist to our knowledge.  
Instead, we selected the Wikipedia Category:Anatomy12 
as a starting point with 50 direct web pages and 20 
sub-categories with 984 web pages in total. Out of these 
we selected about 900 web pages that are relevant to 
human anatomy. We removed for instance all web pages 
that are concerned with animal anatomy. Given the URLs 
for all selected web pages we were then able to generate 
and download an XML version of these using standard 
tools provided by Wikipedia13. As Wikipedia web pages 
consist of both text and structured data we then further 
analysed them to extract only the purely running text 
sections. In fact, we did not actually extract these sections 
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 http://www.snomed.org/ 
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 http://en.wikipedia.org/wiki/Category:Anatomy 
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 http://en.wikipedia.org/wiki/Special:Export 
but defined an extended XML format by which we were 
able to annotate which parts of the Wikipedia web page 
consists of running text vs. structured data. This step in 
the analysis left us with a corpus of around 500.000 
tokens.  
Finally, we ran all text sections through the TnT 
part-of-speech parser (Brants, 2000) to extract all nouns 
in the corpus and to compute a relevance score 
(chi-square) for each by comparing anatomy frequencies 
with those in the British National Corpus (BNC)14. This 
information in turn allowed us to compute the relevance 
of each sentence in the corpus, which we intend to use as a 
further focus in the relation extraction task. A next step 
will be to parse all sentences and annotate them with 
predicate-structure information, which may be then used 
for relation extraction along the lines of (Schutz and 
Buitelaar, 2005). 
4. Data processing 
In this section we describe the data processing steps in 
using the FMA ontology and RadLex terminological 
resource to identify the most relevant anatomy and 
radiology concepts in the Wikipedia anatomy corpus.  
These two external knowledge resources provide 
valuable and publicly available domain information in a 
very specific and sensitive domain as medicine and 
especially when the clinical expert knowledge is not 
available or not easily accessible. Moreover, as these two 
resources are developed together by domain experts and 
computer scientists, they are reliable, hence suit our 
purposes well.  
Furthermore, extracted terms from each resource are 
compared and aligned to obtain an integrated radiology 
view of human anatomy, on which we intend to focus the 
relation extraction and query pattern mining task. Data 
processing for each resource both for binary mappings 
between the two resources and for those with the 
Wikipedia was done based on exact term matching. 
Currently, no term variations or synonyms have been 
considered but remains as future work. 
4.1 FMA Concepts and Relations  
The concepts and relationships from the FMA ontology 
are used to identify the human anatomy relevant terms 
and relationships from the Wikipedia anatomy corpus.  
As a first step the concepts and the relationships from the 
FMA ontology were extracted yielding a list of 124,769 
entries. However, this list includes very generic terms 
such as Anatomical structure as well as very specific 
terms such as Anastomotic branch of right anterior 
inferior cerebellar artery with right superior cerebellar 
artery. Generic terms were filtered out from the list as 
they will not deliver sufficient information because any 
human body part can be an anatomical structure. 
Similarly, very specific terms are also filtered out as they 
most likely will not occur in the Wikipedia corpus (or in 
any other corpus for that matter). After filtering such 
terms, the resulting list consists of 19,367 terms 
(consisting of one, two or three words) such as: 
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 The BNC (http://www.natcorp.ox.ac.uk/) is a 100 
million word collection of samples of written and spoken 
language from a wide range of sources, designed to 
represent a wide cross-section of current British English. 
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 abdominal lymph node 
femoral head 
jugular lymphatic trunk 
left radial neck 
ligament of neck 
lymph node 
lymph node capsule 
… 
 
The statistically most relevant FMA terms were 
identified on the basis of chi-square scores computed for 
nouns in the anatomy corpus (see section 3.3 above). 
Single word terms in the FMA and occurring in the corpus 
correspond directly to the noun that the term is build up of 
(e.g. the noun ‘ear’ corresponds to the FMA term ear). In 
this case, the statistical relevance of the term is the 
chi-square score of the corresponding noun.  In the case of 
multi-word terms occurring in the corpus, the statistical 
relevance is computed on basis of the chi-square score for 
each constituting noun and/or adjective in the term, 
summed and normalized over the length of the term, e.g. 
the relevance value for lymph node is the summation of 
the chi-square scores for ‘lymph’ and ‘node’ divided by 2. 
In order to take frequency in account, we further 
multiplied the summed relevance value by the frequency 
of the term. This assures that only frequently occurring 
terms are judged as relevant. A selection (top 20) of the 
resulting list of most relevant FMA terms is shown in 
Table 1 below: 
 
FMA Terms Relevance 
Lateral 109407852 
Anterior 76204800 
Muscle 69101264 
Posterior 36516690 
Medial 33953121 
Artery 27914139 
Cortex 21314304 
Dorsal 19520100 
Inferior 16855128 
Superior 14028800 
Deep 9763904 
Central 8763650 
Internal 7883937 
Duct 7659345 
Bone 6976292 
Membrane 6202856 
Embryo 5469423 
Ligament 5372510 
Organ 5119666 
Gland 4480047 
Table 1: Top 20 of statistically most relevant FMA 
terms in the anatomy corpus 
We then further studied the context of selected relevant 
FMA terms, i.e. the sentences in which they occurred in 
the anatomy corpus. For instance, the term cervical lymph 
node occurs in the Wikipedia page on cervical lymph 
nodes15 as follows: …cervical lymph nodes are lymph 
nodes found in the neck. This information is of importance 
as it delivers spatial information on the location of 
cervical lymph nodes (i.e. in the neck), which is not trivial 
for image parsing and pattern recognition algorithms to 
obtain automatically. Such an observation motivates a 
statistical and linguistic analysis of the terms cervical 
lymph nodes, neck and the verb found to determine if their 
coocurrence could be formalized as the located_in 
relation between these two concepts and whether this is a 
common pattern. If so, a corresponding query pattern 
hypothesis can be generated as follows: 
 
cervical lymph 
nodes located_in 
[ HEAD NECK  
   REGION ] 
AND 
[HEAD NECK 
     REGION] has_part neck 
 
After evaluation by the clinical experts, the statistical 
and linguistic analysis can be tuned to obtain the required 
level of granularity. 
4.2 RadLex Concepts and Relations  
Following a similar approach, RadLex was used to 
identify the most relevant radiology terms in the anatomy 
corpus. RadLex includes only the radiology relevant part 
of human anatomy knowledge, therefore the RadLex 
terminology is more lightweight compared to that of the 
FMA. Complex morphological information and cascaded 
structures are seldom.  
An initial list of terms that consisted of 13,156 entries 
was extracted from the RadLex controlled vocabulary by 
parsing the downloadable version from the project web 
site. After manual clean up, such as removing the 
duplicates, the list was reduced to a subset of 12,055 
entries. In contrast to the FMA, the resulting term list 
contains also very specific terms, longer than 3 words. It 
was not necessary to exclude them as there are only few 
and keeping them did not particularly increase the size of 
the term list to cause efficiency problems. 
One-word terms however require an additional step of 
handling abbreviations, which is currently not addressed 
in our work. Since Radlex is designed as a unifying 
resource it contains a wide range of domain specific 
abbreviations from pathology, physiology, radiology etc. 
Abbreviation resolution in the biomedical domain is an 
active research field on its own – see e.g. (Chang et al., 
2002), (Yu et al., 2004), (Schwartz and Hearst, 2003).  
The RadLex vocabulary includes several types of 
relationships, e.g. is a, part of, contained in, continuous 
with. These relationships are included as terms in the list 
as well as radiology specific relationships such as 
“advanced analytic difficulty”. Table 2 shows results for 
the statistical relevance analysis for RadLex terms: 
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 http://en.wikipedia.org/wiki/Cervical_lymph_nodes 
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RadLex Terms Relevance 
Anterior 228614400 
Lateral 109407852 
Posterior 73033380 
First 47752592 
Small 45871353 
Large 34303500 
Medial 33953121 
Tissue 32979809 
Artery 27914139 
Cortex 21314304 
Dorsal 19520100 
Inferior 16855128 
Superior 14028800 
Body 10360776 
Deep 9763904 
Long 9604980 
Brain 8765497 
Central 8763650 
Major 8696892 
Blood 8655100 
Table 2: Top 20 of statistically  most relevant RadLex 
terms in the anatomy corpus 
Studying the corpus context of the RadLex term 
lymphoma showed that it frequently occurs with terms 
such as Hodgkin’s Disease and Non-Hodgkin lymphoma 
as in: … lymphoma (previously called Hodgkin's Disease) 
and Non-Hodgkin lymphoma 16 . These observations, 
again, motivate a further linguistic and statistical analysis 
to see if a structural query pattern can be discovered for 
these terms and relations between them. For example we 
may hypothesize that Hodgkin lymphoma and 
Non-Hodgkin lymphoma are common lymphoma types 
that clinicians would typically search for. 
4.3 Correspondence between RadLex and FMA 
In the process of preparing the human anatomy data set 
with a radiology perspective, it was necessary to identify 
the correspondences between the two vocabularies. As 
both vocabularies are designed for different purposes, 
their range and granularity are also different. 
Consequently, the FMA has a much more detailed view of 
human anatomy, which may result in information 
overload for the purpose of image annotation. The 
RadLex vocabulary on the other hand, does cover 
anatomical information but may not suffice occasionally. 
Nevertheless, it includes image specific information, such 
as image quality, which is not typically found in an 
anatomy ontology. The image quality information can be 
useful for image annotation scenarios, where the 
radiologist wants to filter out all images whose resolution 
fall below a certain threshold. In order to bring out the 
best of both, we started with a comparison of both 
vocabularies at the lexical level.  
Accordingly, the two (subset) term lists, namely those of 
the RadLex and the FMA were compared to each other to 
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 http://en.wikipedia.org/wiki/Ann_Arbor_staging 
identify the intersections. As a result, 1259 perfect 
matches were identified, i.e. they were identical in both 
terminologies. Some examples of these terms are 
abdominal lymph node, adrenal cortex, foramen magnum 
etc.  
The comparison results showed that often one RadLex 
term occurs within an FMA term as in: 
 
RadLex term:  iliac crest 
FMA term:  left iliac crest  
FMA term:  left iliac crest tubercle 
 
The reason for this is twofold. Firstly, as discussed, the 
level of granularity in the FMA is much finer than that of 
RadLex. Hence, there can be multiple terms to describe 
one anatomical structure. Secondly, as mentioned earlier, 
linguistically the FMA terms have a much more complex 
structure. This can be observed also in the following case: 
 
RadLex term:   arcuate nucleus 
FMA Term:  arcuate nucleus-1 
FMA term:   arcuate nucleus-2 
FMA term:   arcuate nucleus-3 
 
This situation has also consequences on the semantic 
level in that the mapping between RadLex and 
corresponding FMA concepts becomes ambiguous. As a 
first step to address these problems, the terms of both 
vocabularies are ranked according to simple string 
similarity – here we build on work described in 
(submitted). More sophisticated, semantic similarity 
measures do exist for the biological domain (Pedersen et 
al, 2007) that can as next be incorporated for the purposes 
of this work. 
An example of such a mapping between RadLex and 
FMA terms is shown in Table 3 below. The numbers in 
the third column show the simple string distance 
according to different characters. 
 
RadLex Term FMA Term String Distance 
anconeus subanconeus 3
 left anconeus 5
 right anconeus 6
 nerve to anconeus 9
 fascia of anconeus 10
Table 3: RadLex term with list of corresponding FMA 
terms according to string distance 
5. Conclusions and Future Work 
We described our ongoing work towards establishing a 
data set for human anatomy, which we intend to use for 
relation extraction and query pattern mining in the context 
of semantic retrieval of radiology images. 
In a next phase we will extend the current data set with 
related scientific abstracts that can be obtained from 
PubMed. Here we intend to exploit our analysis of term 
relevance as discussed in this paper, by selecting 
primarily PubMed articles related to the top most relevant 
terms (FMA/RadLex) that we identified in the Wikipedia 
anatomy corpus.  
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We realize that the most relevant data resource for the 
detection of potentially relevant query patterns may in 
fact be clinical protocols (patient records) rather than 
anatomy textbook articles as found on Wikipedia or even 
scientific abstracts from PubMed. Typically, patient 
records include information about image findings, 
diagnosis, symptoms, disease codes etc. On the downside 
however, they are very difficult to obtain because of data 
protection and confidentiality matters. Consequently, we 
therefore decided to consult open source knowledge 
resources such as Wikipedia and PubMed in the initial 
phase, but we will be able to obtain a relevant set of 
patient records during the course of the project.  
After all of the knowledge sources are in place however, 
we will be able to identify a coherent picture of anatomy 
concepts in the context of radiology images and their 
relations as expressed in biomedical theory (Wikipedia, 
PubMed) and clinical practice (PubMed, patient records). 
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